Processing 00000000.tx.1: Down-regulation of WW Domain-containing Oxidoreductase Induces Tau Phosphorylation in Vitro A POTENTIAL ROLE IN ALZHEIMER'S DISEASE* Chun-I Sze, Meng Su, Subbiah Pugazhenthi, Purevsuren Jambal, Li-Jin Hsu||, John Heath, Lori Schultz, and Nan-Shan Chang** From the Departments of Pathology and Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262 and the Laboratory of Molecular Immunology, Guthrie Research Institute, Sayre, Pennsylvania 18840 Received for publication, February 9, 2004 , and in revised form, April 13, 2004.  

Phrase: "Down-regulation of WW Domain-containing Oxidoreductase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0013081:Down-Regulation [Cell Function,Molecular Function]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "Induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "Tau Phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "in Vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "A POTENTIAL ROLE IN ALZHEIMER'S DISEASE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "* Chun-I Sze,"

Phrase: "Meng Su,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705534:SU [Idea or Concept]

Phrase: "Subbiah Pugazhenthi,"

Phrase: "Purevsuren Jambal,"

Phrase: "Li-Jin Hsu||,"

Phrase: "John Heath,"

Phrase: "Lori Schultz,"

Phrase: "and"

Phrase: "Nan-Shan Chang"

Phrase: "*"

Phrase: "*"

Phrase: "From the Departments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704729:Department [Organization]

Phrase: "of Pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]

Phrase: "and"

Phrase: "Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013227:Medicine, NOS [Pharmacologic Substance]
  1000   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "University of Colorado Health Sciences Center,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   839   C0475309:Health center [Health Care Related Organization,Manufactured Object]
   827   C1512352:Health Sciences [Biomedical Occupation or Discipline]
   799   C0009399:Colorado [Geographic Area]
   799   C0018684:Health [Idea or Concept]
   799   C0036397:Sciences [Occupation or Discipline]
   799   C0041740:University [Manufactured Object,Organization]
   799   C0205099:Center [Spatial Concept]

Phrase: "Denver,"

Phrase: "Colorado 80262"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0009399:Colorado [Geographic Area]

Phrase: "and"

Phrase: "the Laboratory of Molecular Immunology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0022877:Laboratory [Manufactured Object,Organization]
   760   C3244292:laboratory [Functional Concept]

Phrase: "Guthrie Research Institute,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0035172:Research Institute [Organization]
   827   C0021622:institute [Organization]
   827   C0035168:research [Research Activity]
   827   C0242481:Research [Research Activity]
   827   C1272753:Institute [Idea or Concept]

Phrase: "Sayre,"

Phrase: "Pennsylvania 18840"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030853:Pennsylvania [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "February 9,"

Phrase: "2004 ,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "April 13,"

Phrase: "2004."
Processing 00000000.tx.2: ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Numerous enzymes hyperphosphorylate Tau in vivo, leading to the formation of neurofibrillary tangles (NFTs) in the neurons of Alzheimer's disease (AD). 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Numerous enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]

Phrase: "hyperphosphorylate"

Phrase: "Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "leading to the formation of neurofibrillary tangles (NFTs)"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   778   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   748   C0220781:formation [Biologic Function]
   748   C0332152:Leading [Temporal Concept]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]
   748   C1522538:Leading [Functional Concept]
   745 E C3543859:neurofibrillary tangle [Cell Component]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in the neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "of Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD"

Phrase: ")."
Processing 00000000.tx.3: Compared with age-matched normal controls, we demonstrated here that the protein levels of WW domain-containing oxidoreductase WOX1 (also known as WWOX or FOR), its Tyr33-phosphorylated form, and WOX2 were significantly down-regulated in the neurons of AD hippocampi. 

Phrase: "Compared with age-matched normal controls,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   756   C2705716:normal control [Qualitative Concept]
   753   C0001779:Age [Organism Attribute]
   753   C0150103:matched [Research Activity]
   753   C0205307:Normal [Qualitative Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C1707455:Compared [Activity]
   753   C1708943:Matched [Qualitative Concept]
   753   C2347086:% Normal [Quantitative Concept]
   719   C0243148:control [Qualitative Concept]
   719   C1550141:Control [Substance]
   719   C1882979:Control [Conceptual Entity]
   719   C2587213:Control [Functional Concept]
   719   C3274648:Control [Qualitative Concept]

Phrase: "we"

Phrase: "demonstrated"

Phrase: "here"

Phrase: "that"

Phrase: "the protein levels of WW domain-containing oxidoreductase WOX1"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   762   C0162808:Protein Domain [Spatial Concept]
   762   C1514562:Protein Domain [Amino Acid Sequence]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0441889:Levels [Qualitative Concept]
   731   C0428479:Protein level [Laboratory or Test Result]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "(also"

Phrase: "known as WWOX"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205309:Known [Qualitative Concept]
   790   C1421525:WWOX [Gene or Genome]

Phrase: "or FOR"

Phrase: ")"

Phrase: ","

Phrase: "its Tyr33-phosphorylated form,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0348078:Form [Qualitative Concept]
   827   C0376315:Form [Manufactured Object]
   827   C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "WOX2"

Phrase: "were"

Phrase: "significantly"

Phrase: "down-regulated in the neurons of AD hippocampi."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   744   C0027882:Neurons [Cell]
   744   C0851285:Regulated [Governmental or Regulatory Activity]
   744   C0949582:Hippocampus [Fish]
   744   C1029104:Hippocampus [Fish]
   744   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
Processing 00000000.tx.4: Remarkably knock-down of WOX1 expression by small interfering RNA in neuroblastoma SK-N-SH cells spontaneously induced Tau phosphorylation at Thr212/Thr231 and Ser515/Ser516, enhanced phosphorylation of glycogen synthase kinase 3 (GSK-3) and ERK, and enhanced NFT formation. 

Phrase: "Remarkably knock-down of WOX1 expression"

Phrase: "by small interfering RNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0521102:interfering [Qualitative Concept]
   827   C0700321:Small [Quantitative Concept]

Phrase: "in neuroblastoma SK-N-SH cells spontaneously induced Tau phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0031715:Phosphorylation [Molecular Function]
   791   C1158886:Phosphorylation [Molecular Function]

Phrase: "at Thr212/Thr231"

Phrase: "and"

Phrase: "Ser515/Ser516,"

Phrase: "enhanced phosphorylation of glycogen synthase kinase 3 (GSK-3)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "ERK,"

Phrase: "and"

Phrase: "enhanced NFT formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
Processing 00000000.tx.5: Also an increased binding of phospho-GSK-3 with phospho-Tau was observed in these WOX1 knock-down cells. 

Phrase: "Also"

Phrase: "an increased binding of phospho-GSK-3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C1149289:kinase binding [Molecular Function]
   762   C3270761:glycogen binding [Molecular Function]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]

Phrase: "with phospho-Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "was"

Phrase: "observed in these WOX1 knock-down cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   774   C1517676:Knock-in [Research Activity]
   748   C0007634:Cells [Cell]
   748   C1421525:WOX1 [Gene or Genome]
   748   C1441672:Observed [Functional Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.6: In comparison, increased phosphorylation of Tau, GSK-3, and ERK, as well as NFT formation, was observed in the AD hippocampi. 

Phrase: "In comparison,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "increased phosphorylation of Tau,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "GSK-3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "ERK,"

Phrase: "as well as"

Phrase: "NFT formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "was"

Phrase: "observed in the AD hippocampi."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   760   C0949582:Hippocampus [Fish]
   760   C1029104:Hippocampus [Fish]
   760   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
   760   C1441672:Observed [Functional Concept]
Processing 00000000.tx.7: Activation of JNK1 by anisomycin further increased Tau phosphorylation, and SP600125 (a JNK inhibitor) and PD-98059 (an MEK1/2 inhibitor) blocked Tau phosphorylation and NFT formation in these WOX1 knock-down cells. 

Phrase: "Activation of JNK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "by anisomycin further increased Tau phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0031715:Phosphorylation [Molecular Function]
   804   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "SP600125"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0968383:SP600125 [Organic Chemical,Pharmacologic Substance]

Phrase: "("

Phrase: "a JNK inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "PD-98059"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0298346:PD 98059 [Organic Chemical,Pharmacologic Substance]

Phrase: "("

Phrase: "an MEK1/2 inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: ")"

Phrase: "blocked Tau phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "NFT formation in these WOX1 knock-down cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C1522492:Formation [Functional Concept]
Processing 00000000.tx.8: Ectopic or endogenous WOX1 colocalized with Tau, JNK1, and GSK-3 in neurons and cultured cells. 

Phrase: "Ectopic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0574895:Ectopic [Spatial Concept]

Phrase: "or"

Phrase: "endogenous WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1421525:WOX1 [Gene or Genome]

Phrase: "colocalized with Tau,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720655:Tau [Intellectual Product]
   790   C1947974:Tau [Research Activity]

Phrase: "JNK1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367731:JNK1 [Gene or Genome]
  1000   C1705632:JNK1 [Gene or Genome]

Phrase: "and"

Phrase: "GSK-3 in neurons"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   882   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "cultured cells."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.9: 17-Estradiol, a neuronal protective hormone, increased the binding of WOX1 and GSK-3 with Tau. 

Phrase: "17-Estradiol,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "a neuronal protective hormone,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0019932:Hormone [Hormone]
   755 E C0458083:Hormonal [Qualitative Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the binding of WOX1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "GSK-3 with Tau."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   882   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   783   C2362079:TAU 3 [Immunologic Factor]
   753   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.10: Mapping analysis showed that WOX1 bound Tau via its COOH-terminal short-chain alcohol dehydrogenase/reductase domain. 

Phrase: "Mapping analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421525:WOX1 [Gene or Genome]

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "via its COOH-terminal short-chain alcohol dehydrogenase/reductase domain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.11: Together WOX1 binds Tau via its short-chain alcohol dehydrogenase/reductase domain and is likely to play a critical role in regulating Tau hyperphosphorylation and NFT formation in vivo.  

Phrase: "Together WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1421525:WOX1 [Gene or Genome]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "Tau via its short-chain alcohol dehydrogenase/reductase domain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1720655:Tau [Intellectual Product]
   742   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a critical role in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "regulating"

Phrase: "Tau hyperphosphorylation"

Phrase: "and"

Phrase: "NFT formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.12: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Alzheimer's disease (AD)1 is a neurodegenerative disorder characterized by progressive cognitive impairment. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD)1"

Phrase: "is"

Phrase: "a neurodegenerative disorder"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Disorder [Disease or Syndrome]
   861   C0012634:Disorder [Disease or Syndrome]

Phrase: "characterized by progressive cognitive impairment."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0338656:Cognitive impairment [Mental or Behavioral Dysfunction]
   760   C0205329:Progressive [Functional Concept]
   760   C0684336:Impairment [Pathologic Function]
   760   C1516691:Cognitive [Functional Concept]
   760   C1880022:Characterized [Activity]
Processing 00000000.tx.13: AD is associated with cortical neuronal loss with gliosis, synaptic dysfunction, and widespread senile plaques consisting of amyloid and neurofibrillary tangles (NFTs). 

Phrase: "AD"

Phrase: "is"

Phrase: "associated with cortical neuronal loss"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   862   C1833299:Cortical neuronal loss [Finding]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C1850496:Neuronal loss [Finding]
   770 E C0598940:neuron loss [Finding]
   760   C0001613:Cortical [Body Part, Organ, or Organ Component]
   760   C0007776:Cortical [Body Part, Organ, or Organ Component]
   760   C0022655:Cortical [Body Part, Organ, or Organ Component]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C1517945:Loss [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   704 E C0234875:bark [Organism Attribute]
   704 E C2700441:Bark [Plant]

Phrase: "with gliosis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017639:Gliosis [Pathologic Function]

Phrase: "synaptic dysfunction,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "and"

Phrase: "widespread senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   827   C0392079:Senile [Finding]
   793 E C0011389:Plaque [Disease or Syndrome]
   793 E C0332461:Plaque [Finding]
   771 E C0231337:Old age [Finding]
   771 E C1999167:Old age [Population Group]

Phrase: "consisting of amyloid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0011560:Amyloid [Pathologic Function]
   790   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0332529:CONSIST [Qualitative Concept]

Phrase: "and"

Phrase: "neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "(NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: ")."
Processing 00000000.tx.14: Substantial evidence has demonstrated that cortical neurons and glial cells undergo apoptotic cell death in AD (14), and activation of the apoptotic pathways may contribute to the pathogenesis of AD and other neurological diseases (5, 6). 

Phrase: "Substantial evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "has"

Phrase: "demonstrated"

Phrase: "that cortical neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "glial cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0027836:Glial Cells [Cell]
           Glial
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789 E C1087003:Glia [Plant]

Phrase: "undergo"

Phrase: "apoptotic cell death in AD (14"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0162638:apoptotic cell death [Cell Function]
   790   C0007587:Cell Death [Cell Function]
   753   C0007634:Cell [Cell]
   753   C0011065:Death [Organism Function]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "activation of the apoptotic pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   820   C3266896:activation of apoptosis [Cell Function]
   760   C1879547:Activation [Activity]

Phrase: "may"

Phrase: "contribute to the pathogenesis of AD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0543483:pathogenesis [Functional Concept]
   753   C0699748:Pathogenesis [Pathologic Function]
   753   C1880177:Contribute [Activity]

Phrase: "and"

Phrase: "other neurological diseases"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C0027765:neurological disease [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.15: WW domain-containing oxidoreductase WWOX/FOR/WOX1 is a proapoptotic protein (711). 

Phrase: "WW domain-containing oxidoreductase WWOX/"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1421525:WWOX [Gene or Genome]
           WW DOMAIN-CONTAINING OXIDOREDUCTASE

Phrase: "FOR/WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421525:WOX1 [Gene or Genome]

Phrase: "is"

Phrase: "a proapoptotic protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(711"

Phrase: ")."
Processing 00000000.tx.16: The wild type WOX1 (46 kDa) possesses two NH2-terminal WW domains (containing conserved tryptophan residues), a nuclear localization sequence, and a COOH-terminal short-chain alcohol dehydrogenase/reductase (ADH/SDR) domain. 

Phrase: "The wild type WOX1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1421525:WOX1 [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "(46 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "possesses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "two NH2-terminal WW domains"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1861696:WW [Disease or Syndrome]
   771   C1880389:Domain [Functional Concept]
   771   C1883221:Domain [Conceptual Entity]
   771   C3541951:Domain [Intellectual Product]

Phrase: "("

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "conserved tryptophan residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "a nuclear localization sequence,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C0475264:Localisation [Functional Concept]
   827   C0521447:Nuclear [Spatial Concept]
   827   C1519249:Sequence [Functional Concept]
   827   C1744691:localisation [Biologic Function]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "a COOH-terminal short-chain alcohol dehydrogenase/reductase (ADH/SDR) domain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.17: The WW domain sequence is conserved. 

Phrase: "The WW domain sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "is"

Phrase: "conserved."
Processing 00000000.tx.18: A mitochondria-targeting region has been identified in the ADH/SDR domain of WOX1, and a portion of cytosolic WOX1 is present in the mitochondria (7). 

Phrase: "A mitochondria-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "targeting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeting [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "has"

Phrase: "been"

Phrase: "identified in the ADH/SDR domain of WOX1,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   764   C0001942:Alcohol dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0001962:ALCOHOL [Organic Chemical]
   742   C0001975:Alcohol [Organic Chemical,Pharmacologic Substance]
   742   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
           Reductase
   742   C0205396:Identified [Qualitative Concept]
   742   C1421525:WOX1 [Gene or Genome]
   742   C1550043:Identified [Finding]
   742   C1551388:Identified [Functional Concept]
   742   C1880389:Domain [Functional Concept]
   742   C1883221:Domain [Conceptual Entity]
   742   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "a portion of cytosolic WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449719:Portion [Spatial Concept]

Phrase: "is"

Phrase: "present in the mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.19: During apoptosis, mitochondrial WOX1, along with cytochrome c, is released and translocated to the nucleus (7). 

Phrase: "During apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "mitochondrial WOX1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1421525:WOX1 [Gene or Genome]

Phrase: "along with cytochrome c,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
  1000   C1153524:cytochrome c [Molecular Function]
  1000   C1426584:CYTOCHROME C [Gene or Genome]
   861   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1325304:cytochrome [Molecular Function]

Phrase: "is"

Phrase: "released"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0391871:Released [Functional Concept]
  1000   C1283071:Released [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "translocated to the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0007610:Nucleus [Cell Component]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.20: Stress stimuli such as anisomycin and UV light stimulate WOX1 phosphorylation at Tyr33, leading to the binding of WOX1 with p53 and JNK1 (c-Jun NH2-terminal kinase) (10). 

Phrase: "Stress stimuli such as anisomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0234402:Stimuli [Phenomenon or Process]

Phrase: "and"

Phrase: "UV light"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0041625:UV Light [Natural Phenomenon or Process]
           UV
   861   C0023693:Light [Natural Phenomenon or Process]
   861   C1306462:Light [Functional Concept]
   861   C1881376:Light [Qualitative Concept]
   861   C1961129:uV [Quantitative Concept]

Phrase: "stimulate"

Phrase: "WOX1 phosphorylation at Tyr33,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "leading to the binding of WOX1"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   753   C0243122:binding [Functional Concept]
   753   C0332152:Leading [Temporal Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1421525:WOX1 [Gene or Genome]
   753   C1522538:Leading [Functional Concept]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "with p53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:P53 [Gene or Genome]
  1000   C1705526:p53 [Gene or Genome]

Phrase: "and"

Phrase: "JNK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367731:JNK1 [Gene or Genome]
  1000   C1705632:JNK1 [Gene or Genome]

Phrase: "(c-Jun NH2-terminal kinase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   937   C0248813:jun-NH2-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   911   C0872123:c JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0872053:JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C1334482:Jun kinase [Gene or Genome]
   875   C1367019:Jun Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   708   C1707271:C-Terminal [Amino Acid Sequence]

Phrase: ")"

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.21: Overexpressed WOX1 induces apoptosis synergistically with p53 (7). 

Phrase: "Overexpressed WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1421525:WOX1 [Gene or Genome]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis synergistically with p53"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162638:Apoptosis [Cell Function]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.22: p53 apoptosis is abolished by antisense WOX1 (7) or by a dominant negative WOX1 (10), indicating a functional cooperation between p53 and WOX1. 

Phrase: "p53 apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "is"

Phrase: "abolished by antisense WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1421525:WOX1 [Gene or Genome]

Phrase: "(7"

Phrase: ")"

Phrase: "or by a dominant negative WOX1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   753   C0205160:Negative [Qualitative Concept]
   753   C1421525:WOX1 [Gene or Genome]
   753   C1513916:Negative [Finding]
   753   C1527180:Dominant [Functional Concept]
   753   C2825415:Negative [Conceptual Entity]
   753   C2825491:Negative [Qualitative Concept]

Phrase: "(10"

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "a functional cooperation between p53"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392337:cooperation [Social Behavior]

Phrase: "and"

Phrase: "WOX1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421525:WOX1 [Gene or Genome]
Processing 00000000.tx.23: Human WWOX gene, encoding the WWOX/FOR/WOX1 family proteins, has been mapped to a fragile site on chromosome 16q23.2 (for reviews, see Refs. 8, 9, and 11). 

Phrase: "Human WWOX gene,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0314604:Human gene [Gene or Genome]
   901   C1421525:WWOX gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the WWOX/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421525:WWOX [Gene or Genome]

Phrase: "FOR/WOX1 family proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "mapped to a fragile site"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0677504:Fragile Site [Nucleotide Sequence]
   760   C0205145:Site [Spatial Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]
   726   C0024779:Map [Manufactured Object]
   726   C1706473:Map [Conceptual Entity]

Phrase: "on chromosome 16q23.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0008662:Chromosome 2 [Cell Component]
   827   C0008633:Chromosome [Cell Component]

Phrase: "("

Phrase: "for reviews,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0282443:reviews [Intellectual Product]
   966 E C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Refs. 8,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: "9,"

Phrase: "and"

Phrase: "11"

Phrase: ")."
Processing 00000000.tx.24: Approximately 50% of loss of heterozygosity of this gene is found in breast, prostate, lung, and esophageal squamous carcinomas. 

Phrase: "Approximately 50% of loss of heterozygosity of this gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   781   C0524869:Loss of Heterozygosity [Genetic Function]
           Heterozygosity Loss
   742   C0017337:Gene [Gene or Genome]
   742   C0019425:Heterozygosity [Organism Attribute]
   742   C0332232:Approximately [Qualitative Concept]
   742   C1517945:Loss [Quantitative Concept]

Phrase: "is"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "in breast, prostate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033572:Prostate [Body Part, Organ, or Organ Component]
   827   C1278980:Prostate [Body Part, Organ, or Organ Component]

Phrase: "lung,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0024109:Lung [Body Part, Organ, or Organ Component]
  1000   C0819757:LUNG [Tissue]
  1000   C1278908:Lung [Body Part, Organ, or Organ Component]
   944 E C2707265:Pulmonary [Clinical Attribute]
   944 E C2709248:Pulmonary [Qualitative Concept]
   907 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "and"

Phrase: "esophageal squamous carcinomas."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0007137:Squamous Carcinomas [Neoplastic Process]
   896   C0152018:Esophageal carcinoma [Neoplastic Process]
   827   C0007097:Carcinomas [Neoplastic Process]
   827   C1182670:Squamous [Qualitative Concept]
Processing 00000000.tx.25: Additionally at least eight aberrant mRNA transcripts have been found in cancer cells (11). 

Phrase: "Additionally at least eight aberrant mRNA transcripts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0205454:Eight [Quantitative Concept]
   748   C0443127:Aberrant [Qualitative Concept]
   748   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "have"

Phrase: "been"

Phrase: "found in cancer cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   833   C0334227:cancer cells [Cell]
   770   C0006826:Cancer [Neoplastic Process]
   770   C0007634:Cells [Cell]
   770   C0150312:Found [Quantitative Concept]
   770   C0998265:Cancer [Eukaryote]
   770   C1306459:Cancer [Finding]
   770   C3282337:Cells [Cell]
   737 E C0243095:Find [Finding]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.26: WOX1 is considered to be a candidate tumor suppressor (1114). 

Phrase: "WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421525:WOX1 [Gene or Genome]

Phrase: "is"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a candidate tumor suppressor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0079427:Tumor Suppressor [Gene or Genome]
   901   C1325410:tumor suppressor [Cell Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1578706:Tumor [Intellectual Product]
   827   C1710252:Suppressor [Manufactured Object]
   827   C2954564:Suppressor [Pharmacologic Substance]
   827   C3273930:Tumor [Finding]

Phrase: "(1114"

Phrase: ")."
Processing 00000000.tx.27: Nonetheless the protein level of WOX1 is significantly increased in several cancers, raising the question whether WOX1 can act as a tumor suppressor (15). 

Phrase: "Nonetheless"

Phrase: "the protein level of WOX1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0428479:Protein level [Laboratory or Test Result]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "significantly"

Phrase: "increased in several cancers,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0006826:Cancer [Neoplastic Process]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C0998265:Cancer [Eukaryote]
   770   C1306459:Cancer [Finding]

Phrase: "raising"

Phrase: "the question"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "whether"

Phrase: "WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421525:WOX1 [Gene or Genome]

Phrase: "can"

Phrase: "act as a tumor suppressor"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0079427:Tumor Suppressor [Gene or Genome]
   806   C1325410:tumor suppressor [Cell Function]
   760   C0027651:Tumor [Neoplastic Process]
   760   C0079613:ACT [Therapeutic or Preventive Procedure]
   760   C1578706:Tumor [Intellectual Product]
   760   C1710252:Suppressor [Manufactured Object]
   760   C2954564:Suppressor [Pharmacologic Substance]
   760   C3273930:Tumor [Finding]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.28: The role of WOX1 in regulating the development and function of neural cells is largely unknown. 

Phrase: "The role of WOX1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in"

Phrase: "regulating"

Phrase: "the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "and"

Phrase: "function of neural cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0007613:cells function [Cell Function]
   819   C0700630:neural function [Physiologic Function]
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: "largely unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.29: Our recent study demonstrated that WOX1 is likely to play a role in the developing nervous system (16). 

Phrase: "Our recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "demonstrated"

Phrase: "that WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421525:WOX1 [Gene or Genome]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in the developing nervous system"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.30: WOX1 is differentially expressed during various stages of brain development in mice. 

Phrase: "WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421525:WOX1 [Gene or Genome]

Phrase: "is"

Phrase: "differentially"

Phrase: "expressed during various stages of brain development"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   778   C1160340:brain development [Organ or Tissue Function]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0243107:development [Physiologic Function]
   748   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   748   C0678723:Development [Organism Function]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1306673:Stages [Qualitative Concept]
   748   C1527148:Development [Functional Concept]
   738   C0870411:Developmental stages [Temporal Concept]
   714 E C0205390:Stage [Temporal Concept]
   714 E C1300072:Stage [Clinical Attribute]

Phrase: "in mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.31: Most interestingly, high levels of WOX1 expression are observed in the neural crest-derived structures such as cranial and spinal ganglia, skin pigment cells, and mesenchyme in the head, indicating a potential role of WOX1 in promoting neuronal differentiation and maturation. 

Phrase: "Most interestingly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205393:Most [Quantitative Concept]

Phrase: "high levels of WOX1 expression"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   781   C3244092:expression level [Idea or Concept]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "observed in the neural crest-derived structures"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0027789:Neural Crest [Embryonic Structure]
   748   C0332243:crest [Functional Concept]
   748   C0599851:Neural [Functional Concept]
   748   C0678594:structures [Spatial Concept]
   748   C1441547:Derived [Qualitative Concept]
   748   C1441672:Observed [Functional Concept]
   748   C1947915:Crest [Spatial Concept]
   748   C2948667:Crest [Pharmacologic Substance]
   748   C3245521:derived [Idea or Concept]
   746   C0027740:nerve structures [Tissue]

Phrase: "such as cranial"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0037303:Cranial [Body Part, Organ, or Organ Component]
  1000   C3163632:Cranial [Spatial Concept]
   928 E C1279062:Cranium [Body Part, Organ, or Organ Component]
   928 E C1690093:Crania [Eukaryote]

Phrase: "and"

Phrase: "spinal ganglia,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0017070:Ganglia, Spinal [Body Part, Organ, or Organ Component]
  1000   C1182736:Spinal ganglia [Body Part, Organ, or Organ Component]
   966 E C1761610:Spinal ganglion [Body Part, Organ, or Organ Component]
   861   C0017067:Ganglia [Body Part, Organ, or Organ Component]
   861   C0521329:Spinal [Spatial Concept]
   827 E C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]

Phrase: "skin pigment cells,"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   901   C0191391:skin pigment [Individual Behavior]
   901   C0440745:Pigment cells [Cell]
   901   C1269684:skin pigment [Finding]
   901   C1704421:skin pigment [Disease or Syndrome]
   896   C0814995:Skin cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0031916:Pigment [Chemical Viewed Functionally]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0333610:Pigmented [Qualitative Concept]

Phrase: "and"

Phrase: "mesenchyme in the head,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162415:Mesenchyme [Embryonic Structure]

Phrase: "indicating"

Phrase: "a potential role of WOX1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in promoting neuronal differentiation"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C1518294:Neuronal Differentiation [Finding]
   865 E C1159970:neuron differentiation [Cell Function]
   827   C0007589:Differentiation [Cell Function]
   827   C1511938:Differentiation [Clinical Attribute]
   827   C2945687:Differentiation [Functional Concept]
   755 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "maturation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0678723:Maturation [Organism Function]
  1000   C0870861:maturation [Phenomenon or Process]
  1000   C1254042:Maturation [Physiologic Function]
Processing 00000000.tx.32: Compared with cognitive normal age-matched controls, we demonstrated here that the protein levels of WOX1, its isoform WOX2 (17), and Tyr33 phosphorylation in WOX1 (p-WOX1) (10) were significantly down-regulated in the hippocampi of AD patients. 

Phrase: "Compared with cognitive normal age-matched controls,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   757   C2705716:normal control [Qualitative Concept]
   748   C0001779:Age [Organism Attribute]
   748   C0150103:matched [Research Activity]
   748   C0205307:Normal [Qualitative Concept]
   748   C0439166:% normal [Quantitative Concept]
   748   C1516691:Cognitive [Functional Concept]
   748   C1707455:Compared [Activity]
   748   C1708943:Matched [Qualitative Concept]
   748   C2347086:% Normal [Quantitative Concept]
   714   C0243148:control [Qualitative Concept]
   714   C1550141:Control [Substance]
   714   C1882979:Control [Conceptual Entity]
   714   C2587213:Control [Functional Concept]
   714   C3274648:Control [Qualitative Concept]

Phrase: "we"

Phrase: "demonstrated"

Phrase: "here"

Phrase: "that"

Phrase: "the protein levels of WOX1,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   773   C0428479:Protein level [Laboratory or Test Result]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "its isoform WOX2"

Phrase: "(17"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Tyr33 phosphorylation in WOX1 (p-WOX1)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "(10"

Phrase: ")"

Phrase: "were"

Phrase: "significantly"

Phrase: "down-regulated in the hippocampi of AD patients."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   744   C0030705:Patients [Patient or Disabled Group]
   744   C0851285:Regulated [Governmental or Regulatory Activity]
   744   C0949582:Hippocampus [Fish]
   744   C1029104:Hippocampus [Fish]
   744   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
Processing 00000000.tx.33: In contrast, phosphorylation of Tau, ERK, and GSK-3 and NFT formation were significantly up-regulated in the AD hippocampi. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "phosphorylation of Tau,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "ERK,"

Phrase: "and"

Phrase: "GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "NFT formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "were"

Phrase: "significantly"

Phrase: "up-regulated in the AD hippocampi."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   753   C0547043:Up [Spatial Concept]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   753   C0949582:Hippocampus [Fish]
   753   C1029104:Hippocampus [Fish]
   753   C1282911:Up [Spatial Concept]
   753   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
Processing 00000000.tx.34: Specifically we determined that Tau phosphorylation at Thr205/Thr212/Thr231 and Ser202/Ser422/Ser515/Ser516 was significantly increased. 

Phrase: "Specifically"

Phrase: "we"

Phrase: "determined"

Phrase: "that Tau phosphorylation at Thr205/Thr212/Thr231"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "Ser202/Ser422/Ser515/Ser516"

Phrase: "was"

Phrase: "significantly"

Phrase: "increased."
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.35: These phosphorylation sites are regulated by GSK-3, cdk5, and ERK (or mitogen-activated protein kinase) (1824). 

Phrase: "These phosphorylation sites"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   966   C1519063:Phosphorylation Site [Amino Acid Sequence]
   861   C0031715:Phosphorylation [Molecular Function]
   861   C0205145:Sites [Spatial Concept]
   861   C1158886:Phosphorylation [Molecular Function]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "regulated by GSK-3,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   882   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "cdk5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CDK5 [Gene or Genome]

Phrase: "and"

Phrase: "ERK ("

Phrase: "or"

Phrase: "mitogen-activated protein kinase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: ")"

Phrase: "(1824"

Phrase: ")."
Processing 00000000.tx.36: In AD brains, activated GSK-3, cdk5, JNK, p38, ERK, and other kinases are known to hyperphosphorylate Tau, leading to the formation of NFTs in degenerative neurons (1824). 

Phrase: "In AD brains,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "activated GSK-3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "cdk5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CDK5 [Gene or Genome]

Phrase: "JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "p38,"

Phrase: "ERK,"

Phrase: "and"

Phrase: "other kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "hyperphosphorylate"

Phrase: "Tau,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "leading to the formation of NFTs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   778   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   748   C0220781:formation [Biologic Function]
   748   C0332152:Leading [Temporal Concept]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]
   748   C1522538:Leading [Functional Concept]
   745 E C3543859:neurofibrillary tangle [Cell Component]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in degenerative neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(1824"

Phrase: ")."
Processing 00000000.tx.37: To examine whether down-regulation of WOX1 is essential for Tau phosphorylation in AD, we determined that suppression of WOX1 expression by small interfering RNA (siRNA) spontaneously induced phosphorylation of Tau at Thr212/Thr231 and Ser515/Ser516, phosphorylation of GSK-3 and ERK, and NFT formation in neuroblastoma SK-N-SH cells and L929 fibroblasts. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "whether"

Phrase: "down-regulation of WOX1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0013081:Down-Regulation [Cell Function,Molecular Function]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]
   715   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   715   C2626739:Lanugo [Eukaryote]

Phrase: "is"

Phrase: "essential for Tau phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205224:Essential [Qualitative Concept]

Phrase: "in AD,"

Phrase: "we"

Phrase: "determined"

Phrase: "that suppression of WOX1 expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0221103:Suppression [Pathologic Function]
   760   C0301625:Suppression [Organism Function]
   760   C0439181:% suppression [Quantitative Concept]
   760   C0728721:suppression [Mental Process]

Phrase: "by small interfering RNA (siRNA) spontaneously induced phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0031715:Phosphorylation [Molecular Function]
   799   C1158886:Phosphorylation [Molecular Function]

Phrase: "of Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "at Thr212/Thr231"

Phrase: "and"

Phrase: "Ser515/Ser516,"

Phrase: "phosphorylation of GSK-3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
   716   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "ERK,"

Phrase: "and"

Phrase: "NFT formation in neuroblastoma SK-N-SH cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "L929 fibroblasts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]
Processing 00000000.tx.38: Anisomycin, an activator of JNK1, also induced Tau phosphorylation at Thr212/Thr231 and Ser515/Ser516. 

Phrase: "Anisomycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003082:Anisomycin [Antibiotic,Organic Chemical]

Phrase: "an activator of JNK1,"

Phrase: "also induced Tau phosphorylation at Thr212/Thr231"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "Ser515/Ser516."
Processing 00000000.tx.39: SP600125 (a JNK inhibitor) and PD-98059 (an MEK1/2 inhibitor) blocked the Tau phosphorylation and NFT formation, indicating that JNK1 and ERK induce Tau phosphorylation and NFT formation in the WOX1 knock-down cells. 

Phrase: "SP600125"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0968383:SP600125 [Organic Chemical,Pharmacologic Substance]

Phrase: "("

Phrase: "a JNK inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "PD-98059"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0298346:PD 98059 [Organic Chemical,Pharmacologic Substance]

Phrase: "("

Phrase: "an MEK1/2 inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: ")"

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "the Tau phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "NFT formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "indicating"

Phrase: "that JNK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367731:JNK1 [Gene or Genome]
  1000   C1705632:JNK1 [Gene or Genome]

Phrase: "and"

Phrase: "ERK"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "Tau phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "NFT formation in the WOX1 knock-down cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C1522492:Formation [Functional Concept]
Processing 00000000.tx.40: To further establish the underlying mechanism, we showed that WOX1 colocalized with JNK1, GSK-3, and Tau in the hippocampal neurons. 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "the underlying mechanism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "we"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421525:WOX1 [Gene or Genome]

Phrase: "colocalized with JNK1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1367731:JNK1 [Gene or Genome]
   790   C1705632:JNK1 [Gene or Genome]

Phrase: "GSK-3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "Tau in the hippocampal neurons."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]
Processing 00000000.tx.41: 17-Estradiol (E2), an estrogen, enhanced the binding of WOX1 with phosphorylated Tau. 

Phrase: "17-Estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "(E2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539520:E2 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "an estrogen,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
  1000   C2936882:Estrogen [Pharmacologic Substance]
   928 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "the binding of WOX1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "with phosphorylated Tau."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]
Processing 00000000.tx.42: Estrogen protects neuronal cells from apoptosis (2528). 

Phrase: "Estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
  1000   C2936882:Estrogen [Pharmacologic Substance]
   928 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "protects"

Phrase: "neuronal cells from apoptosis"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   870   C1660771:neuronal cell apoptosis [Cell Function]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(2528"

Phrase: ")."
Processing 00000000.tx.43: As mapped by yeast two-hybrid analysis (7, 10), we determined that the ADH/SDR domain of WOX1 interacted with Tau. 

Phrase: "As"

Phrase: "mapped by yeast two-hybrid analysis"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0599647:Two Hybrid [Molecular Biology Research Technique]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0020205:Hybrid [Organism]
   753   C0036025:yeast [Fungus]
   753   C0043392:Yeast [Food]
   753   C0043393:Yeast [Fungus]
   753   C0205448:Two [Quantitative Concept]
   753   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   719   C0024779:Map [Manufactured Object]
   719   C1706473:Map [Conceptual Entity]

Phrase: "(7,"

Phrase: "10"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "determined"

Phrase: "that"

Phrase: "the ADH/SDR domain of WOX1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]

Phrase: "interacted with Tau."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720655:Tau [Intellectual Product]
   790   C1947974:Tau [Research Activity]
Processing 00000000.tx.44: How WOX1 regulates Tau phosphorylation and the functional significance of WOX1 down-regulation in AD are discussed.  

Phrase: "How WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1421525:WOX1 [Gene or Genome]

Phrase: "regulates"

Phrase: "Tau phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "the functional significance of WOX1 down-regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237881:Significance [Quantitative Concept]
   748   C0750502:Significance [Idea or Concept]

Phrase: "in AD"

Phrase: "are"

Phrase: "discussed."
Processing 00000000.tx.45: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Cell Lines and ChemicalsCell lines used in these studies were human neuroblastoma SK-N-SH cells, murine L929 fibroblasts, and monkey kidney COS7 fibroblasts. 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cell Lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "ChemicalsCell lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "used in these studies"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   802   C0869040:Use studies [Research Activity]
   770   C0947630:studies [Laboratory Procedure]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C1947944:Use [Intellectual Product]
   737 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "human neuroblastoma SK-N-SH cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   895   C0427861:Human cells [Laboratory or Test Result]
   859   C0815000:neuroblastoma cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "murine L929 fibroblasts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016030:Fibroblasts [Cell]

Phrase: "and"

Phrase: "monkey kidney COS7 fibroblasts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0016030:Fibroblasts [Cell]
Processing 00000000.tx.46: These cells have been routinely grown in our laboratories according to the instructions of ATCC. 

Phrase: "These cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "been"

Phrase: "routinely"

Phrase: "grown in our laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0022877:Laboratories [Manufactured Object,Organization]
   770   C1619828:Laboratories [Intellectual Product]
   737 E C3244292:laboratory [Functional Concept]

Phrase: "according to the instructions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302828:instructions [Intellectual Product]
  1000   C1442085:Instructions [Idea or Concept]
  1000   C3263700:Instructions [Clinical Attribute]
   966 E C0039401:Instruction [Educational Activity]

Phrase: "of ATCC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598079:ATCC [Intellectual Product]
Processing 00000000.tx.47: E2 and anisomycin, an activator of JNK1 (10), were from Sigma. 

Phrase: "E2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539520:E2 [Gene or Genome]

Phrase: "and"

Phrase: "anisomycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003082:Anisomycin [Antibiotic,Organic Chemical]

Phrase: "an activator of JNK1"

Phrase: "(10"

Phrase: ")"

Phrase: ","

Phrase: "were from Sigma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1719918:Sigma [Intellectual Product]
Processing 00000000.tx.48: SP600125, an inhibitor of JNK1 (29), was from Biomol. 

Phrase: "SP600125,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0968383:SP600125 [Organic Chemical,Pharmacologic Substance]

Phrase: "an inhibitor of JNK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(29"

Phrase: ")"

Phrase: ","

Phrase: "was from Biomol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.49: PD-98059, an inhibitor of MEK1/2, was from Calbiochem. 

Phrase: "PD-98059,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0298346:PD 98059 [Organic Chemical,Pharmacologic Substance]

Phrase: "an inhibitor of MEK1/2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "was from Calbiochem."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.50: AntibodiesGeneration of rabbit antibody against a synthetic peptide, corresponding to amino acids 89107 of the NH2-terminal murine WOX1, was performed as described previously (7). 

Phrase: "AntibodiesGeneration of rabbit antibody"

Phrase: "against a synthetic peptide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C1883254:synthetic [Activity]

Phrase: "corresponding to amino acids 89107 of the NH2-terminal murine WOX1,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   756   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   738   C0001128:Acids [Chemical]
   738   C0002508:NH2 [Organic Chemical]
   738   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   738   C0026809:Murine [Mammal]
   738   C0205088:Terminal [Temporal Concept]
   738   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   738   C1421525:WOX1 [Gene or Genome]
   738   C1705314:Terminal [Manufactured Object]
   738   C1705315:Terminal [Spatial Concept]
   722 E C2917660:Amino Acid [Pharmacologic Substance]
   704 E C0202406:Acid [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.51: It is a pan antibody that interacts with the wild type murine, rat, and human WOX1 and other WOX family proteins possessing an intact NH2-terminal WW domain. 

Phrase: "It"

Phrase: "is"

Phrase: "a pan antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "that"

Phrase: "interacts with the wild type murine, rat,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C1883559:Wild Type [Organism Attribute]
   774   C0034693:Wild rat [Mammal]
           Rat, NOS
   748   C0026809:Murine [Mammal]
   748   C0034721:Rat [Mammal]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   748   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "human WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1421525:WOX1 [Gene or Genome]

Phrase: "and"

Phrase: "other WOX family proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "possessing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0850310:possess [Mental or Behavioral Dysfunction]
   966   C3154893:Possess [Idea or Concept]

Phrase: "an intact NH2-terminal WW domain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1861696:WW [Disease or Syndrome]
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.52: Antibodies were also generated against the unique COOH termini of human WOX1 (amino acids 397414, NH2-LWALSERLIQERLGSQSG-COOH) and human WOX2 (also known as FOR1, amino acids 353363, NH2-VSDCLVEGGHF-COOH). 

Phrase: "Antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "also"

Phrase: "generated against the unique COOH termini of human WOX1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0086418:Human [Human]
   742   C1421525:WOX1 [Gene or Genome]
   742   C1710548:Unique [Qualitative Concept]
   742   C3146294:Generated [Activity]

Phrase: "(amino acids 397414,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "NH2-LWALSERLIQERLGSQSG-COOH"

Phrase: ")"

Phrase: "and"

Phrase: "human WOX2"

Phrase: "(also"

Phrase: "known as FOR1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205309:Known [Qualitative Concept]

Phrase: "amino acids 353363,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "NH2-VSDCLVEGGHF-COOH"

Phrase: ")."
Processing 00000000.tx.53: Additionally antibody production against a synthetic peptide, NH-CKDGWVYPYANHTEEKT-COOH (where PY is phosphotyrosine), was performed as described previously (10). 

Phrase: "Additionally antibody production against a synthetic peptide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0003261:Antibody Production [Biologic Function]
   748   C0033268:production [Occupational Activity]

Phrase: "NH-CKDGWVYPYANHTEEKT-COOH"

Phrase: "(where PY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030428:PY [Geographic Area]
   861   C3538810:PY [Idea or Concept]

Phrase: "is"

Phrase: "phosphotyrosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070948:Phosphotyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.54: Additional antibodies used were against the following: 1) human p53, JNK1, Tau, phosphorylated Tau (Ser515/Ser516), GSK-3, and phosphorylated GSK-3 (Tyr216) (Santa Cruz Biotechnologies); 

Phrase: "Additional antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "were against the following"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0332283:follow [Temporal Concept]
   737   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "human p53,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079419:P53 [Gene or Genome]
   861   C1705526:p53 [Gene or Genome]

Phrase: "JNK1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367731:JNK1 [Gene or Genome]
  1000   C1705632:JNK1 [Gene or Genome]

Phrase: "Tau,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "phosphorylated Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "(Ser515/Ser516"

Phrase: ")"

Phrase: ","

Phrase: "GSK-3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "phosphorylated GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Tyr216"

Phrase: ")"

Phrase: "(Santa Cruz Biotechnologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnologies [Biomedical Occupation or Discipline]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.55: 2) human PHF-Tau with Alzheimer-specific epitope of AT100 (Thr212/Ser214) (Pierce); 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "human PHF-Tau with Alzheimer-specific epitope of AT100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C2700455:PHF-Tau [Amino Acid, Peptide, or Protein]
   742   C1720655:Tau [Intellectual Product]
   742   C1947974:Tau [Research Activity]

Phrase: "(Thr212/Ser214"

Phrase: ")"

Phrase: "(Pierce"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.56: 3) -tubulin (used in the Sze laboratory, Roche Applied Science); 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ") -"

Phrase: "tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "("

Phrase: "used in the Sze laboratory,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0022877:Laboratory [Manufactured Object,Organization]
   760   C1273517:used [Finding]
   760   C3244292:laboratory [Functional Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "Roche Applied Science"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0681834:Applied Science [Research Activity]
   827   C0036397:Science [Occupation or Discipline]
   827   C0185125:Applied [Health Care Activity]
   793 E C1632850:Apply [Functional Concept]
   793 E C1879355:Apply [Functional Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.57: 4) -actin (used in the Pugazhenthi laboratory, Roche Applied Science); 

Phrase: "4"

Phrase: ") -"

Phrase: "actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "("

Phrase: "used in the Pugazhenthi laboratory,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0022877:Laboratory [Manufactured Object,Organization]
   760   C1273517:used [Finding]
   760   C3244292:laboratory [Functional Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "Roche Applied Science"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0681834:Applied Science [Research Activity]
   827   C0036397:Science [Occupation or Discipline]
   827   C0185125:Applied [Health Care Activity]
   793 E C1632850:Apply [Functional Concept]
   793 E C1879355:Apply [Functional Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.58: and 4) -tubulin (used in the Chang laboratory, Accurate Chemicals). 

Phrase: "and"

Phrase: "4"

Phrase: ") -"

Phrase: "tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "("

Phrase: "used in the Chang laboratory,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0022877:Laboratory [Manufactured Object,Organization]
   760   C1273517:used [Finding]
   760   C3244292:laboratory [Functional Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "Accurate Chemicals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0220806:Chemicals [Chemical]
   827 E C3272558:Chemical [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.59: A sampler pack of antibodies against Tau was from BIOSOURCE that included a Tau pan antibody, an NFT antibody, and 11 antibodies for site-specific phosphorylation in the human Tau (Thr(P)181, Ser(P)202, Thr(P)205, Thr(P)212, Ser(P)214, Thr(P)231, Ser(P)262, Ser(P)396, Ser(P)404, Ser(P)409, and Ser(P)422). 

Phrase: "A sampler pack of antibodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1968515:Pack [Medical Device]
   760   C2825051:Pack [Drug Delivery Device]
   760   C2828395:Pack [Activity]

Phrase: "against Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "was from BIOSOURCE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]

Phrase: "that"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "a Tau pan antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "an NFT antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "11 antibodies for site-specific phosphorylation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "in the human Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "(Thr(P)181,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040005:Thr [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "Ser(P)202,"

Phrase: "Thr(P)205,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040005:Thr [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "Thr(P)212,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040005:Thr [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "Ser(P)214,"

Phrase: "Thr(P)231,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040005:Thr [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "Ser(P)262,"

Phrase: "Ser(P)396,"

Phrase: "Ser(P)404,"

Phrase: "Ser(P)409,"

Phrase: "and"

Phrase: "Ser(P)422"

Phrase: ")."
Processing 00000000.tx.60: Autopsy Brain SamplesEight frozen hippocampi of postmortem brains were from clinically and pathologically confirmed AD patients (mean age, 79 years; 

Phrase: "Autopsy Brain SamplesEight frozen hippocampi of postmortem brains"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0019564:BRAIN, HIPPOCAMPUS [Body Part, Organ, or Organ Component]
           Hippocampus
   744   C0949582:Hippocampus [Fish]
   744   C1029104:Hippocampus [Fish]
   744   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "were from clinically"

Phrase: "and"

Phrase: "pathologically"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "(mean age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: "79 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.61: postmortem delay: range, 616 h; 

Phrase: "postmortem delay"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205421:Delay [Temporal Concept]

Phrase: ":"

Phrase: "range,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514721:Range [Quantitative Concept]
  1000   C2348147:Range [Quantitative Concept]
  1000   C3542016:Range [Intellectual Product]

Phrase: "616 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.62: mean, 11 h). 

Phrase: "mean,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "11 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.63: Control samples were eight age-matched subjects (mean age, 74 years; 

Phrase: "Control samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "eight age-matched subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0681850:Subject [Group]
   779   C1550501:{Subject} [Idea or Concept]
   779   C1706203:Subject [Idea or Concept]
   779   C2349001:Subject [Human]
   779   C2697811:Subject [Functional Concept]

Phrase: "(mean age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: "74 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.64: postmortem delay: range, 316 h; 

Phrase: "postmortem delay"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205421:Delay [Temporal Concept]

Phrase: ":"

Phrase: "range,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514721:Range [Quantitative Concept]
  1000   C2348147:Range [Quantitative Concept]
  1000   C3542016:Range [Intellectual Product]

Phrase: "316 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.65: mean, 8 h) without evidence of clinical or brain pathology. 

Phrase: "mean,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "8 h) without evidence of clinical"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]

Phrase: "or"

Phrase: "brain pathology."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0006119:Brain Pathology [Pathologic Function]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   789 E C1521733:Pathologic [Functional Concept]
Processing 00000000.tx.66: These materials were from the Brain Bank at the Department of Pathology, University of Colorado Health Sciences Center. 

Phrase: "These materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "were from the Brain Bank"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0442598:Bank [Manufactured Object]
   760   C0872261:Bank [Manufactured Object]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "at the Department"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704729:Department [Organization]

Phrase: "of Pathology,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]

Phrase: "University of Colorado Health Sciences Center."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   839   C0475309:Health center [Health Care Related Organization,Manufactured Object]
   827   C1512352:Health Sciences [Biomedical Occupation or Discipline]
   799   C0009399:Colorado [Geographic Area]
   799   C0018684:Health [Idea or Concept]
   799   C0036397:Sciences [Occupation or Discipline]
   799   C0041740:University [Manufactured Object,Organization]
   799   C0205099:Center [Spatial Concept]
Processing 00000000.tx.67: The diagnoses of AD were formulated based on the criteria from the Consortium to Establish a Registry for Alzheimer's Disease (30). 

Phrase: "The diagnoses of AD"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0011900:Diagnoses [Finding]
   737 E C1704338:diagnosis [Qualitative Concept]
   737 E C1704656:DIAGNOSIS [Research Activity]

Phrase: "were"

Phrase: "formulated"

Phrase: "based on the criteria"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0243161:criteria [Intellectual Product]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "from the Consortium to Establish a Registry for Alzheimer's Disease"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   812   C0002395:Alzheimer's Disease [Disease or Syndrome]
   812   C1521724:Alzheimer's Disease [Pathologic Function]
   793   C0012634:Disease [Disease or Syndrome]
   793   C0034975:Registry [Intellectual Product]
   793   C0443211:establish [Qualitative Concept]
   793   C1513822:Consortium [Professional or Occupational Group]
   793   C1880171:Consortium [Professional or Occupational Group]
   737 E C1836721:MALS [Finding]
   737 E C3538764:MALS [Gene or Genome]
   737 E C3540595:MAL [Gene or Genome]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.68: ImmunohistochemistryThe above mentioned hippocampal tissues were formalin-fixed and paraffin-imbedded. 

Phrase: "ImmunohistochemistryThe above mentioned hippocampal tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0040300:Tissues [Tissue]
   771 E C1547928:Tissue [Intellectual Product]

Phrase: "were"

Phrase: "formalin-fixed"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0231441:Fixed [Finding]
   861   C0443218:Fixed [Qualitative Concept]
   861   C0949307:Formalin [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   861   C2827483:Fixed [Body Substance]

Phrase: "and"

Phrase: "paraffin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030415:Paraffin [Biomedical or Dental Material,Lipid]

Phrase: "imbedded."
Processing 00000000.tx.69: The blocks were sectioned (5 m) and mounted on plus slides. 

Phrase: "The blocks"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:blocks [Pathologic Function]
  1000   C0332206:Blocks [Functional Concept]
  1000   C1533157:Blocks [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]
   916 E C2983591:BLOCKED [Research Activity]

Phrase: "were"

Phrase: "sectioned"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "m)"

Phrase: "and"

Phrase: "mounted on plus slides."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0332287:Plus [Qualitative Concept]
   770   C0444330:slides [Research Device]
   770   C0449878:mounted [Finding]
   737 E C0181909:Mount [Medical Device]
   737 E C1705201:Slide [Manufactured Object]
Processing 00000000.tx.70: The tissues were deparaffinized and hydrated through serial ethanol solutions and finally in distilled water. 

Phrase: "The tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "were"

Phrase: "deparaffinized"

Phrase: "and"

Phrase: "hydrated through serial ethanol solutions"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0001962:Ethanol [Organic Chemical]
   760   C0031082:serial [Intellectual Product,Manufactured Object]
   760   C0037633:Solutions [Substance]
   760   C0720930:hydrated [Organic Chemical,Pharmacologic Substance]
   726 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "and"

Phrase: "finally in distilled water."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0790233:Distilled water [Inorganic Chemical,Pharmacologic Substance]
   770   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   770   C0599638:WATER [Substance]
   770   C0681549:distilled [Occupational Activity]
   770   C1550678:Water [Inorganic Chemical]
Processing 00000000.tx.71: The hydrated tissue sections were steamed in 10 mM sodium citrate buffer (pH 6.0) for 30 min for antigen retrieval followed by treatment with 1% hydrogen peroxide (10 min) and blocking with 5% horse serum (1 h) at room temperature. 

Phrase: "The hydrated tissue sections"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C2316368:Tissue section [Tissue]
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "steamed in 10 mM sodium citrate buffer"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0142825:sodium citrate [Organic Chemical,Pharmacologic Substance]
   778   C3256468:citrate buffer [Pharmacologic Substance]
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0008857:Citrate [Organic Chemical]
   748   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   748   C0038225:steamed [Inorganic Chemical]
   748   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
   748   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(pH 6.0"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "for antigen retrieval"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0003320:Antigen [Immunologic Factor]
   861   C1514918:Retrieval [Health Care Activity]
   761 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "followed by treatment"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with 1% hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0020275:Hydrogen [Element, Ion, or Isotope]
   827   C0031180:Peroxide [Inorganic Chemical]
   827   C0523702:HYDROGEN [Laboratory Procedure]
   827   C0885426:hydrogen [Inorganic Chemical]

Phrase: "(10 min)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "blocking with 5% horse serum"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   806   C1518416:Serum, Horse [Immunologic Factor]
   760   C0019944:Horse [Mammal]
   760   C0229671:Serum [Body Substance]
   760   C0233660:Blocking [Mental or Behavioral Dysfunction]
   760   C0242616:Horse [Mammal]
   760   C0332206:Blocking [Functional Concept]
   760   C1265527:Horse [Mammal]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   726 E C0028778:Block [Pathologic Function]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]

Phrase: "(1 h) at room temperature."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0700308:1 H [Element, Ion, or Isotope]
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.72: The tissue sections were incubated with aliquots of antibodies (1:200 final dilution) against WOX1, WOX2, and p-WOX1, respectively, in Tris-buffered saline (pH 7.4) at 4 C overnight. 

Phrase: "The tissue sections"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   983   C2316368:Tissue section [Tissue]
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "incubated with aliquots of antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C1439852:Incubated [Laboratory Procedure]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   726   C1510844:Aliquot [Quantitative Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200 final dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0079240:Dilution [Laboratory Procedure]
   827   C1948037:Dilution [Functional Concept]

Phrase: ")"

Phrase: "against WOX1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421525:WOX1 [Gene or Genome]

Phrase: "WOX2,"

Phrase: "and"

Phrase: "p-WOX1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "respectively,"

Phrase: "in Tris-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0036082:Saline [Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "(pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "at 4 C overnight."
Processing 00000000.tx.73: Aliquots of biotinylated secondary antibodies were then added. 

Phrase: "Aliquots of biotinylated secondary antibodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "added."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]
Processing 00000000.tx.74: Color development was performed using a labeled streptavidin biotin plus horseradish peroxidase kit (Dako). 

Phrase: "Color development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a labeled streptavidin biotin plus horseradish peroxidase kit (Dako"

Phrase: ")."
Processing 00000000.tx.75: In negative controls, tissue sections were stained with aliquots of prebled rabbit sera. 

Phrase: "In negative controls,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   966   C1639518:% negative control [Quantitative Concept]
   966   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "tissue sections"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   983   C2316368:Tissue section [Tissue]
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "stained with aliquots of prebled rabbit sera."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   748   C0034493:Rabbit [Mammal]
   748   C0229671:Sera [Body Substance]
   748   C1151254:SerA [Molecular Function]
   748   C2986582:Stained [Qualitative Concept]
   714 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   714   C1510844:Aliquot [Quantitative Concept]
   714 E C1546774:Serum [Intellectual Product]
   714 E C1550100:Serum [Body Substance]
Processing 00000000.tx.76: Where indicated, synthetic peptides (100 M) were premixed with the above mentioned antisera (5 min at room temperature) prior to immunostaining. 

Phrase: "Where"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "synthetic peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C1883254:synthetic [Activity]

Phrase: "(100"

Phrase: "M)"

Phrase: "were"

Phrase: "premixed with the above mentioned antisera"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(5 min at room temperature"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0702093:/min [Temporal Concept]

Phrase: ")"

Phrase: "prior to immunostaining."
Processing 00000000.tx.77: Immunofluorescence MicroscopyIn some experiments, the hippocampal tissues were stained with antibodies against JNK1 (rabbit antibody) and/or Tau (goat antibody) followed by addition of secondary fluorescein isothiocyanate-conjugated anti-rabbit IgG and Texas Red-conjugated anti-goat IgG (7). 

Phrase: "Immunofluorescence MicroscopyIn"

Phrase: "some experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "the hippocampal tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "were"

Phrase: "stained with antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   790   C2986582:Stained [Qualitative Concept]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "against JNK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367731:JNK1 [Gene or Genome]
  1000   C1705632:JNK1 [Gene or Genome]

Phrase: "(rabbit antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")"

Phrase: "and/or"

Phrase: "Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "(goat antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")"

Phrase: "followed by addition of secondary fluorescein isothiocyanate-conjugated anti-rabbit IgG"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   756   C0332283:Followed by [Temporal Concept]
           followed
   754   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0027627:secondary [Neoplastic Process]
   738   C0034493:Rabbit [Mammal]
   738   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   738   C0124209:Isothiocyanate [Organic Chemical]
   738   C0175668:Secondary [Temporal Concept]
   738   C0205436:Secondary [Quantitative Concept]
   738   C0206359:isothiocyanate [Organic Chemical]
   738   C0522529:Conjugated [Spatial Concept]
   738   C1883712:Addition [Functional Concept]
   704 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "Texas Red-conjugated anti-goat IgG"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   839   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0018019:goat [Mammal]
   799   C1265549:goat [Mammal]
   799   C1510458:Goat [Mammal]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.78: The nuclei were stained with 4',6-diamidino-2-phenylindole (DAPI, Calbiochem). 

Phrase: "The nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007610:Nucleus [Cell Component]

Phrase: "were"

Phrase: "stained with 4',"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "6-diamidino-2-phenylindole"

Phrase: "(DAPI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0057142:DAPI [Organic Chemical,Pharmacologic Substance]

Phrase: "Calbiochem"

Phrase: ")."
Processing 00000000.tx.79: The slides were examined by fluorescence microscopy as described previously (7). 

Phrase: "The slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0444330:slides [Research Device]
   966 E C1705201:Slide [Manufactured Object]

Phrase: "were"

Phrase: "examined by fluorescence microscopy"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0026022:Microscopy, Fluorescence [Laboratory Procedure]
   770   C0016315:Fluorescence [Natural Phenomenon or Process]
   770   C0026018:Microscopy [Laboratory Procedure]
   770   C0332128:Examined [Finding]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.80: Where indicated, other antibodies were used in dual immunostaining. 

Phrase: "Where"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "other antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "used in dual immunostaining."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1273517:used [Finding]
   770   C1554184:Dual [Intellectual Product]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.81: Western BlottingA 2- or 4-mm Acu-Punch (Acuderm) was used to obtain hippocampal tissues (100200 mg) from frozen postmortem brain slabs. 

Phrase: "Western BlottingA 2-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705493:Western [Spatial Concept]

Phrase: "or"

Phrase: "4-mm Acu-Punch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0182555:Punch [Medical Device]

Phrase: "(Acuderm"

Phrase: ")"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "hippocampal tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "(100200 mg) from frozen postmortem brain slabs."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0439269:mg% [Quantitative Concept]
   748   C1960952:mg % [Quantitative Concept]
   748   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.82: The tissues had been stored at -80 C and then warmed to -20 C overnight prior to sampling. 

Phrase: "The tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "had"

Phrase: "been"

Phrase: "stored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1698986:Store [Functional Concept]

Phrase: "at -80 C"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "warmed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0687712:warmed [Natural Phenomenon or Process]

Phrase: "to -20 C overnight prior to sampling."
Processing 00000000.tx.83: These samples were Dounce-extracted in the presence of a mixture of protease inhibitors (Sigma) and then centrifuged at 10,000 rpm for 10 min to remove debris as described previously (31). 

Phrase: "These samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "Dounce-"

Phrase: "extracted in the presence of a mixture of protease inhibitors"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   760   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   739   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   739   C0185115:Extracted [Therapeutic or Preventive Procedure]
   739   C0243077:inhibitors [Chemical Viewed Functionally]
   739   C0392148:Presence [Therapeutic or Preventive Procedure]
   739   C0439962:Mixture [Substance]
   739   C1947941:Protease [Enzyme]
   739   C3541890:EXTRACTED [Finding]
   726 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   706 E C1999216:Inhibitor [Qualitative Concept]
   706 E C2828366:Extract [Substance]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "centrifuged at 10,000 rpm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0582523:rpm [Quantitative Concept]
   726   C0179834:centrifuge [Medical Device]

Phrase: "for 10 min to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0456692:/10 min [Temporal Concept]
   827   C0702093:/min [Temporal Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "debris"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0440266:Debris [Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.84: The samples (50 g/lane) were quantified by the Bradford method (Bio-Rad) and subjected to SDS-PAGE, electroblotting, and Western blotting as described previously (31). 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "(50 g/lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "quantified by the Bradford method"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0025663:Method [Intellectual Product]
   760   C0449851:Method [Functional Concept]
   760   C0871511:METHOD [Intellectual Product]
   726   C1709793:Quantify [Quantitative Concept]

Phrase: "(Bio-Rad)"

Phrase: "and"

Phrase: "subjected to SDS-PAGE,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "electroblotting"

Phrase: ","

Phrase: "and"

Phrase: "Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.85: Scanning and quantification were performed using BioRad Fluor-STM MultiImager and Quantity One software. 

Phrase: "Scanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034606:Scanning [Diagnostic Procedure]
  1000   C0441633:Scanning [Diagnostic Procedure]

Phrase: "and"

Phrase: "quantification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantification [Quantitative Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "BioRad Fluor-STM MultiImager"

Phrase: "and"

Phrase: "Quantity One software."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.86: The extent of protein expression was expressed as relative OD as determined by comparing the density and area of an immunoreactive band in each lane with those of control lanes in the same blot. 

Phrase: "The extent of protein expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439792:Extent [Spatial Concept]

Phrase: "was"

Phrase: "expressed as relative OD"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0029421:OD [Disease or Syndrome]
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C0439164:OD [Quantitative Concept]
   770   C1512019:OD [Intellectual Product]
   770   C1547039:*Relative [Quantitative Concept]

Phrase: "as"

Phrase: "determined by comparing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1707455:Compare [Activity]

Phrase: "the density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0178587:density [Quantitative Concept]
   928 E C0439794:Dense [Qualitative Concept]

Phrase: "and"

Phrase: "area of an immunoreactive band"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017446:Area [Geographic Area]
   760   C0205146:Area [Spatial Concept]

Phrase: "in each lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "with those"

Phrase: "of control lanes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "in the same blot."
Processing 00000000.tx.87: The data were assessed by Student's t test and Spearman correlation procedure. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "assessed by Student's t test"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0022885:Test [Laboratory Procedure]
   760   C0038492:student [Professional or Occupational Group]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]
   760   C1516048:Assessed [Activity]
   760   C1551041:student [Idea or Concept]
   760   C1552573:student [Intellectual Product]

Phrase: "and"

Phrase: "Spearman correlation procedure."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C1948041:Procedure [Therapeutic or Preventive Procedure]
   827   C2700391:Procedure [Activity]
   827   C3274430:PROCEDURE [Health Care Activity]
   827   C3538935:Procedure [Idea or Concept]
   827   C3539779:Procedure [Intellectual Product]
   734   C1710141:Spearman Correlation [Intellectual Product]
Processing 00000000.tx.88: Co-immunoprecipitationWhere indicated, L929 or other cells treated with or without E2 were extracted using a cytoplasmic and nuclear extraction kit (Pierce) (7, 10). 

Phrase: "Co-immunoprecipitationWhere"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "L929"

Phrase: "or"

Phrase: "other cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "treated with"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   833   C1522326:Treated [Functional Concept]
   799 E C1292734:TREAT [Functional Concept]

Phrase: "or without E2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3539520:E2 [Gene or Genome]

Phrase: "were"

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a cytoplasmic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010834:Cytoplasmic [Cell Component]
  1000   C0521449:Cytoplasmic [Body Location or Region]

Phrase: "and"

Phrase: "nuclear extraction kit (Pierce"

Phrase: ")"

Phrase: "(7,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.89: These protein preparations (1 mg of protein) were quantified and co-immunoprecipitated (7, 10) using specific antibodies against p-WOX1 or GSK-3. 

Phrase: "These protein preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0455052:Preparation [Health Care Activity]
   827   C1521827:Preparation [Functional Concept]

Phrase: "(1 mg of protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439269:mg% [Quantitative Concept]
   770   C1960952:mg % [Quantitative Concept]
   770   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")"

Phrase: "were"

Phrase: "quantified"

Phrase: "and"

Phrase: "co-immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(7,"

Phrase: "10"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "specific antibodies against p-WOX1"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   773   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0031715:Phosphorylation [Molecular Function]
   753   C0205369:Specific [Qualitative Concept]
   753   C1158886:Phosphorylation [Molecular Function]
   753   C1421525:WOX1 [Gene or Genome]
   753   C1552740:specific [Intellectual Product]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "or"

Phrase: "GSK-3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.90: Mammalian Expression ConstructsMurine GFP-WOX1 (in pEGFP-C1, Clontech) was made as described previously (7, 10). 

Phrase: "Mammalian Expression ConstructsMurine GFP-WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1421525:WOX1 [Gene or Genome]

Phrase: "("

Phrase: "in pEGFP-C1,"

Phrase: "Clontech"

Phrase: ")"

Phrase: "was"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(7,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.91: The coding sequence of the ADH/SDR domain in WOX1, designated GFP-WOX1adh, was also constructed in pEGFP-C1. 

Phrase: "The coding sequence of the ADH/SDR domain"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   764   C0079941:Coding Sequence [Gene or Genome]
   742   C0004793:Sequence [Nucleotide Sequence]
   742   C0009219:Coding [Occupational Activity]
   742   C0162326:Sequence [Nucleotide Sequence]
   742   C0162327:Sequence [Nucleotide Sequence]
   742   C1519249:Sequence [Functional Concept]
   708 E C0805701:Code [Intellectual Product]

Phrase: "in WOX1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421525:WOX1 [Gene or Genome]

Phrase: "designated GFP-WOX1adh,"

Phrase: "was"

Phrase: "also"

Phrase: "constructed in pEGFP-C1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C2827421:Construct [Classification]
Processing 00000000.tx.92: COS7 or the indicated cells were electroporated with these cDNA constructs or the "empty" pEGFP-C1 vector as controls. 

Phrase: "COS7"

Phrase: "or"

Phrase: "the indicated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "electroporated with these cDNA constructs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   726   C2827421:Construct [Classification]

Phrase: "or"

Phrase: "the ""empty"" pEGFP-C1 vector as controls."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0031249:control vector [Occupational Activity]
   748   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0442335:Vector [Spatial Concept]
   748   C1705099:Vector [Idea or Concept]
Processing 00000000.tx.93: Protein expression was examined by fluorescence microscopy and Western blotting (7, 10). 

Phrase: "Protein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1171362:protein expression [Genetic Function]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "examined by fluorescence microscopy"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0026022:Microscopy, Fluorescence [Laboratory Procedure]
   770   C0016315:Fluorescence [Natural Phenomenon or Process]
   770   C0026018:Microscopy [Laboratory Procedure]
   770   C0332128:Examined [Finding]

Phrase: "and"

Phrase: "Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "(7,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.94: Alternatively liposome-based Fu-GENE 6 (Roche Applied Science) or GeneFector (Venn Nova) was used for transferring cDNA constructs into cells (7, 10). 

Phrase: "Alternatively liposome-based Fu-GENE 6"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   799   C0016360:FU [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   799   C0017337:Gene [Gene or Genome]
   799   C0023828:Liposome [Lipid]
   799   C1424823:FU [Gene or Genome]
   799   C1527178:Based [Functional Concept]
   799   C1705938:Based [Idea or Concept]
   766 E C0002055:base [Inorganic Chemical]
   766 E C0178499:Base [Chemical Viewed Functionally]
   766 E C1880279:Base [Biomedical or Dental Material]

Phrase: "(Roche Applied Science"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0681834:Applied Science [Research Activity]
   827   C0036397:Science [Occupation or Discipline]
   827   C0185125:Applied [Health Care Activity]
   793 E C1632850:Apply [Functional Concept]
   793 E C1879355:Apply [Functional Concept]

Phrase: ")"

Phrase: "or"

Phrase: "GeneFector"

Phrase: "(Venn Nova"

Phrase: ")"

Phrase: "was"

Phrase: "used for transferring cDNA"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   770   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1273517:used [Finding]
   770   C1540850:Transferring [Activity]
   737 E C0040671:Transfer [Mental Process]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1705822:Transfer [Activity]
   737 E C1947944:Use [Intellectual Product]

Phrase: "constructs into cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C2827421:Construct [Classification]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "(7,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.95: Cytoplasmic Yeast Two-hybrid AnalysisRas rescue-based yeast two-hybrid analysis (CytoTrap, Stratagene) was performed as described previously (7, 10). 

Phrase: "Cytoplasmic Yeast Two-hybrid AnalysisRas"

Phrase: "rescue-"

Phrase: "based yeast two-hybrid analysis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   840   C0599647:Two Hybrid [Molecular Biology Research Technique]
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0020205:Hybrid [Organism]
   804   C0036025:yeast [Fungus]
   804   C0043392:Yeast [Food]
   804   C0043393:Yeast [Fungus]
   804   C0205448:Two [Quantitative Concept]
   804   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   804   C0936012:Analysis [Research Activity]
   804   C1524024:analysis [Functional Concept]

Phrase: "(CytoTrap,"

Phrase: "Stratagene"

Phrase: ")"

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(7,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.96: Briefly binding of a cytosolic Sos-tagged bait protein to a cell membrane-anchored target protein (tagged with a myristoylation signal) activates the Ras signaling pathway in yeast. 

Phrase: "Briefly"

Phrase: "binding of a cytosolic Sos-tagged bait protein"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   767   C0033618:Protein Binding [Molecular Function]
   767   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   767   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0246703:SOS Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750   C1818826:protein tag [Molecular Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1383501:Cytosolic [Cell Component]
   744   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   744   C1708632:Tagged [Qualitative Concept]
   711 E C0037293:Tag [Neoplastic Process]
   711 E C0181496:Tag [Manufactured Object]
   711 E C1710492:TAG [Gene or Genome]

Phrase: "to a cell membrane-anchored target protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   885   C1179841:Cell membrane protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   858   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "tagged with a myristoylation signal"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0598434:myristoylation [Molecular Function]
   760   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   760   C1708632:Tagged [Qualitative Concept]
   760   C1710082:Signal [Phenomenon or Process]
   726 E C0037293:Tag [Neoplastic Process]
   726 E C0181496:Tag [Manufactured Object]
   726 E C1710492:TAG [Gene or Genome]

Phrase: ")"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the Ras signaling pathway in yeast."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C1514731:Ras Signaling Pathway [Molecular Function]
   790   C0037083:signaling pathway [Cell Function]
   790   C0086982:Signaling Pathway [Molecular Function]
   783 E C0037080:pathway signaling [Molecular Function]
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.97: This activation allows mutant yeast cdc25H to grow in 37 C using a selective agarose plate containing galactose. 

Phrase: "This activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "mutant yeast cdc25H to"

Phrase: "grow in 37 C"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a selective agarose plate containing galactose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0016945:Galactose [Biologically Active Substance,Carbohydrate]
Processing 00000000.tx.98: Without binding, yeast cells fail to grow at 37 C. 

Phrase: "Without binding,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "yeast cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
  1000   C2700289:Yeast Cells [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C0036025:yeast [Fungus]
   861   C0043392:Yeast [Food]
   861   C0043393:Yeast [Fungus]
   861   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "grow at 37 C."
Processing 00000000.tx.99: Constructs (in pSos vector) used as baits were as follows: 1) a murine full-length WOX1, 2) an NH2-terminal WW domain area of WOX1, 3) a COOH-terminal ADH/SDR domain area of WOX1, and 4) a Y33R mutant in the WW domain area (for the above constructs as baits) (7, 10). 

Phrase: "Constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "("

Phrase: "in pSos vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: "used as baits"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "a murine full-length WOX1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1421525:WOX1 [Gene or Genome]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "an NH2-terminal WW domain area of WOX1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0017446:Area [Geographic Area]
   744   C0205146:Area [Spatial Concept]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "a COOH-terminal ADH/SDR domain area of WOX1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0017446:Area [Geographic Area]
   739   C0205146:Area [Spatial Concept]

Phrase: "and"

Phrase: "4"

Phrase: ")"

Phrase: "a Y33R mutant in the WW domain area"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "("

Phrase: "for the above constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "as baits"

Phrase: ")"

Phrase: "(7,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.100: For target, a construct for human Tau, with three repeats of a microtubule-binding domain (GenBankTM accession number BC000558 [GenBank] ), was made in pMyr vector. 

Phrase: "For target,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "a construct for human Tau,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2827421:Construct [Classification]

Phrase: "with three repeats"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205341:repeats [Functional Concept]
   861   C1705914:Repeats [Conceptual Entity]
   827 E C1547730:Repeat [Temporal Concept]

Phrase: "of a microtubule-binding domain"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C1149274:microtubule binding [Molecular Function]
   827   C0026046:Micro-tubule [Cell Component]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "(GenBankTM accession number BC000558 [GenBank]"

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "made in pMyr vector."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vector [Spatial Concept]
   770   C1705099:Vector [Idea or Concept]
   737   C1881534:Make [Functional Concept]
Processing 00000000.tx.101: Additional constructs for the binding experiments were human p53 (in pMyr) and MafB (in both pMyr and pSos) (7). 

Phrase: "Additional constructs for the binding experiments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C2827421:Construct [Classification]

Phrase: "were"

Phrase: "human p53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079419:P53 [Gene or Genome]
   861   C1705526:p53 [Gene or Genome]

Phrase: "("

Phrase: "in pMyr"

Phrase: ")"

Phrase: "and"

Phrase: "MafB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416710:MAFB [Gene or Genome]
  1000   C1565054:MAFB [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "in both pMyr"

Phrase: "and"

Phrase: "pSos"

Phrase: ")"

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.102: siRNA-targeting WOX1A retroviral siRNA expression construct for targeting human WOX1 was made (in pSupressorRetro) using a Gene-Suppressor construction kit from Imgenex. 

Phrase: "siRNA-targeting WOX1A retroviral siRNA expression construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C2827421:Construct [Classification]

Phrase: "for targeting human WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1421525:WOX1 [Gene or Genome]

Phrase: "was"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "("

Phrase: "in pSupressorRetro"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Gene-Suppressor construction kit from Imgenex."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0920288:KIT Gene [Gene or Genome]
   774   C1416655:KIT gene [Gene or Genome]
   748   C0812225:KIT [Medical Device]
   748   C1150635:KIT [Molecular Function]
   748   C1705212:Kit [Medical Device]
   748   C1705213:KIT [Medical Device]
   748   C3273202:Kit [Manufactured Object]
Processing 00000000.tx.103: The synthetic primers (MWG Biotech) for making the expression construct were as follows: 1) forward, 5'-TCGAGCCAAGTCCATGCAACAGGGGAGTACTGCCCTGTTGCATGGACTTT, and 2) reverse, 5'-CTAGAAAAACCAAGTCCATGCACAGGGCAGTACTCCCCTGTTGCATGGACTTGGC. 

Phrase: "The synthetic primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(MWG Biotech"

Phrase: ")"

Phrase: "for making"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "the expression construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827421:Construct [Classification]

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: ","

Phrase: "5'-TCGAGCCAAGTCCATGCAACAGGGGAGTACTGCCCTGTTGCATGGACTTT,"

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: ","

Phrase: "5'-CTAGAAAAACCAAGTCCATGCACAGGGCAGTACTCCCCTGTTGCATGGACTTGGC."
Processing 00000000.tx.104: The resulting siRNA targets a sequence at the 3' end of WOX1 mRNA. 

Phrase: "The resulting siRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0521102:interfering [Qualitative Concept]
   812   C0700321:Small [Quantitative Concept]

Phrase: "targets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "a sequence at the 3' end of WOX1 mRNA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0004793:Sequence [Nucleotide Sequence]
   742   C0162326:Sequence [Nucleotide Sequence]
   742   C0162327:Sequence [Nucleotide Sequence]
   742   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.105: An empty vector was used as a control. 

Phrase: "An empty vector"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]
   861   C1880497:Empty [Qualitative Concept]
   805 E C0333668:Depleted [Functional Concept]
   777 E C1550032:Unload [Idea or Concept]
   777 E C1996907:Emptying [Activity]

Phrase: "was"

Phrase: "used as a control."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.106: Production of retrovirus and transfection to target cells were performed according to the manufacturer's instructions. 

Phrase: "Production of retrovirus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "transfection to target cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   861   C0221284:Target cells [Cell]
   861   C3272919:Target Cells [Laboratory Procedure]
   812   C0007634:Cells [Cell]
   812   C1521840:Target [Functional Concept]
   812   C2986546:TARGET [Diagnostic Procedure]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "performed according to the manufacturer's instructions."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0302828:instructions [Intellectual Product]
   753   C0680240:according [Social Behavior]
   753   C0884358:Performed [Functional Concept]
   753   C0947322:Manufacturer [Intellectual Product]
   753   C1442085:Instructions [Idea or Concept]
   753   C1705426:Manufacturer [Population Group]
   753   C3263700:Instructions [Clinical Attribute]
   719 E C0039401:Instruction [Educational Activity]
   719 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.107: A similar construct was made using a mammalian expression plasmid, pSuppressorNeo, from Imgenex. 

Phrase: "A similar construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827421:Construct [Classification]

Phrase: "was"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a mammalian expression plasmid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "pSuppressorNeo,"

Phrase: "from Imgenex."
Processing 00000000.tx.108: Also, a negative control vector with a scrambled sequence was from Imgenex. 

Phrase: "Also,"

Phrase: "a negative control vector with a scrambled sequence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0031249:control vector [Occupational Activity]
   744   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0442335:Vector [Spatial Concept]
   744   C1705099:Vector [Idea or Concept]

Phrase: "was from Imgenex."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.109: In addition, we selected a conserved sequence region at the WW domain of WOX1 for siRNA targeting. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "a conserved sequence region at the WW domain of WOX1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0017446:Region [Geographic Area]
   739   C0205147:Region [Spatial Concept]

Phrase: "for siRNA targeting."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C1521840:Targeting [Functional Concept]
   779 E C2986546:TARGET [Diagnostic Procedure]
   756   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.110: This sequence is identical in human, mouse, and zebrafish. 

Phrase: "This sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "is"

Phrase: "identical in human,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205280:Identical [Qualitative Concept]

Phrase: "mouse,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "zebrafish."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043457:Zebra Fish [Fish]
Processing 00000000.tx.111: Synthetic primers for making the WOX1si construct (in pSuppressorNeo) were as follows: forward, 5'-TCGAGCCAAGTCCATGCACAGGGGAGTACTGCCCTGTTGCATGGACTTGGTTTTT, and reverse, 5'-CTAGAAAAACCAAGTCCATGCACAGGGCAGTACTCCCCTGTTGCATGGACTTGGC. 

Phrase: "Synthetic primers for making"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "the WOX1si construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827421:Construct [Classification]

Phrase: "("

Phrase: "in pSuppressorNeo"

Phrase: ")"

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "forward, 5'-TCGAGCCAAGTCCATGCACAGGGGAGTACTGCCCTGTTGCATGGACTTGGTTTTT,"

Phrase: "and"

Phrase: "reverse, 5'-CTAGAAAAACCAAGTCCATGCACAGGGCAGTACTCCCCTGTTGCATGGACTTGGC."
Processing 00000000.tx.112: Where indicated, L929 and SK-N-SH cells were transfected with these constructs by electroporation. 

Phrase: "Where"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "L929"

Phrase: "and"

Phrase: "SK-N-SH cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with these constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C2827421:Construct [Classification]

Phrase: "by electroporation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206691:Electroporation [Laboratory Procedure,Research Activity]
Processing 00000000.tx.113: Stable transfectants were selected using G418 (300 g/ml) during 23 weeks in culture (7, 10).  

Phrase: "Stable transfectants"

Phrase: "were"

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "G418"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052009:G418 [Antibiotic,Organic Chemical]

Phrase: "(300 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "ml) during 23 weeks"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0066650:ML 23 [Organic Chemical,Pharmacologic Substance]
   770   C0439526:/mL [Quantitative Concept]

Phrase: "in culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "(7,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.114: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Down-regulation of WOX1, p-WOX1, and WOX2 in the Hippocampal Neurons and Extracts of AD BrainsAs determined by immunohistochemistry, WOX1 is present mainly in the perinuclear areas of both healthy and degenerative neurons from an AD hippocampus (Fig. 1A). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Down-regulation of WOX1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0013081:Down-Regulation [Cell Function,Molecular Function]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]
   715   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   715   C2626739:Lanugo [Eukaryote]

Phrase: "p-WOX1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "WOX2 in the Hippocampal Neurons"

Phrase: "and"

Phrase: "Extracts of AD BrainsAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2828366:Extract [Substance]

Phrase: "determined by immunohistochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421525:WOX1 [Gene or Genome]

Phrase: "is"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "mainly in the perinuclear areas of both healthy"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0205146:areas [Spatial Concept]
   711 E C0017446:Area [Geographic Area]

Phrase: "and"

Phrase: "degenerative neurons from an AD hippocampus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0027882:Neurons [Cell]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.115: Degenerative neurons possess cytoplasmic NFTs and/or granulovacuolar degeneration (Fig. 1A). 

Phrase: "Degenerative neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "possess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "cytoplasmic NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   901   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   867 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "and/or"

Phrase: "granulovacuolar degeneration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0333454:Granulovacuolar degeneration [Pathologic Function]
   861   C0011164:Degeneration [Pathologic Function]
   861   C1880269:Degeneration [Functional Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.116: Compared with healthy neurons, these degenerative neurons have reduced levels of WOX1. 

Phrase: "Compared with healthy neurons,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0027882:Neurons [Cell]
   770   C1707455:Compared [Activity]

Phrase: "these degenerative neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "have"

Phrase: "reduced levels of WOX1."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.117: Similarly dystrophic neuritic plaques, an important diagnostic feature for AD, were weakly immunoreactive to WOX1 antibodies (Fig. 1A). 

Phrase: "Similarly dystrophic neuritic plaques,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0333463:Neuritic Plaques [Acquired Abnormality]
           plaques
   779 E C0011389:Plaque [Disease or Syndrome]
   779 E C0332461:Plaque [Finding]
   741   C0027813:Neuritides [Disease or Syndrome]

Phrase: "an important diagnostic feature for AD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1521970:Feature [Qualitative Concept]
   753   C1706388:Feature [Conceptual Entity]
   753   C2346469:Feature [Qualitative Concept]
   753   C2348519:Feature [Qualitative Concept]

Phrase: "were"

Phrase: "weakly immunoreactive to WOX1 antibodies"

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.118: View larger version (75K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(75K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.119: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.120: Down-regulation of WOX1, p-WOX1, and WOX2 expression in the hippocampal neurons of AD brains. 

Phrase: "Down-regulation of WOX1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0013081:Down-Regulation [Cell Function,Molecular Function]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]
   715   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   715   C2626739:Lanugo [Eukaryote]

Phrase: "p-WOX1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "WOX2 expression in the hippocampal neurons of AD brains."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.121: A, in the healthy neuron (arrowhead), WOX1 is located mainly in the perinuclear area (left panel). 

Phrase: "A,"

Phrase: "in the healthy neuron"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(arrowhead"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0453107:Arrowhead [Food]
  1000   C1080898:Arrowhead [Plant]

Phrase: ")"

Phrase: ","

Phrase: "WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421525:WOX1 [Gene or Genome]

Phrase: "is"

Phrase: "located"

Phrase: "mainly in the perinuclear area"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017446:Area [Geographic Area]
   760   C0205146:Area [Spatial Concept]

Phrase: "(left panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.122: Degenerative neurons possess cytoplasmic NFTs (open arrow) or granulovacuolar degeneration (solid arrow). 

Phrase: "Degenerative neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "possess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "cytoplasmic NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   901   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   867 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "(open arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: "or"

Phrase: "granulovacuolar degeneration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0333454:Granulovacuolar degeneration [Pathologic Function]
   861   C0011164:Degeneration [Pathologic Function]
   861   C1880269:Degeneration [Functional Concept]

Phrase: "(solid arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:Arrow [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.123: WOX1 is weakly expressed in dystrophic neuritic plaque (open arrow) and is also present in small neuron (arrowhead) and astrocytic glial cell (solid arrow) (right panel). 

Phrase: "WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421525:WOX1 [Gene or Genome]

Phrase: "is"

Phrase: "weakly"

Phrase: "expressed in dystrophic neuritic plaque"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0333463:Plaque, Neuritic [Acquired Abnormality]
           plaque
   760   C0011389:Plaque [Disease or Syndrome]
   760   C0332461:Plaque [Finding]
   760   C0333607:Dystrophic [Functional Concept]

Phrase: "(open arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "is"

Phrase: "also"

Phrase: "present in small neuron"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0228075:Small neuron [Cell]
   770   C0027882:Neuron [Cell]
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
   770   C0700321:Small [Quantitative Concept]

Phrase: "(arrowhead"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0453107:Arrowhead [Food]
  1000   C1080898:Arrowhead [Plant]

Phrase: ")"

Phrase: "and"

Phrase: "astrocytic glial cell"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0027836:Glial cell [Cell]
           Glial
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   755 E C1087003:Glia [Plant]

Phrase: "(solid arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: "(right panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.124: Immunostaining was performed using antibodies against a conserved segment in the NH2 terminus of WOX1 (7). 

Phrase: "Immunostaining"

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibodies against a conserved segment"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "in the NH2 terminus"

Phrase: "of WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421525:WOX1 [Gene or Genome]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.125: B, WOX1 expression is down-regulated in the neurons of AD hippocampi compared with normal controls (a representative set from five immunostains; amplification, 200x). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "WOX1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "down-regulated in the neurons of AD hippocampi"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   744   C0027882:Neurons [Cell]
   744   C0851285:Regulated [Governmental or Regulatory Activity]
   744   C0949582:Hippocampus [Fish]
   744   C1029104:Hippocampus [Fish]
   744   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "compared with normal controls"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   799   C2705716:normal control [Qualitative Concept]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C1707455:Compared [Activity]
   770   C2347086:% Normal [Quantitative Concept]
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]

Phrase: "("

Phrase: "a representative set from five immunostains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0036849:Set [Mental Process]
   753   C1442518:Set [Functional Concept]
   753   C1705195:Set [Conceptual Entity]

Phrase: "; amplification,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1517480:Amplification [Molecular Biology Research Technique]
  1000   C1521871:Amplification [Phenomenon or Process]
  1000   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "200x"

Phrase: ")."
Processing 00000000.tx.126: Antiserum against the unique COOH terminus of human WOX1 was used in the immunohistochemistry (see "Experimental Procedures"). 

Phrase: "Antiserum against the unique COOH terminus of human WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "used in the immunohistochemistry"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0021044:Immunohistochemistry [Laboratory Procedure]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "(see ""Experimental Procedures"""
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0025664:procedures [Intellectual Product]
   827   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C2700391:procedures [Activity]
   793 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   793 E C3274430:PROCEDURE [Health Care Activity]
   793 E C3538935:Procedure [Idea or Concept]
   793 E C3539779:Procedure [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.127: This newly produced antiserum interacted with the full-length 46-kDa WOX1 in the extract (50 g) of a normal human brain. 

Phrase: "This newly produced antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "interacted with the full-length 46-kDa WOX1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0443225:Full [Qualitative Concept]
   744   C1421525:WOX1 [Gene or Genome]
   744   C1444754:Length [Quantitative Concept]
   744   C1532717:kDa [Quantitative Concept]
   744   C1706316:LENGTH [Research Activity]

Phrase: "in the extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828366:Extract [Substance]

Phrase: "(50 g) of a normal human brain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.128: C, our newly generated antibodies interacted with the 41-kDa WOX2 in the extract (50 g) of a normal human brain. 

Phrase: "C,"

Phrase: "our newly generated antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "interacted with the 41-kDa WOX2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1532717:kDa [Quantitative Concept]

Phrase: "in the extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828366:Extract [Substance]

Phrase: "(50 g) of a normal human brain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.129: Reduced immunoreactivity of WOX2 was found in the neurons of AD brains compared with those cells in control brains (amplification, 200x). 

Phrase: "Reduced immunoreactivity of WOX2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "found in the neurons of AD brains"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0006104:Brains [Body Part, Organ, or Organ Component]
   748   C0027882:Neurons [Cell]
   748   C0150312:Found [Quantitative Concept]
   714 E C0243095:Find [Finding]
   714 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "compared with those cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1707455:Compared [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "in control brains"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(amplification,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1517480:Amplification [Molecular Biology Research Technique]
  1000   C1521871:Amplification [Phenomenon or Process]
  1000   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "200x"

Phrase: ")."
Processing 00000000.tx.130: Ab, antibody.  

Phrase: "Ab,"

Phrase: "antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.131: Compared with normal controls, down-regulation of WOX1 was observed in the hippocampal neurons in AD (Fig. 1B). 

Phrase: "Compared with normal controls,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   799   C2705716:normal control [Qualitative Concept]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C1707455:Compared [Activity]
   770   C2347086:% Normal [Quantitative Concept]
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]

Phrase: "down-regulation of WOX1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0013081:Down-Regulation [Cell Function,Molecular Function]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]
   715   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   715   C2626739:Lanugo [Eukaryote]

Phrase: "was"

Phrase: "observed in the hippocampal neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   760   C0027882:Neurons [Cell]
   760   C1441672:Observed [Functional Concept]

Phrase: "in AD (Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.132: The results were observed using antibodies against the unique COOH terminus of human WOX1 (Fig. 1B). 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibodies against the unique COOH terminus of human WOX1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   708 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.133: The full-length WOX1 (46 kDa) is the major species found in tissues and cultured cells compared with other members of the WWOX/FOR/WOX1 protein family (7, 11). 

Phrase: "The full-length WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1421525:WOX1 [Gene or Genome]

Phrase: "(46 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "is"

Phrase: "the major species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "found in tissues"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0040300:Tissues [Tissue]
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]
   756 E C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "cultured cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "compared with other members of the WWOX/"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0680022:members [Population Group]
   748   C1421525:WWOX [Gene or Genome]
   748   C1707455:Compared [Activity]
   714 E C2698041:Member [Professional or Occupational Group]

Phrase: "FOR/WOX1 protein family"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0015576:Family [Family Group]
   827   C1704727:Family [Conceptual Entity]
   755 E C0241888:Familial [Functional Concept]

Phrase: "(7,"

Phrase: "11"

Phrase: ")."
Processing 00000000.tx.134: Similar results were also obtained using our previously developed antibodies against the NH2 terminus of WOX1 (7) (see Supplemental Figs. 13). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "also"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "our previously developed antibodies against the NH2 terminus of WOX1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   706 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(7"

Phrase: ")"

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Supplemental Figs. 13"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0349966:Figs [Food]
   827   C2348609:Supplemental [Functional Concept]
   793 E C1337208:FIG [Food]
   755 E C0242295:Supplement [Food]
   755 E C1947943:Supplement [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.135: In parallel with the above results, the level of a WOX1 isoform, WOX2 (41 kDa), was relatively higher in healthy neurons than that in the AD (Fig. 1C). 

Phrase: "In parallel with the above results,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0150312:In [Quantitative Concept]
   753   C0332285:In [Spatial Concept]
   753   C2348042:Parallel [Qualitative Concept]
   753   C2826345:PARALLEL [Research Activity]

Phrase: "the level of a WOX1 isoform,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "WOX2"

Phrase: "(41 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "relatively higher in healthy neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "than that"

Phrase: "in the AD (Fig. 1C"

Phrase: ")."
Processing 00000000.tx.136: The specificity of anti-WOX2 antibodies is shown in Western blotting using a control brain extract (Fig. 1C). 

Phrase: "The specificity of anti-WOX2 antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   783   C0003264:antibodies specificity [Molecular Function]
   753   C0037791:Specificity [Quantitative Concept]
   753   C1511884:Specificity [Quantitative Concept]
   731 E C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "shown in Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]
   737   C1547282:Show [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a control brain extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "(Fig. 1C"

Phrase: ")."
Processing 00000000.tx.137: Although WOX1 is phosphorylated at Tyr33 during stress and apoptotic responses (10), a portion of endogenous WOX1 is indeed Tyr33-phosphorylated in numerous cultured cell lines, brains, and other organs.2 Significant reduction of Tyr33 phosphorylation in WOX1 was also observed in the hippocampal neurons of AD brains compared with normal controls (see Supplemental Figs. 13). 

Phrase: "Although"

Phrase: "WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421525:WOX1 [Gene or Genome]

Phrase: "is"

Phrase: "phosphorylated at Tyr33"

Phrase: "during stress"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0038435:Stress [Finding]
   928 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "apoptotic responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0871261:responses [Organism Attribute]
   827 E C1704632:Response [Finding]
   827 E C1706817:Response [Intellectual Product]
   827 E C2911692:Response [Mental Process]

Phrase: "(10"

Phrase: ")"

Phrase: ","

Phrase: "a portion of endogenous WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449719:Portion [Spatial Concept]

Phrase: "is"

Phrase: "indeed Tyr33-"

Phrase: "phosphorylated in numerous cultured cell lines,"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   799   C0007600:Cultured Cell Line [Cell]
           Cell lines
   790   C0007635:cultured cell [Cell]
   773 E C0007585:culture cell [Laboratory Procedure]
   753   C0007634:Cell [Cell]
   753   C0205132:lines [Spatial Concept]
   753   C0439064:Numerous [Quantitative Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]
   719   C2242979:Culture [Laboratory Procedure]

Phrase: "brains,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "other organs.2 Significant reduction of Tyr33 phosphorylation in WOX1"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   757   C0682323:Significant other [Family Group]
   757   C1553704:significant other [Intellectual Product]
   739   C0031715:Phosphorylation [Molecular Function]
   739   C0178784:organs [Body Part, Organ, or Organ Component]
   739   C0205394:Other [Qualitative Concept]
   739   C0237881:significant [Quantitative Concept]
   739   C0301630:Reduction [Natural Phenomenon or Process]
   739   C0392756:Reduction [Qualitative Concept]
   739   C0441610:Reduction [Therapeutic or Preventive Procedure]
   739   C0750502:Significant [Idea or Concept]
   739   C1158886:Phosphorylation [Molecular Function]
   739   C1421525:WOX1 [Gene or Genome]
   739   C1546944:Significant [Qualitative Concept]

Phrase: "was"

Phrase: "also"

Phrase: "observed in the hippocampal neurons of AD brains"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   744   C0006104:Brains [Body Part, Organ, or Organ Component]
   744   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   744   C0027882:Neurons [Cell]
   744   C1441672:Observed [Functional Concept]
   711 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "compared with normal controls"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   799   C2705716:normal control [Qualitative Concept]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C1707455:Compared [Activity]
   770   C2347086:% Normal [Quantitative Concept]
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Supplemental Figs. 13"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0349966:Figs [Food]
   827   C2348609:Supplemental [Functional Concept]
   793 E C1337208:FIG [Food]
   755 E C0242295:Supplement [Food]
   755 E C1947943:Supplement [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.138: In appropriate controls, tissue sections were stained with prebled rabbit sera or preblocked with specific synthetic peptides and shown to be negative for immunoreactivity (data not shown). 

Phrase: "In appropriate controls,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "tissue sections"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   983   C2316368:Tissue section [Tissue]
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "stained with prebled rabbit sera"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0034493:Rabbit [Mammal]
   760   C0229671:Sera [Body Substance]
   760   C1151254:SerA [Molecular Function]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   726 E C1546774:Serum [Intellectual Product]
   726 E C1550100:Serum [Body Substance]

Phrase: "or"

Phrase: "preblocked with specific synthetic peptides"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   773   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   760   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   760   C0205369:Specific [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]
   760   C1883254:synthetic [Activity]

Phrase: "and"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "negative for immunoreactivity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205160:Negative [Qualitative Concept]
   790   C1513916:Negative [Finding]
   790   C2825415:Negative [Conceptual Entity]
   790   C2825491:Negative [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.139: We confirmed the validity of the above observations by determining the expression of WOX1 and its isoforms in the extracts of AD and control hippocampi. 

Phrase: "We"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the validity of the above observations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2349101:Validity [Quantitative Concept]

Phrase: "by determining"

Phrase: "the expression of WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "its isoforms in the extracts of AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "control hippocampi."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   861   C0949582:Hippocampus [Fish]
   861   C1029104:Hippocampus [Fish]
   861   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
Processing 00000000.tx.140: Shown in Fig. 

Phrase: "Shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.141: 2 are representative immunoblots of WOX1, p-WOX1, WOX2, and -tubulin from the extracts of AD and control hippocampi. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "are"

Phrase: "representative immunoblots of WOX1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "p-WOX1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "WOX2,"

Phrase: "and -"

Phrase: "tubulin from the extracts of AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C2937342:tubulin [Cell Component]

Phrase: "and"

Phrase: "control hippocampi."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   861   C0949582:Hippocampus [Fish]
   861   C1029104:Hippocampus [Fish]
   861   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
Processing 00000000.tx.142: The results demonstrate significant down-regulation of WOX1, p-WOX1, and WOX2 in the AD brain extracts compared with age-matched controls (32  5% reduction, Fig. 2). 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "significant down-regulation of WOX1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0013081:Down-Regulation [Cell Function,Molecular Function]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]
   704   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   704   C2626739:Lanugo [Eukaryote]

Phrase: "p-WOX1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "WOX2 in the AD brain extracts"

Phrase: "compared with age-matched controls"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0001779:Age [Organism Attribute]
   760   C0150103:matched [Research Activity]
   760   C1707455:Compared [Activity]
   760   C1708943:Matched [Qualitative Concept]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "(32  5% reduction,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0301630:Reduction [Natural Phenomenon or Process]
   827   C0392756:Reduction [Qualitative Concept]
   827   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.143: View larger version (32K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(32K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.144: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.145: Down-regulation of WOX1, WOX2, and p-WOX1 in AD hippocampi compared with age-matched controls. 

Phrase: "Down-regulation of WOX1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0013081:Down-Regulation [Cell Function,Molecular Function]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]
   715   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   715   C2626739:Lanugo [Eukaryote]

Phrase: "WOX2,"

Phrase: "and"

Phrase: "p-WOX1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "in AD hippocampi"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   861   C0949582:Hippocampus [Fish]
   861   C1029104:Hippocampus [Fish]
   861   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "compared with age-matched controls."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0001779:Age [Organism Attribute]
   760   C0150103:matched [Research Activity]
   760   C1707455:Compared [Activity]
   760   C1708943:Matched [Qualitative Concept]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.146: A, representative immunoblots of WOX1 (46 kDa), WOX2 (41 kDa), p-WOX1 (46 kDa), and -tubulin (55 kDa) are shown using the extracts of AD and control hippocampi. 

Phrase: "A,"

Phrase: "representative immunoblots of WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "(46 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "WOX2"

Phrase: "(41 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "p-WOX1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "(46 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and -"

Phrase: "tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "(55 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "are"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the extracts of AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C2828366:Extract [Substance]

Phrase: "and"

Phrase: "control hippocampi."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   861   C0949582:Hippocampus [Fish]
   861   C1029104:Hippocampus [Fish]
   861   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
Processing 00000000.tx.147: B, a scatter plot of the tested samples is shown. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "a scatter plot of the tested samples"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439742:scatter [Spatial Concept]

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.148: Significant down-regulation of WOX1 (n = 8), WOX2 (n = 8), and p-WOX1 (n = 6) is shown in the AD hippocampi compared with age-matched normal controls (32  5% reduction). 

Phrase: "Significant down-regulation of WOX1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0013081:Down-Regulation [Cell Function,Molecular Function]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]
   704   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   704   C2626739:Lanugo [Eukaryote]

Phrase: "(n = 8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "WOX2"

Phrase: "(n = 8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "p-WOX1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "(n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "is"

Phrase: "shown in the AD hippocampi"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   760   C0949582:Hippocampus [Fish]
   760   C1029104:Hippocampus [Fish]
   760   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
   726   C1547282:Show [Intellectual Product]

Phrase: "compared with age-matched normal controls"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   756   C2705716:normal control [Qualitative Concept]
   753   C0001779:Age [Organism Attribute]
   753   C0150103:matched [Research Activity]
   753   C0205307:Normal [Qualitative Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C1707455:Compared [Activity]
   753   C1708943:Matched [Qualitative Concept]
   753   C2347086:% Normal [Quantitative Concept]
   719   C0243148:control [Qualitative Concept]
   719   C1550141:Control [Substance]
   719   C1882979:Control [Conceptual Entity]
   719   C2587213:Control [Functional Concept]
   719   C3274648:Control [Qualitative Concept]

Phrase: "(32  5% reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0301630:Reduction [Natural Phenomenon or Process]
   827   C0392756:Reduction [Qualitative Concept]
   827   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: ")."
Processing 00000000.tx.149: C, control.  

Phrase: "C,"

Phrase: "control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.150: Knock-down of WOX1 Expression Induces Tau Phosphorylation at Thr212/Thr231 and NFT FormationTo determine the potential functional significance regarding WOX1 down-regulation in the AD hippocampi, we knocked down WOX1 expression by siRNA (WOX1si, constructed in pSuppressorNeo plasmid) in human SK-N-SH neuroblastoma cells. 

Phrase: "Knock-down of WOX1 Expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   704   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   704   C2626739:Lanugo [Eukaryote]

Phrase: "Induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "Tau Phosphorylation at Thr212/Thr231"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "NFT FormationTo"

Phrase: "determine"

Phrase: "the potential functional significance regarding WOX1 down-regulation in the AD hippocampi,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0013081:Down-Regulation [Cell Function,Molecular Function]
   736   C0851285:Regulation [Governmental or Regulatory Activity]
   736   C1327622:Regulation [Biologic Function]

Phrase: "we"

Phrase: "knocked down WOX1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C1421525:WOX1 [Gene or Genome]

Phrase: "by siRNA (WOX1si,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "constructed in pSuppressorNeo plasmid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   737   C2827421:Construct [Classification]

Phrase: ")"

Phrase: "in human SK-N-SH neuroblastoma cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   895   C0427861:Human cells [Laboratory or Test Result]
   810   C0815000:neuroblastoma cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.151: The designed siRNA targeted the unique 3' end sequence of human WOX1 mRNA. 

Phrase: "The designed siRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0521102:interfering [Qualitative Concept]
   812   C0700321:Small [Quantitative Concept]

Phrase: "targeted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeted [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "the unique 3' end sequence of human WOX1 mRNA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0004793:Sequence [Nucleotide Sequence]
   742   C0162326:Sequence [Nucleotide Sequence]
   742   C0162327:Sequence [Nucleotide Sequence]
   742   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.152: Transient expression of WOXsi in SK-N-SH cells suppressed WOX1 protein expression by greater than 50% compared with control cells expressing a scrambled siRNA (Fig. 3A). 

Phrase: "Transient expression of WOXsi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in SK-N-SH cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]

Phrase: "WOX1 protein expression by greater"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1171362:protein expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "than 50%"

Phrase: "compared with control cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   770   C0007634:Cells [Cell]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "a scrambled siRNA (Fig. 3A"

Phrase: ")."
Processing 00000000.tx.153: In these WOX1si-expressing cells, phosphorylation of Tau at Thr231 (55 kDa but not 100 kDa) and Thr212 (120 kDa) was significantly increased (Fig. 3A). 

Phrase: "In these WOX1si-expressing cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "phosphorylation of Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "at Thr231"

Phrase: "(55 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "but"

Phrase: "not 100 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1532717:kDa [Quantitative Concept]

Phrase: "and"

Phrase: "Thr212"

Phrase: "(120 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "was"

Phrase: "significantly"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.154: Phosphorylation of these sites is GSK-3-dependent. 

Phrase: "Phosphorylation of these sites"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C1519063:Phosphorylation Site [Amino Acid Sequence]
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "is"

Phrase: "GSK-3-dependent."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0851827:Dependent [Qualitative Concept]
   804   C1701901:Dependent [Qualitative Concept]
   804   C3244310:dependent [Functional Concept]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.155: Also WOX1si increased NFT formation in SK-N-SH cells as determined by cell immunostaining and Western blotting (Fig. 3B). 

Phrase: "Also WOX1si"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "NFT formation in SK-N-SH cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]

Phrase: "as"

Phrase: "determined by cell immunostaining"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.156: The soluble fraction of NFTs (55, 75, and 120 kDa) was shown in Western blotting. 

Phrase: "The soluble fraction of NFTs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1264633:Fraction of [Quantitative Concept]
           Fraction
   753   C1554103:Fraction [Idea or Concept]

Phrase: "(55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "75,"

Phrase: "and"

Phrase: "120 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "was"

Phrase: "shown in Western blotting."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.157: The Thr212-phosphorylated Tau (120 kDa) in SK-N-SH cells corresponds to the soluble 120-kDa NFTs, suggesting that Thr212 is phosphorylated when Tau is polymerized to this size. 

Phrase: "The Thr212-phosphorylated Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "(120 kDa) in SK-N-SH cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1532717:kDa [Quantitative Concept]

Phrase: "corresponds to the soluble 120-kDa NFTs,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   744   C1532717:kDa [Quantitative Concept]
   744   C1749467:soluble [Cell Component]
   744   C1948047:Soluble [Qualitative Concept]
   737 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that Thr212"

Phrase: "is"

Phrase: "phosphorylated"

Phrase: "when"

Phrase: "Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "is"

Phrase: "polymerized to this size."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0314672:Polymerized [Phenomenon or Process]
   770   C0456389:size [Spatial Concept]
Processing 00000000.tx.158: View larger version (43K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(43K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.159: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.160: Suppression of WOX1 expression by siRNA (WOX1si) induces Tau phosphorylation at Thr231 and Thr212 in SK-N-SH neuroblastoma cells. 

Phrase: "Suppression of WOX1 expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0221103:Suppression [Pathologic Function]
   770   C0301625:Suppression [Organism Function]
   770   C0439181:% suppression [Quantitative Concept]
   770   C0728721:suppression [Mental Process]

Phrase: "by siRNA (WOX1si"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "Tau phosphorylation at Thr231"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "Thr212 in SK-N-SH neuroblastoma cells."
Processing 00000000.tx.161: A, transient expression of WOXsi (in pSuppressorNeo) in SK-N-SH cells inhibited WOX1 protein expression (>50%) as compared with scrambled siRNA-expressing cells. 

Phrase: "A,"

Phrase: "transient expression of WOXsi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: "in pSuppressorNeo"

Phrase: ")"

Phrase: "in SK-N-SH cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "WOX1 protein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1171362:protein expression [Genetic Function]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: ">50%"

Phrase: ")"

Phrase: "as"

Phrase: "compared with scrambled siRNA-expressing cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   800   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0007634:Cells [Cell]
   744   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0521102:interfering [Qualitative Concept]
   744   C0700321:Small [Quantitative Concept]
   744   C1707455:Compared [Activity]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.162: WOX1si targeted the 3' end of the human WOX1 mRNA. 

Phrase: "WOX1si"

Phrase: "targeted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeted [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "the 3' end of the human WOX1 mRNA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0444930:End [Spatial Concept]
   744   C2746065:End [Temporal Concept]
Processing 00000000.tx.163: Phosphorylation of Tau at Thr231 (55 kDa) and Thr212 (120 kDa) was increased in the WOXsi-expressing cells. 

Phrase: "Phosphorylation of Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "at Thr231"

Phrase: "(55 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "and"

Phrase: "Thr212"

Phrase: "(120 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "was"

Phrase: "increased in the WOXsi-expressing cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0007634:Cells [Cell]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.164: Activation of JNK1 in these cells by anisomycin (100 M, 1 h) further induced Tau phosphorylation at these sites. 

Phrase: "Activation of JNK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "in these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "by anisomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003082:Anisomycin [Antibiotic,Organic Chemical]

Phrase: "(100 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "1 h) further induced Tau phosphorylation at these sites."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   745   C1519063:Phosphorylation Site [Amino Acid Sequence]
   742   C0031715:Phosphorylation [Molecular Function]
   742   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.165: Percent increases in Tau phosphorylation are indicated. 

Phrase: "Percent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439165:Percent [Quantitative Concept]

Phrase: "increases in Tau phosphorylation"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C0442805:Increase [Functional Concept]
   770   C1158886:Phosphorylation [Molecular Function]
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]
   715 E C1517378:Gain [Quantitative Concept]

Phrase: "are"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.166: B, similarly SK-N-SH cells were transfected with the above siRNA constructs, cultured for 48 h, and stained with specific antibody against NFTs (red). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "similarly SK-N-SH cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with the above siRNA constructs,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   800   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0521102:interfering [Qualitative Concept]
   744   C0700321:Small [Quantitative Concept]
   711   C2827421:Construct [Classification]

Phrase: "cultured for 48 h,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "stained with specific antibody"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0205369:Specific [Qualitative Concept]
   770   C1552740:specific [Intellectual Product]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "against NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "(red"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.167: Nuclei were stained with 4',6-diamidino-2-phenylindole (DAPI; blue). 

Phrase: "Nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007610:Nucleus [Cell Component]

Phrase: "were"

Phrase: "stained with 4',"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "6-diamidino-2-phenylindole (DAPI; blue)."
Processing 00000000.tx.168: Increased NFT formation is shown in the WOXsi-expressing cells as determined by both cell immunostaining and Western blotting (soluble fractions of NFTs). 

Phrase: "Increased NFT formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "is"

Phrase: "shown in the WOXsi-expressing cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719   C1547282:Show [Intellectual Product]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "determined by both cell immunostaining"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0007634:Cell [Cell]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "(soluble fractions of NFTs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1264633:Fraction of [Quantitative Concept]
           Fractions
   726 E C1554103:Fraction [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.169: C, phosphorylation of Thr231 (p-T231) and Thr212 (p-T212) were significantly increased in the AD hippocampi (n = 8) compared with age-matched controls (n = 8). 

Phrase: "C,"

Phrase: "phosphorylation of Thr231 (p-T231)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "Thr212"

Phrase: "(p-T212"

Phrase: ")"

Phrase: "were"

Phrase: "significantly"

Phrase: "increased in the AD hippocampi"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0949582:Hippocampus [Fish]
   760   C1029104:Hippocampus [Fish]
   760   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "(n = 8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "compared with age-matched controls"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0001779:Age [Organism Attribute]
   760   C0150103:matched [Research Activity]
   760   C1707455:Compared [Activity]
   760   C1708943:Matched [Qualitative Concept]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "(n = 8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.170: Four representative data are shown in the Western blot. 

Phrase: "Four representative data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "shown in the Western blot."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   806   C0949466:Western Blot [Laboratory Procedure]
   760   C1705493:Western [Spatial Concept]
   726   C1547282:Show [Intellectual Product]
Processing 00000000.tx.171: **, p < 0.05; 

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.172: ***, p < 0.01 (Student's t test). 

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "(Student's t test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.173: Cont, control.  

Phrase: "Cont,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2826258:CONT [Event]

Phrase: "control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.174: In parallel, Tau phosphorylation at Thr231 and Thr212 was also significantly increased in the AD hippocampi (Fig. 3C). 

Phrase: "In parallel, Tau phosphorylation at Thr231"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "Thr212"

Phrase: "was"

Phrase: "also significantly"

Phrase: "increased in the AD hippocampi"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0949582:Hippocampus [Fish]
   760   C1029104:Hippocampus [Fish]
   760   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.175: Activation of JNK1 by anisomycin further increased phosphorylation of Tau at Thr231 and Thr212 in scrambled siRNA- and WOX1si-expressing cells (Fig. 3A). 

Phrase: "Activation of JNK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "by anisomycin further increased phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031715:Phosphorylation [Molecular Function]
   812   C1158886:Phosphorylation [Molecular Function]

Phrase: "of Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "at Thr231"

Phrase: "and"

Phrase: "Thr212 in scrambled siRNA-"

Phrase: "and"

Phrase: "WOX1si-expressing cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.176: These observations suggest that, under stress conditions, JNK1 is able to phosphorylate Tau at Thr231 and Thr212. 

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that,"

Phrase: "under stress conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "JNK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367731:JNK1 [Gene or Genome]
  1000   C1705632:JNK1 [Gene or Genome]

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "phosphorylate"

Phrase: "Tau at Thr231"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720655:Tau [Intellectual Product]
   790   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "Thr212."
Processing 00000000.tx.177: Conserved phosphorylation sites are found in Tau isoforms from 35 to 75 kDa. 

Phrase: "Conserved phosphorylation sites"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   867   C1519063:Phosphorylation Site [Amino Acid Sequence]
   827   C0031715:Phosphorylation [Molecular Function]
   827   C0205145:Sites [Spatial Concept]
   827   C1158886:Phosphorylation [Molecular Function]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "found in Tau isoforms"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0150312:Found [Quantitative Concept]
   770   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]
   737 E C0243095:Find [Finding]

Phrase: "from 35"

Phrase: "to 75 kDa."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]
Processing 00000000.tx.178: Tau possesses three repeats of a microtubule-binding domain (35-kDa Tau) or three to four repeats (>35-kDa Tau) (23, 32). 

Phrase: "Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "possesses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "three repeats of a microtubule-binding domain"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0205341:repeats [Functional Concept]
   748   C1705914:Repeats [Conceptual Entity]
   714 E C1547730:Repeat [Temporal Concept]

Phrase: "(35-kDa Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: ")"

Phrase: "or"

Phrase: "three to four repeats"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205341:repeats [Functional Concept]
   770   C0205449:Three [Quantitative Concept]
   770   C0205450:Four [Quantitative Concept]
   770   C1705914:Repeats [Conceptual Entity]
   737 E C1547730:Repeat [Temporal Concept]

Phrase: "("

Phrase: ">35-kDa Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: ")"

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.179: Phosphorylation of these sites has been found in PHF-Tau or tangled Tau (3335). 

Phrase: "Phosphorylation of these sites"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C1519063:Phosphorylation Site [Amino Acid Sequence]
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "has"

Phrase: "been"

Phrase: "found in PHF-Tau"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C2700455:PHF-Tau [Amino Acid, Peptide, or Protein]
   770   C0150312:Found [Quantitative Concept]
   770   C0597162:PHF [Cell or Molecular Dysfunction]
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]
   737 E C0243095:Find [Finding]

Phrase: "or"

Phrase: "tangled Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "(3335"

Phrase: ")."
Processing 00000000.tx.180: Compared with age-matched controls, a panel of Tau phosphorylation at various threonine and serine sites in the AD hippocampi is shown in Supplemental Figs. 

Phrase: "Compared with age-matched controls,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0001779:Age [Organism Attribute]
   760   C0150103:matched [Research Activity]
   760   C1707455:Compared [Activity]
   760   C1708943:Matched [Qualitative Concept]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "a panel of Tau phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0441833:Panel [Idea or Concept]
   760   C1999270:Panel [Intellectual Product]
   760   C3537156:Panel [Manufactured Object]

Phrase: "at various threonine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040005:Threonine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "serine sites in the AD hippocampi"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0205145:Sites [Spatial Concept]
   719 E C1515974:Site [Body Location or Region]
   719 E C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "shown in Supplemental Figs."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0349966:Figs [Food]
   770   C2348609:Supplemental [Functional Concept]
   737 E C1337208:FIG [Food]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.181: 13. 

Phrase: "13."
Processing 00000000.tx.182: Retroviral Expression of WOX1siThe above observations were further verified using retroviral expression of WOX1si (targeting the same 3' end region of WOX1 mRNA as indicated above). 

Phrase: "Retroviral Expression of WOX1siThe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "above observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "were"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "verified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verified [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "retroviral expression of WOX1si"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: "targeting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeting [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "the same 3' end region of WOX1 mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0017446:Region [Geographic Area]
   744   C0205147:Region [Spatial Concept]

Phrase: "as"

Phrase: "indicated above"

Phrase: ")."
Processing 00000000.tx.183: Cells were transfected with the WOX1si or an empty retrovirus and cultured for 48 h. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with the WOX1si"

Phrase: "or"

Phrase: "an empty retrovirus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035366:Retrovirus [Virus]

Phrase: "and"

Phrase: "cultured for 48 h."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.184: Suppression of WOX1 expression in SK-N-SH cells was observed (Fig. 4A). 

Phrase: "Suppression of WOX1 expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0221103:Suppression [Pathologic Function]
   770   C0301625:Suppression [Organism Function]
   770   C0439181:% suppression [Quantitative Concept]
   770   C0728721:suppression [Mental Process]

Phrase: "in SK-N-SH cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.185: View larger version (57K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(57K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.186: 4. 

Phrase: "4."
Processing 00000000.tx.187: Retroviral expression of WOX1si induces phosphorylation of GSK-3 and ERK and Tau phosphorylation at Ser515/Ser516 and Thr212/Ser214 in SK-N-SH cells. 

Phrase: "Retroviral expression of WOX1si"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "phosphorylation of GSK-3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
   716   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "ERK"

Phrase: "and"

Phrase: "Tau phosphorylation at Ser515/Ser516"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "Thr212/Ser214 in SK-N-SH cells."
Processing 00000000.tx.188: A, retroviral expression of WOX1si (in pSuppressorRetro) in SK-N-SH cells suppressed cytosolic WOX1 protein expression in 48 h (duplicate loadings). 

Phrase: "A,"

Phrase: "retroviral expression of WOX1si"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: "in pSuppressorRetro"

Phrase: ")"

Phrase: "in SK-N-SH cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]

Phrase: "cytosolic WOX1 protein expression in 48 h (duplicate loadings"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1171362:protein expression [Genetic Function]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: ")."
Processing 00000000.tx.189: WOX1si targeted the 3' end of the human WOX1 mRNA (as indicated in Fig. 3). 

Phrase: "WOX1si"

Phrase: "targeted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeted [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "the 3' end of the human WOX1 mRNA ("
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0444930:End [Spatial Concept]
   744   C2746065:End [Temporal Concept]

Phrase: "as"

Phrase: "indicated in Fig. 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0349966:Fig [Food]
   770   C1337208:FIG [Food]
   770   C1444656:Indicated [Finding]

Phrase: ")."
Processing 00000000.tx.190: Suppression of WOX1 by siRNA induced phosphorylation of Tau at Ser515/Ser516 and Thr212/Ser214 (AT100 epitope in PHF-Tau). 

Phrase: "Suppression of WOX1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0221103:Suppression [Pathologic Function]
   790   C0301625:Suppression [Organism Function]
   790   C0439181:% suppression [Quantitative Concept]
   790   C0728721:suppression [Mental Process]

Phrase: "by siRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0521102:interfering [Qualitative Concept]
   827   C0700321:Small [Quantitative Concept]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "phosphorylation of Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "at Ser515/Ser516"

Phrase: "and"

Phrase: "Thr212/Ser214"

Phrase: "(AT100 epitope in PHF-Tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0003316:Epitope [Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.191: Enhanced phosphorylation of GSK-3 and ERK was observed. 

Phrase: "Enhanced phosphorylation of GSK-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "ERK"

Phrase: "was"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.192: E2 (40 nM) had no apparent effect on Tau phosphorylation after treatment of these cells for 30 min. 

Phrase: "E2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539520:E2 [Gene or Genome]

Phrase: "(40 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "had"

Phrase: "no apparent effect on Tau phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "after treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "of these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "for 30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.193: B, as determined by co-immunoprecipitation, an increased binding of phospho-GSK-3 with phospho-Tau in these WOX1 knock-down cells was observed. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "as"

Phrase: "determined by co-immunoprecipitation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   770   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "an increased binding of phospho-GSK-3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C1149289:kinase binding [Molecular Function]
   762   C3270761:glycogen binding [Molecular Function]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]

Phrase: "with phospho-Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "in these WOX1 knock-down cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.194: C, in comparison, ERK-dependent phosphorylation of Ser515/Ser516 was significantly increased in the AD hippocampi compared with age-matched controls. 

Phrase: "C,"

Phrase: "in comparison,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "ERK-dependent phosphorylation of Ser515/Ser516"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "significantly"

Phrase: "increased in the AD hippocampi"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0949582:Hippocampus [Fish]
   760   C1029104:Hippocampus [Fish]
   760   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "compared with age-matched controls."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0001779:Age [Organism Attribute]
   760   C0150103:matched [Research Activity]
   760   C1707455:Compared [Activity]
   760   C1708943:Matched [Qualitative Concept]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.195: A representative result from eight samples is shown. 

Phrase: "A representative result from eight samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.196: IgH, IgG heavy chain; 

Phrase: "IgH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017351:IGH [Gene or Genome]

Phrase: "IgG heavy chain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1440809:IgG.heavy chain [Immunologic Factor]
   901   C1420192:heavy chain [Gene or Genome]
   827   C0337112:Chain [Manufactured Object]
   827   C0439539:Heavy [Qualitative Concept]
   827   C1524075:Chain [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.197: IP, immunoprecipitation.  

Phrase: "IP,"

Phrase: "immunoprecipitation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]
Processing 00000000.tx.198: Suppression of WOX1 by siRNA increased phosphorylation of Tau at Ser515/Ser516 and Thr212/Ser214 (by 100%), and this positively correlates with enhanced phosphorylation of GSK-3 and ERK (Fig. 4A). 

Phrase: "Suppression of WOX1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0221103:Suppression [Pathologic Function]
   790   C0301625:Suppression [Organism Function]
   790   C0439181:% suppression [Quantitative Concept]
   790   C0728721:suppression [Mental Process]

Phrase: "by siRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0521102:interfering [Qualitative Concept]
   827   C0700321:Small [Quantitative Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "phosphorylation of Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "at Ser515/Ser516"

Phrase: "and"

Phrase: "Thr212/Ser214"

Phrase: "("

Phrase: "by 100%"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "this positively"

Phrase: "correlates with enhanced phosphorylation of GSK-3"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   818   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   742   C0031715:Phosphorylation [Molecular Function]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1158886:Phosphorylation [Molecular Function]
   742   C2349975:Enhanced [Activity]

Phrase: "and"

Phrase: "ERK (Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450373:4a [Intellectual Product]
   827   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.199: As determined by co-immunoprecipitation, there was an increased binding of phosphorylated GSK-3 with phospho-Tau in these WOX1 knock-down cells (Fig. 4B). 

Phrase: "As"

Phrase: "determined by co-immunoprecipitation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   770   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "there"

Phrase: "was"

Phrase: "an increased binding of phosphorylated GSK-3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C1149289:kinase binding [Molecular Function]
   762   C3270761:glycogen binding [Molecular Function]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]

Phrase: "with phospho-Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "in these WOX1 knock-down cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.200: In comparison, Tau phosphorylation at Ser515/Ser516 in control and AD hippocampi is shown (Fig. 4C). 

Phrase: "In comparison,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "Tau phosphorylation at Ser515/Ser516"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "in control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "AD hippocampi"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   861   C0949582:Hippocampus [Fish]
   861   C1029104:Hippocampus [Fish]
   861   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "(Fig. 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.201: Phosphorylation of Ser515/Ser516, Thr212, and Ser214 in Tau is mediated by ERK, GSK-3, and protein kinase A, respectively. 

Phrase: "Phosphorylation of Ser515/Ser516,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "Thr212,"

Phrase: "and"

Phrase: "Ser214 in Tau"

Phrase: "is"

Phrase: "mediated by ERK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "GSK-3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "protein kinase A,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "respectively."
Processing 00000000.tx.202: Phosphorylation of Thr212/Ser214 was determined using PHF-Tau antibodies (AT100). 

Phrase: "Phosphorylation of Thr212/Ser214"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PHF-Tau antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C2700455:PHF-Tau [Amino Acid, Peptide, or Protein]

Phrase: "(AT100"

Phrase: ")."
Processing 00000000.tx.203: The Alzheimer-specific AT100 epitope in Tau is present only in its PHF conformation (3235). 

Phrase: "The Alzheimer-specific AT100 epitope in Tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0003316:Epitope [Immunologic Factor]

Phrase: "is"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "only in its PHF conformation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0026377:Conformation [Spatial Concept]
   760   C0205171:Only [Quantitative Concept]
   760   C0597162:PHF [Cell or Molecular Dysfunction]
   760   C1720467:Only [Intellectual Product]

Phrase: "(3235"

Phrase: ")."
Processing 00000000.tx.204: Nonetheless little or no phosphorylation of Ser214 was observed in the hippocampi and SK-N-SH cells (data not shown) as determined using specific anti-Ser(P)214 antibodies. 

Phrase: "Nonetheless little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
   861   C0700321:Little [Quantitative Concept]
   861   C2700395:Little [Quantitative Concept]

Phrase: "or"

Phrase: "no phosphorylation of Ser214"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "observed in the hippocampi"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   770   C0949582:Hippocampus [Fish]
   770   C1029104:Hippocampus [Fish]
   770   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
   770   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "SK-N-SH cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "as"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "specific anti-Ser(P)214 antibodies."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   878   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   876   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   859 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   766 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.205: A recent study has shown that phosphorylation of Thr212 may affect the subsequent phosphorylation of Ser214 (36). 

Phrase: "A recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "has"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that phosphorylation of Thr212"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "may"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the subsequent phosphorylation of Ser214"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.206: Also Ser214 was not phosphorylated in a P301S Tau transgenic mouse model (37). 

Phrase: "Also Ser214"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "phosphorylated in a P301S Tau transgenic mouse model"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0025936:Mouse, Transgenic [Mammal]
   770   C2986594:Mouse Model [Experimental Model of Disease]
   767   C1519606:Transgenic Model [Experimental Model of Disease]
   744   C0003069:Transgenic [Animal]
   744   C0025914:Mouse [Mammal]
   744   C0025929:mouse [Mammal]
   744   C0026809:Mouse [Mammal]
   744   C1720655:Tau [Intellectual Product]
   744   C1947974:Tau [Research Activity]
   744   C3161035:Model [Intellectual Product]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.207: E2 protects SK-N-SH cells from apoptosis (25). 

Phrase: "E2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539520:E2 [Gene or Genome]

Phrase: "protects"

Phrase: "SK-N-SH cells from apoptosis"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.208: The above SK-N-SH cells were treated with E2 for 30 min. 

Phrase: "The above SK-N-SH cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with E2"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C1522326:Treated [Functional Concept]
   790   C3539520:E2 [Gene or Genome]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "for 30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.209: E2 had no apparent effect on the phosphorylation of Tau in both control and WOX1si-expressing SK-N-SH cells during a short term treatment (Fig. 4A), although it can effectively activate WOX1 in various types of cancer cells.2 Inhibition of Tau Phosphorylation and NFT Formation by PD-98059 and SP600125 in WOX1si-expressing CellsTo further substantiate our observations, we selected a sequence in the WW domain area for siRNA targeting. 

Phrase: "E2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539520:E2 [Gene or Genome]

Phrase: "had"

Phrase: "no apparent effect on the phosphorylation of Tau"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1301751:No effect [Qualitative Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "in both control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "WOX1si-expressing SK-N-SH cells during a short term treatment"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   738   C0007634:Cells [Cell]
   738   C3282337:Cells [Cell]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "it"

Phrase: "can"

Phrase: "effectively"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "WOX1 in various types of cancer cells.2 Inhibition of Tau Phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C1421525:WOX1 [Gene or Genome]

Phrase: "and"

Phrase: "NFT Formation by PD-98059"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "SP600125 in WOX1si-expressing CellsTo further"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0968383:SP600125 [Organic Chemical,Pharmacologic Substance]

Phrase: "substantiate"

Phrase: "our observations,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "we"

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "a sequence in the WW domain area"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C1519249:Sequence [Functional Concept]

Phrase: "for siRNA targeting."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C1521840:Targeting [Functional Concept]
   779 E C2986546:TARGET [Diagnostic Procedure]
   756   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.210: We established stable transfectants of L929 and SK-N-SH cells expressing the constructed WOX1si (in pSuppressorNeo) or a scrambled siRNA. 

Phrase: "We"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "stable transfectants of L929"

Phrase: "and"

Phrase: "SK-N-SH cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "the constructed WOX1si"

Phrase: "("

Phrase: "in pSuppressorNeo"

Phrase: ")"

Phrase: "or"

Phrase: "a scrambled siRNA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0521102:interfering [Qualitative Concept]
   812   C0700321:Small [Quantitative Concept]
Processing 00000000.tx.211: As expected, knock-down of WOX1 expression significantly induced NFT formation in L929 cells (Fig. 5A). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "knock-down of WOX1 expression significantly induced NFT formation"

Phrase: "in L929 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.212: The increased NFT formation was inhibited by exposure of these cells to an MEK1/2 inhibitor, PD-98059, and a JNK inhibitor, SP600125, for 1 h (Fig. 5A). 

Phrase: "The increased NFT formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "was"

Phrase: "inhibited by exposure of these cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0007634:Cells [Cell]
   753   C0274281:Exposure, NOS [Injury or Poisoning]
   753   C0311403:Inhibited [Qualitative Concept]
   753   C0332157:Exposure [Clinical Attribute]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "to an MEK1/2 inhibitor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "PD-98059,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0298346:PD 98059 [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "a JNK inhibitor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "SP600125,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0968383:SP600125 [Organic Chemical,Pharmacologic Substance]

Phrase: "for 1 h (Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.213: These chemicals also reduced the phosphorylation of Tau at Ser515/Ser516 (Fig. 5B, data not shown for PD-98059). 

Phrase: "These chemicals also"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0220806:Chemicals [Chemical]
   827 E C3272558:Chemical [Intellectual Product]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the phosphorylation of Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "at Ser515/Ser516"

Phrase: "(Fig. 5B,"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown for PD-98059"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0298346:PD 98059 [Organic Chemical,Pharmacologic Substance]
   737   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.214: These observations suggest that both ERK and JNK1 participate in the formation of NFTs in these WOX1si-expressing cells. 

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "both ERK"

Phrase: "and"

Phrase: "JNK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367731:JNK1 [Gene or Genome]
  1000   C1705632:JNK1 [Gene or Genome]

Phrase: "participate in the formation of NFTs"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   778   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]
   745 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "in these WOX1si-expressing cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.215: Similarly the above events were also observed in WOX1si-expressing SK-N-SH cells (data not shown). 

Phrase: "Similarly"

Phrase: "the above events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441471:Events [Event]
   861   C3541888:Events [Classification]

Phrase: "were"

Phrase: "also"

Phrase: "observed in WOX1si-expressing SK-N-SH cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   744   C0007634:Cells [Cell]
   744   C0038108:SH [Geographic Area]
   744   C1441672:Observed [Functional Concept]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.216: View larger version (41K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(41K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.217: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.218: PD-98059 and SP600125 inhibit NFT formation and Tau phosphorylation at Ser515/Ser516 in L929 cells. 

Phrase: "PD-98059"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0298346:PD 98059 [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "SP600125"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0968383:SP600125 [Organic Chemical,Pharmacologic Substance]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "NFT formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "Tau phosphorylation at Ser515/Ser516"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "in L929 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.219: A, stable transfectants of murine L929 cells, expressing a WOX1si (targeting WW domain) and a scrambled siRNA (in pSuppressorNeo), were established. 

Phrase: "A,"

Phrase: "stable transfectants of murine L929 cells,"

Phrase: "expressing"

Phrase: "a WOX1si"

Phrase: "(targeting WW domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1861696:WW [Disease or Syndrome]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "a scrambled siRNA (in pSuppressorNeo"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   814   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0521102:interfering [Qualitative Concept]
   748   C0700321:Small [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "established."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]
Processing 00000000.tx.220: Knock-down of WOX1 expression induced NFT formation in these cells. 

Phrase: "Knock-down of WOX1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   704   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   704   C2626739:Lanugo [Eukaryote]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "NFT formation in these cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]
Processing 00000000.tx.221: The increased NFT formation was blocked by exposure of these cells to an MEK1/2 inhibitor, PD-98059 (40 M), or a JNK inhibitor, SP600125 (40 M), for 1 h. 

Phrase: "The increased NFT formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "was"

Phrase: "blocked by exposure of these cells"
Meta Candidates (Total=13; Excluded=6; Pruned=0; Remaining=7)
   753   C0007634:Cells [Cell]
   753   C0028778:Blocked [Pathologic Function]
   753   C0274281:Exposure, NOS [Injury or Poisoning]
   753   C0332157:Exposure [Clinical Attribute]
   753   C0332206:Blocked [Functional Concept]
   753   C2983591:BLOCKED [Research Activity]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1533157:Block [Substance]
   719 E C1704653:Cell [Medical Device]
   719 E C1706084:Block [Geographic Area]
   719 E C1948049:Cell [Spatial Concept]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "to an MEK1/2 inhibitor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "PD-98059"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0298346:PD 98059 [Organic Chemical,Pharmacologic Substance]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "M)"

Phrase: ","

Phrase: "or"

Phrase: "a JNK inhibitor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "SP600125"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0968383:SP600125 [Organic Chemical,Pharmacologic Substance]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "M)"

Phrase: ","

Phrase: "for 1 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.222: B, similarly SP600125 (40 M, 1 h) blocked the increased Tau phosphorylation at Ser515/Ser516 (35 and 55 kDa, data not shown for the 55-kDa Tau).  

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "similarly SP600125"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0968383:SP600125 [Organic Chemical,Pharmacologic Substance]

Phrase: "(40 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "1 h)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "the increased Tau phosphorylation at Ser515/Ser516"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "(35"

Phrase: "and"

Phrase: "55 kDa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown for the 55-kDa Tau"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0450382:55 [Intellectual Product]
   753   C1532717:kDa [Quantitative Concept]
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]
   719   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.223: Ectopic or Endogenous WOX1 Colocalizes with Tau, JNK1, and GSK-3 in Neurons and Cultured CellsBy fluorescence microscopy, endogenous p-WOX1 was shown to colocalize with phospho-JNK1 (p-JNK1) and Ser(P)515/Ser(P)516-Tau in hippocampal neurons from either AD or age-matched control brains (Fig. 6A, top two panels). 

Phrase: "Ectopic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0574895:Ectopic [Spatial Concept]

Phrase: "or"

Phrase: "Endogenous WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1421525:WOX1 [Gene or Genome]

Phrase: "Colocalizes with Tau,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720655:Tau [Intellectual Product]
   790   C1947974:Tau [Research Activity]

Phrase: "JNK1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367731:JNK1 [Gene or Genome]
  1000   C1705632:JNK1 [Gene or Genome]

Phrase: "and"

Phrase: "GSK-3 in Neurons"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   882   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "Cultured CellsBy fluorescence microscopy,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0026022:Microscopy, Fluorescence [Laboratory Procedure]
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   812   C0026018:Microscopy [Laboratory Procedure]
   741 E C0205288:Microscopic [Qualitative Concept]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "endogenous p-WOX1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "colocalize with phospho-JNK1 (p-JNK1)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1367731:JNK1 [Gene or Genome]
   770   C1705632:JNK1 [Gene or Genome]

Phrase: "and"

Phrase: "Ser(P)515/Ser(P)516-Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C1720655:Tau [Intellectual Product]
   795   C1947974:Tau [Research Activity]

Phrase: "in hippocampal neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "from either AD"

Phrase: "or"

Phrase: "age-matched control brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0006104:Brains [Body Part, Organ, or Organ Component]
   779 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 6A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: "top two panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441833:Panel [Idea or Concept]
   827   C1999270:Panel [Intellectual Product]
   827   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.224: Similar results were observed by examining the colocalization of p-WOX1 with phospho-GSK-3 or p-JNK1 with Ser(P)515/Ser(P)516-Tau (data not shown). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "observed by examining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332128:examining [Finding]
   790   C1441672:Observed [Functional Concept]
   790   C2004054:Examining [Activity]

Phrase: "the colocalization of p-WOX1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
   753   C1421525:WOX1 [Gene or Genome]

Phrase: "with phospho-GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "p-JNK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1367731:JNK1 [Gene or Genome]
   861   C1705632:JNK1 [Gene or Genome]

Phrase: "with Ser(P)515/Ser(P)516-Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C1720655:Tau [Intellectual Product]
   795   C1947974:Tau [Research Activity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.225: Some neurons in the AD brains possessed colocalized p-WOX1 with Ser(P)515/Ser(P)516-Tau in the NFTs (Fig. 6A, bottom panel). 

Phrase: "Some neurons in the AD brains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0027882:Neurons [Cell]

Phrase: "possessed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0850310:Possessed [Mental or Behavioral Dysfunction]
   966 E C3154893:Possess [Idea or Concept]

Phrase: "colocalized p-WOX1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "with Ser(P)515/Ser(P)516-Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C1720655:Tau [Intellectual Product]
   795   C1947974:Tau [Research Activity]

Phrase: "in the NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "(Fig. 6A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: "bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.226: Together these observations suggest that WOX1 physically interacts with both JNK1 and Tau in vivo. 

Phrase: "Together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that WOX1 physically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1421525:WOX1 [Gene or Genome]

Phrase: "interacts with both JNK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1367731:JNK1 [Gene or Genome]
   770   C1705632:JNK1 [Gene or Genome]

Phrase: "and"

Phrase: "Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.227: View larger version (29K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(29K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.228: 6. 

Phrase: "6."
Processing 00000000.tx.229: Colocalization of endogenous or ectopic WOX1 with JNK1 and Tau in neurons and cultured cells. 

Phrase: "Colocalization of endogenous"

Phrase: "or"

Phrase: "ectopic WOX1 with JNK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1421525:WOX1 [Gene or Genome]

Phrase: "and"

Phrase: "Tau in neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720655:Tau [Intellectual Product]
   790   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "cultured cells."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.230: A, fluorescence microscopy shows colocalization of p-WOX1 with p-JNK1 (at Thr183/Tyr185) and p-Tau (at Ser515/Ser516) in healthy neurons (400x, top and middle panels). 

Phrase: "A,"

Phrase: "fluorescence microscopy"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0026022:Microscopy, Fluorescence [Laboratory Procedure]
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   861   C0026018:Microscopy [Laboratory Procedure]
   789 E C0205288:Microscopic [Qualitative Concept]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "colocalization of p-WOX1"

Phrase: "with p-JNK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1367731:JNK1 [Gene or Genome]
   861   C1705632:JNK1 [Gene or Genome]

Phrase: "("

Phrase: "at Thr183/Tyr185"

Phrase: ")"

Phrase: "and"

Phrase: "p-Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "("

Phrase: "at Ser515/Ser516"

Phrase: ")"

Phrase: "in healthy neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(400x,"

Phrase: "top"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "and"

Phrase: "middle panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.231: Colocalization of p-JNK1 with p-Tau was also observed (data not shown). 

Phrase: "Colocalization of p-JNK1"

Phrase: "with p-Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "was"

Phrase: "also"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.232: At a higher magnification (1000x), p-WOX1 colocalized with Ser(P)515/Ser(P)516-Tau in the NFTs of degenerative neurons (bottom panel). 

Phrase: "At a higher magnification"

Phrase: "(1000x"

Phrase: ")"

Phrase: ","

Phrase: "p-WOX1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "colocalized"

Phrase: "with Ser(P)515/Ser(P)516-Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C1720655:Tau [Intellectual Product]
   795   C1947974:Tau [Research Activity]

Phrase: "in the NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "of degenerative neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.233: B, ectopic GFP-WOX1 colocalized with Tau, p-Tau (at Ser515/Ser516), JNK1, and p-JNK1 (at Thr183/Tyr185) in COS7 cells. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "ectopic GFP-WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1421525:WOX1 [Gene or Genome]

Phrase: "colocalized with Tau,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720655:Tau [Intellectual Product]
   790   C1947974:Tau [Research Activity]

Phrase: "p-Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "("

Phrase: "at Ser515/Ser516"

Phrase: ")"

Phrase: ","

Phrase: "JNK1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367731:JNK1 [Gene or Genome]
  1000   C1705632:JNK1 [Gene or Genome]

Phrase: "and"

Phrase: "p-JNK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1367731:JNK1 [Gene or Genome]
   861   C1705632:JNK1 [Gene or Genome]

Phrase: "("

Phrase: "at Thr183/Tyr185"

Phrase: ")"

Phrase: "in COS7 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.234: In controls, ectopic GFP alone could not colocalize with p-Tau.  

Phrase: "In controls,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "ectopic GFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "colocalize with p-Tau."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]
Processing 00000000.tx.235: JNK1 physically interacts with WOX1 and blocks WOX1-mediated apoptosis (10). 

Phrase: "JNK1 physically"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1367731:JNK1 [Gene or Genome]
   861   C1705632:JNK1 [Gene or Genome]

Phrase: "interacts with WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1421525:WOX1 [Gene or Genome]

Phrase: "and"

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "WOX1-mediated apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0162638:Apoptosis [Cell Function]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.236: GSK-3, cdk5, JNK, p38, ERK1/2, and other kinases phosphorylate Tau in AD (1824). 

Phrase: "GSK-3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "cdk5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CDK5 [Gene or Genome]

Phrase: "JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "p38,"

Phrase: "ERK1/2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "other kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "phosphorylate"

Phrase: "Tau in AD (1824"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]

Phrase: ")."
Processing 00000000.tx.237: Ectopic GFP-WOX1 was shown to colocalize with endogenous p-JNK1 and Ser(P)515/Ser(P)516-Tau in COS7 fibroblasts (Fig. 6B). 

Phrase: "Ectopic GFP-WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1421525:WOX1 [Gene or Genome]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "colocalize with endogenous p-JNK1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205227:Endogenous [Functional Concept]
   760   C1367731:JNK1 [Gene or Genome]
   760   C1705632:JNK1 [Gene or Genome]

Phrase: "and"

Phrase: "Ser(P)515/Ser(P)516-Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C1720655:Tau [Intellectual Product]
   795   C1947974:Tau [Research Activity]

Phrase: "in COS7 fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]

Phrase: "(Fig. 6B"

Phrase: ")."
Processing 00000000.tx.238: In controls, GFP alone could not colocalize with the endogenous JNK1 and Tau (Fig. 6B, data not shown for JNK1). 

Phrase: "In controls,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "GFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "colocalize with the endogenous JNK1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205227:Endogenous [Functional Concept]
   760   C1367731:JNK1 [Gene or Genome]
   760   C1705632:JNK1 [Gene or Genome]

Phrase: "and"

Phrase: "Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "(Fig. 6B,"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown for JNK1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1367731:JNK1 [Gene or Genome]
   790   C1705632:JNK1 [Gene or Genome]
   756   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.239: WOX1 Binds Phosphorylated Tau (at Thr212/Ser214 and Ser515/Ser516), and E2 Increases the Binding in L929 Cells Next we determined whether WOX1 physically interacts with Tau in cultured cells. 

Phrase: "WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421525:WOX1 [Gene or Genome]

Phrase: "Binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "Phosphorylated Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "("

Phrase: "at Thr212/Ser214"

Phrase: "and"

Phrase: "Ser515/Ser516"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "E2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539520:E2 [Gene or Genome]

Phrase: "Increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the Binding in L929 Cells Next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "we"

Phrase: "determined"

Phrase: "whether"

Phrase: "WOX1 physically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1421525:WOX1 [Gene or Genome]

Phrase: "interacts with Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720655:Tau [Intellectual Product]
   790   C1947974:Tau [Research Activity]

Phrase: "in cultured cells."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.240: By co-immunoprecipitation using the lysates of L929 fibroblasts, endogenous p-WOX1 physically interacted with a 35-kDa phosphorylated Tau (at Ser515/Ser516 and Thr212/Ser214) in the cytoplasm, and E2 increased the binding interaction (Fig. 7A). 

Phrase: "By co-immunoprecipitation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   861   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the lysates of L929 fibroblasts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1881488:Lysate [Physical Object]

Phrase: "endogenous p-WOX1 physically"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "interacted with a 35-kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1532717:kDa [Quantitative Concept]

Phrase: "phosphorylated"

Phrase: "Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "("

Phrase: "at Ser515/Ser516"

Phrase: "and"

Phrase: "Thr212/Ser214"

Phrase: ")"

Phrase: "in the cytoplasm,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010834:Cytoplasm [Cell Component]
   928 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "and"

Phrase: "E2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539520:E2 [Gene or Genome]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the binding interaction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C1704675:Interaction [Functional Concept]

Phrase: "(Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.241: WOX1 also bound Tau with phosphorylation at Thr231 (data not shown). 

Phrase: "WOX1 also bound Tau with phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]

Phrase: "at Thr231"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.242: Compared with SK-N-SH cells, L929 cells were more responsive to E2-mediated phosphorylation of WOX1 and Tau. 

Phrase: "Compared with SK-N-SH cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0007634:Cells [Cell]
   753   C0038108:SH [Geographic Area]
   753   C1707455:Compared [Activity]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "L929 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "more responsive to E2-mediated phosphorylation of WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205342:Responsive [Functional Concept]

Phrase: "and"

Phrase: "Tau."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]
Processing 00000000.tx.243: E2 also increased the binding of WOX1 with 45- and 55-kDa Tau in SK-N-SH cells (data not shown). 

Phrase: "E2 also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539520:E2 [Gene or Genome]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the binding of WOX1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "with 45-"

Phrase: "and"

Phrase: "55-kDa Tau in SK-N-SH cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1720655:Tau [Intellectual Product]
   744   C1947974:Tau [Research Activity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.244: Our precipitating antibodies bound p-WOX1, and this protein was also recognized by the pan antibodies against the NH2 terminus of WOX1 (Fig. 7A). 

Phrase: "Our precipitating antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "p-WOX1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "this protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "also"

Phrase: "recognized by the pan antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0085999:Pan [Mammal]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against the NH2 terminus"

Phrase: "of WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421525:WOX1 [Gene or Genome]

Phrase: "(Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.245: Similarly E2 increased the binding of GSK-3 with Tau in L929 cells (Fig. 7B). 

Phrase: "Similarly E2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539520:E2 [Gene or Genome]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the binding of GSK-3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C1149289:kinase binding [Molecular Function]
   774   C3270761:glycogen binding [Molecular Function]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "with Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "in L929 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 7B"

Phrase: ")."
Processing 00000000.tx.246: View larger version (40K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(40K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.247: 7. 

Phrase: "7."
Processing 00000000.tx.248: WOX1 physically interacts with Tau, and E2 increases the binding interaction in L929 cells. 

Phrase: "WOX1 physically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1421525:WOX1 [Gene or Genome]

Phrase: "interacts with Tau,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720655:Tau [Intellectual Product]
   790   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "E2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539520:E2 [Gene or Genome]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the binding interaction in L929 cells."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0007582:Cell Interaction [Cell Function]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.249: A, endogenous p-WOX1 physically interacted with a 35-kDa phospho-Tau (at Ser515/Ser516 and Thr212/Ser214) in the cytoplasm of L929 fibroblasts. 

Phrase: "A,"

Phrase: "endogenous p-WOX1 physically"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "interacted with a 35-kDa phospho-Tau"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1532717:kDa [Quantitative Concept]
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]

Phrase: "("

Phrase: "at Ser515/Ser516"

Phrase: "and"

Phrase: "Thr212/Ser214"

Phrase: ")"

Phrase: "in the cytoplasm"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010834:Cytoplasm [Cell Component]
   928 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "of L929 fibroblasts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]
Processing 00000000.tx.250: E2 at 40 nM increased the binding interaction during 30-min treatment. 

Phrase: "E2 at 40 nM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3539520:E2 [Gene or Genome]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the binding interaction during 30-min treatment."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.251: Co-immunoprecipitation was performed using antibodies against p-WOX1. 

Phrase: "Co-immunoprecipitation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   861   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibodies against p-WOX1."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.252: The precipitated p-WOX1 protein was also recognized by pan antibodies against the NH2 terminus of WOX1. 

Phrase: "The precipitated p-WOX1 protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   753   C0031715:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "also"

Phrase: "recognized by pan antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0085999:Pan [Mammal]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against the NH2 terminus"

Phrase: "of WOX1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421525:WOX1 [Gene or Genome]
Processing 00000000.tx.253: One-tenth (40 g) of the total proteins was loaded for SDS-PAGE and Western blotting (see Pre-IP). 

Phrase: "One-tenth"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205444:Tenth [Quantitative Concept]
   861   C0205447:One [Quantitative Concept]

Phrase: "(40 g) of the total proteins"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1955160:40 g [Quantitative Concept]
   783   C0086376:G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   767 E C0060916:protein g [Amino Acid, Peptide, or Protein]
   753   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "loaded for SDS-PAGE"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   770   C1708715:Loaded [Activity]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]

Phrase: "and"

Phrase: "Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Pre-IP"

Phrase: ")."
Processing 00000000.tx.254: B, similarly E2 increased the binding of GSK-3 with Tau in L929 cells. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "similarly E2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539520:E2 [Gene or Genome]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the binding of GSK-3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C1149289:kinase binding [Molecular Function]
   774   C3270761:glycogen binding [Molecular Function]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "with Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "in L929 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.255: IgH, IgG heavy chain; 

Phrase: "IgH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017351:IGH [Gene or Genome]

Phrase: "IgG heavy chain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1440809:IgG.heavy chain [Immunologic Factor]
   901   C1420192:heavy chain [Gene or Genome]
   827   C0337112:Chain [Manufactured Object]
   827   C0439539:Heavy [Qualitative Concept]
   827   C1524075:Chain [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.256: IP, immunoprecipitation.  

Phrase: "IP,"

Phrase: "immunoprecipitation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]
Processing 00000000.tx.257: The COOH-terminal ADH/SDR Domain of WOX1 Physically Interacts with TauWe mapped the domain of WOX1 that interacts with Tau. 

Phrase: "The COOH-terminal ADH/SDR Domain of WOX1 Physically"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C1880389:Domain [Functional Concept]
   739   C1883221:Domain [Conceptual Entity]
   739   C3541951:Domain [Intellectual Product]

Phrase: "Interacts with TauWe"

Phrase: "mapped"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0024779:Map [Manufactured Object]
   966   C1706473:Map [Conceptual Entity]

Phrase: "the domain of WOX1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1880389:Domain [Functional Concept]
   770   C1883221:Domain [Conceptual Entity]
   770   C3541951:Domain [Intellectual Product]

Phrase: "that"

Phrase: "interacts with Tau."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720655:Tau [Intellectual Product]
   790   C1947974:Tau [Research Activity]
Processing 00000000.tx.258: As determined by a Ras rescue-based yeast two-hybrid analysis in the cytoplasm (7, 10), the full-length murine WOX1 interacted with Tau in yeast (Fig. 8). 

Phrase: "As"

Phrase: "determined by a Ras rescue-based yeast two-hybrid analysis"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   760   C0599647:Two Hybrid [Molecular Biology Research Technique]
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0020205:Hybrid [Organism]
   739   C0034678:RAS [Gene or Genome]
   739   C0036025:yeast [Fungus]
   739   C0043392:Yeast [Food]
   739   C0043393:Yeast [Fungus]
   739   C0205448:Two [Quantitative Concept]
   739   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   739   C0936012:Analysis [Research Activity]
   739   C1524024:analysis [Functional Concept]
   739   C1527178:Based [Functional Concept]
   739   C1705938:Based [Idea or Concept]
   706 E C0002055:base [Inorganic Chemical]
   706 E C0178499:Base [Chemical Viewed Functionally]
   706 E C1880279:Base [Biomedical or Dental Material]

Phrase: "in the cytoplasm"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010834:Cytoplasm [Cell Component]
   928 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "(7,"

Phrase: "10"

Phrase: ")"

Phrase: ","

Phrase: "the full-length murine WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1421525:WOX1 [Gene or Genome]

Phrase: "interacted with Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720655:Tau [Intellectual Product]
   790   C1947974:Tau [Research Activity]

Phrase: "in yeast"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036025:yeast [Fungus]
  1000   C0043392:Yeast [Food]
  1000   C0043393:Yeast [Fungus]
  1000   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.259: This human TAU clone (GenBankTM accession number BC000558 [GenBank] ) possesses three repeats of the microtubule-binding domain. 

Phrase: "This human TAU clone"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C0525049:human clone [Research Activity]
   827   C0009013:Clone [Cell]
   827   C1522642:Clone [Tissue]
   755 E C1704387:Clonal [Qualitative Concept]
   727 E C0796368:clonality [Diagnostic Procedure]

Phrase: "(GenBankTM accession number BC000558"

Phrase: "[GenBank"

Phrase: "]"

Phrase: ")"

Phrase: "possesses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "three repeats of the microtubule-binding domain."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0205341:repeats [Functional Concept]
   748   C1705914:Repeats [Conceptual Entity]
   714 E C1547730:Repeat [Temporal Concept]
Processing 00000000.tx.260: However, the NH2-terminal WW domains alone could not interact with Tau (Fig. 8). 

Phrase: "However,"

Phrase: "the NH2-terminal WW domains"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1861696:WW [Disease or Syndrome]
   779   C1880389:Domain [Functional Concept]
   779   C1883221:Domain [Conceptual Entity]
   779   C3541951:Domain [Intellectual Product]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "interact with Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720655:Tau [Intellectual Product]
   790   C1947974:Tau [Research Activity]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.261: Failure of the WW domains binding with Tau was not due to its Tyr33 phosphorylation. 

Phrase: "Failure of the WW domains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0231174:Failure [Functional Concept]
   760   C0680095:failure [Individual Behavior]

Phrase: "binding with Tau"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]
   790   C1720655:Tau [Intellectual Product]
   790   C1947974:Tau [Research Activity]

Phrase: "was"

Phrase: "not due to its Tyr33 phosphorylation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0678226:Due to [Functional Concept]
           due
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
   753   C1518422:Not [Functional Concept]
   753   C3146286:Due [Idea or Concept]
Processing 00000000.tx.262: Alteration of Tyr33 to Arg33 could not induce binding of the WW domains with Tau. 

Phrase: "Alteration of Tyr33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515926:Alteration [Idea or Concept]

Phrase: "to Arg33"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "binding of the WW domains"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C1323337:WW domain binding [Molecular Function]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1861696:WW [Disease or Syndrome]
   726   C1880389:Domain [Functional Concept]
   726   C1883221:Domain [Conceptual Entity]
   726   C3541951:Domain [Intellectual Product]

Phrase: "with Tau."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]
Processing 00000000.tx.263: The ADH/SDR domain alone physically interacted with Tau. 

Phrase: "The ADH/SDR domain alone physically"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1880389:Domain [Functional Concept]
   799   C1883221:Domain [Conceptual Entity]
   799   C3541951:Domain [Intellectual Product]

Phrase: "interacted with Tau."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720655:Tau [Intellectual Product]
   790   C1947974:Tau [Research Activity]
Processing 00000000.tx.264: Thus, these observations indicate that the COOH-terminal ADH/SDR domain of WOX1 is responsible for interacting with Tau. 

Phrase: "Thus,"

Phrase: "these observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "indicate"

Phrase: "that"

Phrase: "the COOH-terminal ADH/SDR domain of WOX1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C1880389:Domain [Functional Concept]
   742   C1883221:Domain [Conceptual Entity]
   742   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "responsible for interacting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1273518:Responsible [Finding]

Phrase: "with Tau."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]
Processing 00000000.tx.265: View larger version (49K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(49K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.266: 8. 

Phrase: "8."
Processing 00000000.tx.267: COOH-terminal ADH/SDR domain of WOX1 physically interacts with Tau. 

Phrase: "COOH-terminal ADH/SDR domain of WOX1 physically"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C1880389:Domain [Functional Concept]
   742   C1883221:Domain [Conceptual Entity]
   742   C3541951:Domain [Intellectual Product]

Phrase: "interacts with Tau."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720655:Tau [Intellectual Product]
   790   C1947974:Tau [Research Activity]
Processing 00000000.tx.268: Mapping of the binding of WOX1 with Tau was performed by a Ras rescue-based yeast two-hybrid analysis (7, 10). 

Phrase: "Mapping of the binding of WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1283195:Mapping [Activity]

Phrase: "with Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "was"

Phrase: "performed by a Ras rescue-based yeast two-hybrid analysis"
Meta Candidates (Total=19; Excluded=4; Pruned=0; Remaining=15)
   760   C0599647:Two Hybrid [Molecular Biology Research Technique]
   760   C1550369:Performed By [Qualitative Concept]
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0020205:Hybrid [Organism]
   739   C0034678:RAS [Gene or Genome]
   739   C0036025:yeast [Fungus]
   739   C0043392:Yeast [Food]
   739   C0043393:Yeast [Fungus]
   739   C0205448:Two [Quantitative Concept]
   739   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   739   C0884358:Performed [Functional Concept]
   739   C0936012:Analysis [Research Activity]
   739   C1524024:analysis [Functional Concept]
   739   C1527178:Based [Functional Concept]
   739   C1705938:Based [Idea or Concept]
   706 E C0002055:base [Inorganic Chemical]
   706 E C0178499:Base [Chemical Viewed Functionally]
   706 E C1880279:Base [Biomedical or Dental Material]
   706 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(7,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.269: In positive controls, there were binding interactions of p53/WOX1 (7) and MafB self-binding interaction as revealed by the growth of mutant cdc25H yeast at 37 C using a selective galactose-agarose plate. 

Phrase: "In positive controls,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   966   C1883676:Positive Control [Conceptual Entity]
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C2825490:Positive [Qualitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "there"

Phrase: "were"

Phrase: "binding interactions of p53/WOX1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1817303:p53 binding [Molecular Function]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   726   C1704675:Interaction [Functional Concept]

Phrase: "(7"

Phrase: ")"

Phrase: "and"

Phrase: "MafB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416710:MAFB [Gene or Genome]
  1000   C1565054:MAFB [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "self-binding"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0036588:Self [Idea or Concept]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C1551994:self [Intellectual Product]
   861   C3244295:Self [Intellectual Product]

Phrase: "interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "as"

Phrase: "revealed by the growth of mutant cdc25H yeast"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   744   C0018270:'growth' NOS [Organism Function]
   744   C0036025:yeast [Fungus]
   744   C0043392:Yeast [Food]
   744   C0043393:Yeast [Fungus]
   744   C0220844:growth [Physiologic Function]
   744   C0443289:Revealed [Qualitative Concept]
   744   C0596988:Mutant [Cell or Molecular Dysfunction]
   744   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2911660:Growth [Activity]

Phrase: "at 37 C"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a selective galactose-agarose plate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005971:Plate [Medical Device]
   812   C1139930:plate [Medical Device]
   812   C3537155:Plate [Manufactured Object]
Processing 00000000.tx.270: In negative controls, no binding interactions were observed for empty vectors. 

Phrase: "In negative controls,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   966   C1639518:% negative control [Quantitative Concept]
   966   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "no binding interactions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   827   C1704675:Interaction [Functional Concept]

Phrase: "were"

Phrase: "observed for empty vectors."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vectors [Spatial Concept]
   770   C1441672:Observed [Functional Concept]
   770   C1880497:Empty [Qualitative Concept]
   737 E C1705099:Vector [Idea or Concept]
   715 E C0333668:Depleted [Functional Concept]
Processing 00000000.tx.271: The full-length murine WOX1 interacted with human Tau via its COOH-terminal ADH/SDR but not NH2-terminal WW domain in yeast. 

Phrase: "The full-length murine WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1421525:WOX1 [Gene or Genome]

Phrase: "interacted with human Tau"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0086418:Human [Human]
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]

Phrase: "via its COOH-terminal ADH/SDR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "but"

Phrase: "not NH2-terminal WW domain in yeast."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1861696:WW [Disease or Syndrome]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.272: This human Tau clone possesses three repeats of the microtubule-binding domain (open ovals). 

Phrase: "This human Tau clone"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C0525049:human clone [Research Activity]
   827   C0009013:Clone [Cell]
   827   C1522642:Clone [Tissue]
   755 E C1704387:Clonal [Qualitative Concept]
   727 E C0796368:clonality [Diagnostic Procedure]

Phrase: "possesses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "three repeats of the microtubule-binding domain"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0205341:repeats [Functional Concept]
   748   C1705914:Repeats [Conceptual Entity]
   714 E C1547730:Repeat [Temporal Concept]

Phrase: "(open ovals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709367:Oval [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.273: Failure of the WW domains interacting with Tau was not due to its Tyr33 phosphorylation. 

Phrase: "Failure of the WW domains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0231174:Failure [Functional Concept]
   760   C0680095:failure [Individual Behavior]

Phrase: "interacting with Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720655:Tau [Intellectual Product]
   790   C1947974:Tau [Research Activity]

Phrase: "was"

Phrase: "not due to its Tyr33 phosphorylation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0678226:Due to [Functional Concept]
           due
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
   753   C1518422:Not [Functional Concept]
   753   C3146286:Due [Idea or Concept]
Processing 00000000.tx.274: Alteration of Tyr33 to Arg33 could not induce binding of the WW domains with Tau.  

Phrase: "Alteration of Tyr33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515926:Alteration [Idea or Concept]

Phrase: "to Arg33"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "binding of the WW domains"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C1323337:WW domain binding [Molecular Function]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1861696:WW [Disease or Syndrome]
   726   C1880389:Domain [Functional Concept]
   726   C1883221:Domain [Conceptual Entity]
   726   C3541951:Domain [Intellectual Product]

Phrase: "with Tau."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]
Processing 00000000.tx.275: In positive controls, there were binding interactions of p53/WOX1 (7, 10) and MafB self-binding interaction (Fig. 8). 

Phrase: "In positive controls,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   966   C1883676:Positive Control [Conceptual Entity]
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C2825490:Positive [Qualitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "there"

Phrase: "were"

Phrase: "binding interactions of p53/WOX1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1817303:p53 binding [Molecular Function]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   726   C1704675:Interaction [Functional Concept]

Phrase: "(7,"

Phrase: "10"

Phrase: ")"

Phrase: "and"

Phrase: "MafB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416710:MAFB [Gene or Genome]
  1000   C1565054:MAFB [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "self-binding"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0036588:Self [Idea or Concept]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C1551994:self [Intellectual Product]
   861   C3244295:Self [Intellectual Product]

Phrase: "interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.276: In negative controls, no binding interactions were observed for empty vectors (Fig. 8).  

Phrase: "In negative controls,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   966   C1639518:% negative control [Quantitative Concept]
   966   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "no binding interactions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   827   C1704675:Interaction [Functional Concept]

Phrase: "were"

Phrase: "observed for empty vectors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vectors [Spatial Concept]
   770   C1441672:Observed [Functional Concept]
   770   C1880497:Empty [Qualitative Concept]
   737 E C1705099:Vector [Idea or Concept]
   715 E C0333668:Depleted [Functional Concept]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.277: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  In this study, we demonstrated that WOX1, p-WOX1, and WOX2 were down-regulated in the AD hippocampi. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES  In this study,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C2985663:Study Reference [Intellectual Product]
   770   C0557651:Study [Manufactured Object]
   770   C1514811:Reference [Idea or Concept]
   770   C1706462:Reference [Conceptual Entity]
   770   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "demonstrated"

Phrase: "that WOX1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421525:WOX1 [Gene or Genome]

Phrase: "p-WOX1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "WOX2"

Phrase: "were"

Phrase: "down-regulated in the AD hippocampi."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   753   C0949582:Hippocampus [Fish]
   753   C1029104:Hippocampus [Fish]
   753   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
Processing 00000000.tx.278: This down-regulation correlates negatively with significant increases in phosphorylation of Tau (at Thr212/Thr231, Ser515/Ser516, and other sites), enhanced GSK-3 phosphorylation, and NFT formation in this brain area. 

Phrase: "This down-regulation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013081:Down-Regulation [Cell Function,Molecular Function]
   861   C0851285:Regulation [Governmental or Regulatory Activity]
   861   C1327622:Regulation [Biologic Function]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "correlates"

Phrase: "negatively with significant increases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0237881:significant [Quantitative Concept]
   770   C0442805:increases [Functional Concept]
   770   C0750502:Significant [Idea or Concept]
   770   C1546944:Significant [Qualitative Concept]

Phrase: "in phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "of Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "("

Phrase: "at Thr212/Thr231,"

Phrase: "Ser515/Ser516,"

Phrase: "and"

Phrase: "other sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "enhanced GSK-3 phosphorylation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0031715:Phosphorylation [Molecular Function]
   799   C1158886:Phosphorylation [Molecular Function]
   734   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "NFT formation in this brain area."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]
Processing 00000000.tx.279: Remarkably, in parallel with these clinical findings, we determined that suppression of WOX1 expression by siRNA in SK-N-SH cells spontaneously induced Tau phosphorylation at Thr212/Thr231 and Ser515/Ser516 and NFT formation, indicating that WOX1 participates in the regulation of Tau phosphorylation in vivo. 

Phrase: "Remarkably,"

Phrase: "in parallel with these clinical findings,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0150312:In [Quantitative Concept]
   753   C0332285:In [Spatial Concept]
   753   C2348042:Parallel [Qualitative Concept]
   753   C2826345:PARALLEL [Research Activity]

Phrase: "we"

Phrase: "determined"

Phrase: "that suppression of WOX1 expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0221103:Suppression [Pathologic Function]
   760   C0301625:Suppression [Organism Function]
   760   C0439181:% suppression [Quantitative Concept]
   760   C0728721:suppression [Mental Process]

Phrase: "by siRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0521102:interfering [Qualitative Concept]
   827   C0700321:Small [Quantitative Concept]

Phrase: "in SK-N-SH cells spontaneously induced Tau phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0031715:Phosphorylation [Molecular Function]
   793   C1158886:Phosphorylation [Molecular Function]

Phrase: "at Thr212/Thr231"

Phrase: "and"

Phrase: "Ser515/Ser516"

Phrase: "and"

Phrase: "NFT formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "indicating"

Phrase: "that WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421525:WOX1 [Gene or Genome]

Phrase: "participates in the regulation of Tau phosphorylation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C1158897:regulation of phosphorylation [Cell Function]
   748   C0031715:Phosphorylation [Molecular Function]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1158886:Phosphorylation [Molecular Function]
   748   C1327622:Regulation [Biologic Function]
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.280: We generated specific antibodies against the COOH-terminal amino acid sequences of human WOX1 and WOX2 and the NH2 terminus of murine WOX1 (7). 

Phrase: "We"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "specific antibodies against the COOH-terminal amino acid sequences of human WOX1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   736   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   736   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   703 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "WOX2"

Phrase: "and"

Phrase: "the NH2 terminus of murine WOX1"

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.281: The antibodies recognized expected protein bands of 46-kDa WOX1 and 41-kDa WOX2 in the human brain extracts. 

Phrase: "The antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "recognized"

Phrase: "expected protein bands of 46-kDa WOX1"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0175723:Bands [Medical Device]
   714 E C0439645:Band [Spatial Concept]
   714 E C1521913:band [Cell Component]

Phrase: "and"

Phrase: "41-kDa WOX2 in the human brain extracts."
Processing 00000000.tx.282: The WOX1 antibodies are expected to interact with a truncated 26-kDa WWOXv4 (according to GenBankTM nomenclature; for a review, see Ref. 11). 

Phrase: "The WOX1 antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "are"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with a truncated 26-kDa WWOXv4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1532717:kDa [Quantitative Concept]

Phrase: "("

Phrase: "according to GenBankTM nomenclature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0600281:Nomenclature [Intellectual Product]
   861   C1524067:Nomenclature [Intellectual Product]

Phrase: ";"

Phrase: "for a review,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Ref. 11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.283: However, we could not identify this protein in the brains. 

Phrase: "However,"

Phrase: "we"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "identify"

Phrase: "this protein in the brains."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.284: The COOH-terminal amino acid sequence of WOX2 is unique, and the antibodies generated did not interact with other WWOX/FOR/WOX1 family proteins. 

Phrase: "The COOH-terminal amino acid sequence of WOX2"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   770   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C2917660:Amino Acid [Pharmacologic Substance]
   744   C0001128:Acid [Chemical]
   744   C0004793:Sequence [Nucleotide Sequence]
   744   C0162326:Sequence [Nucleotide Sequence]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C0202406:Acid [Laboratory Procedure]
   744   C1519249:Sequence [Functional Concept]

Phrase: "is"

Phrase: "unique,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710548:Unique [Qualitative Concept]

Phrase: "and"

Phrase: "the antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "interact with other WWOX/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1421525:WWOX [Gene or Genome]

Phrase: "FOR/WOX1 family proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.285: By using these antibodies in Western blotting and immunohistochemistry, we convincingly showed the significant down-regulation of WOX1 and WOX2 expression in the AD hippocampi as compared with age-matched controls. 

Phrase: "By"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "these antibodies in Western blotting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "immunohistochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "we convincingly"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the significant down-regulation of WOX1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0013081:Down-Regulation [Cell Function,Molecular Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "WOX2 expression in the AD hippocampi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "as"

Phrase: "compared with age-matched controls."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0001779:Age [Organism Attribute]
   760   C0150103:matched [Research Activity]
   760   C1707455:Compared [Activity]
   760   C1708943:Matched [Qualitative Concept]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.286: In addition, we determined that p-WOX1 was significantly down-regulated in the AD hippocampi. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "determined"

Phrase: "that p-WOX1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "significantly"

Phrase: "down-regulated in the AD hippocampi."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   753   C0949582:Hippocampus [Fish]
   753   C1029104:Hippocampus [Fish]
   753   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
Processing 00000000.tx.287: Functional significance of this down-regulation is unknown. 

Phrase: "Functional significance of this down-regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237881:Significance [Quantitative Concept]
   753   C0750502:Significance [Idea or Concept]

Phrase: "is"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.288: WOX1 activation involves Tyr33 phosphorylation and subsequent nuclear translocation (10, 11). 

Phrase: "WOX1 activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "involves"

Phrase: "Tyr33 phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "subsequent nuclear translocation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1518440:Nuclear Translocation [Molecular Function]
   827   C0040715:Translocation [Cell or Molecular Dysfunction]
   827   C2987521:Translocation [Activity]

Phrase: "(10,"

Phrase: "11"

Phrase: ")."
Processing 00000000.tx.289: Ectopic WOX1 induces apoptosis in the nuclear level (7, 10). 

Phrase: "Ectopic WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1421525:WOX1 [Gene or Genome]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis in the nuclear level"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162638:Apoptosis [Cell Function]

Phrase: "(7,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.290: Whether endogenously activated WOX1 initiates apoptosis in the nucleus is unknown. 

Phrase: "Whether"

Phrase: "endogenously activated WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1421525:WOX1 [Gene or Genome]

Phrase: "initiates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "apoptosis in the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162638:Apoptosis [Cell Function]

Phrase: "is"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.291: However, we believe that during neuronal degeneration, WOX1 undergoes Tyr33 phosphorylation and nuclear translocation and participates in the apoptosis of neuronal cells. 

Phrase: "However,"

Phrase: "we"

Phrase: "believe"

Phrase: "that during neuronal degeneration,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0027746:Neuron Degeneration [Cell or Molecular Dysfunction]
   770   C0011164:Degeneration [Pathologic Function]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C1880269:Degeneration [Functional Concept]

Phrase: "WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421525:WOX1 [Gene or Genome]

Phrase: "undergoes"

Phrase: "Tyr33 phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "nuclear translocation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1518440:Nuclear Translocation [Molecular Function]
   861   C0040715:Translocation [Cell or Molecular Dysfunction]
   861   C2987521:Translocation [Activity]

Phrase: "and"

Phrase: "participates in the apoptosis of neuronal cells."
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   853   C1660771:apoptosis of neuronal cells [Cell Function]
           neuronal cell apoptosis
           Apoptosis of neurons
           neuron apoptosis
   748   C0007634:Cells [Cell]
   748   C0162638:Apoptosis [Cell Function]
   748   C0521390:Neuronal [Immunologic Factor]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
   702 E C1836846:Apoptotic neurons [Finding]
Processing 00000000.tx.292: The notion is supported by 1-methyl-4-phenylpyridium intoxication of striatum, which shows a rapid WOX1 activation via Tyr33 phosphorylation followed by nuclear translocation and colocalization with nuclear p53 in damaged neurons.3 Presumably, reduction of Tyr33 phosphorylation in WOX1 indicates a postactivation stage of WOX1 in degenerated neurons. 

Phrase: "The notion"

Phrase: "is"

Phrase: "supported by 1-methyl-4-phenylpyridium intoxication of striatum,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   742   C0010097:Striatum [Body Part, Organ, or Organ Component]
   742   C0162512:Striatum [Body Part, Organ, or Organ Component]
   742   C0728899:Intoxication [Finding]
   742   C1521721:Supported [Conceptual Entity]
   708 E C0183683:Support [Medical Device]

Phrase: "which"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a rapid WOX1 activation via Tyr33 phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1879547:Activation [Activity]

Phrase: "followed by nuclear translocation"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0332283:Followed by [Temporal Concept]
           followed
   833   C1518440:Nuclear Translocation [Molecular Function]
   770   C0040715:Translocation [Cell or Molecular Dysfunction]
   770   C0521447:Nuclear [Spatial Concept]
   770   C2987521:Translocation [Activity]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "colocalization with nuclear p53"

Phrase: "in damaged neurons.3 Presumably,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0027882:Neurons [Cell]
   779   C0010957:Damage [Injury or Poisoning]
   779   C1883709:Damage [Functional Concept]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "reduction of Tyr33 phosphorylation in WOX1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "indicates"

Phrase: "a postactivation stage of WOX1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205390:Stage [Temporal Concept]
   760   C1300072:Stage [Clinical Attribute]
   760   C1306673:Stage [Qualitative Concept]

Phrase: "in degenerated neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.293: NFT and neuron numbers, but not amyloid load, are critical in predicting cognitive status in Alzheimer's disease (38). 

Phrase: "NFT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085400:NFT [Acquired Abnormality]

Phrase: "and"

Phrase: "neuron numbers,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "but"

Phrase: "not amyloid load,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1550025:Load [Idea or Concept]
   827   C1704782:Load [Manufactured Object]
   827   C1708715:Load [Activity]

Phrase: "are"

Phrase: "critical in predicting cognitive status"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511545:Critical [Qualitative Concept]

Phrase: "in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.294: NFTs are present mostly in the CA1, entorhinal cortex, and area 9 (3842). 

Phrase: "NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "are"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "mostly in the CA1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0750554:mostly [Idea or Concept]

Phrase: "entorhinal cortex,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0175196:Entorhinal Cortex [Body Part, Organ, or Organ Component]
  1000   C1289526:Entorhinal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "area 9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017446:Area [Geographic Area]
   861   C0205146:Area [Spatial Concept]

Phrase: "(3842"

Phrase: ")."
Processing 00000000.tx.295: Neurons in CA4 and CA3 areas are less affected in AD patients, while neuronal loss, in association with NFTs and granulovacuolar degeneration, is found mostly in the CA2, CA1, and the entorhinal regions (3842). 

Phrase: "Neurons in CA4"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0027882:Neurons [Cell]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "CA3 areas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0205146:areas [Spatial Concept]
   827 E C0017446:Area [Geographic Area]

Phrase: "are"

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "affected in AD patients,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   819   C0522476:affected patients [Qualitative Concept]
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0392760:Affected [Functional Concept]
   770   C1314939:Affected [Functional Concept]
   737 E C0001721:Affect [Mental Process]

Phrase: "while"

Phrase: "neuronal loss,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1850496:Neuronal loss [Finding]
   964 E C0598940:neuron loss [Finding]
   861   C1517945:Loss [Quantitative Concept]

Phrase: "in association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "with NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "and"

Phrase: "granulovacuolar degeneration,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0333454:Granulovacuolar degeneration [Pathologic Function]
   861   C0011164:Degeneration [Pathologic Function]
   861   C1880269:Degeneration [Functional Concept]

Phrase: "is"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "mostly in the CA2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0750554:mostly [Idea or Concept]

Phrase: "CA1,"

Phrase: "and"

Phrase: "the entorhinal regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "(3842"

Phrase: ")."
Processing 00000000.tx.296: The immunoreactivity of WOX1 and WOX2 appears to be maximally expressed in the neurons of CA4 and CA3 regions but is progressively reduced in the neurons of CA2, CA1, and entorhinal cortex of both control and AD hippocampi (see Supplemental Figs. 13). 

Phrase: "The immunoreactivity of WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0597879:immunoreactivity [Molecular Function]

Phrase: "and"

Phrase: "WOX2"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "maximally"

Phrase: "expressed in the neurons of CA4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0027882:Neurons [Cell]

Phrase: "and"

Phrase: "CA3 regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "but"

Phrase: "is"

Phrase: "progressively"

Phrase: "reduced in the neurons of CA2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0027882:Neurons [Cell]
   753   C0392756:Reduced [Qualitative Concept]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "CA1,"

Phrase: "and"

Phrase: "entorhinal cortex of both control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0175196:Entorhinal Cortex [Body Part, Organ, or Organ Component]
   806   C1289526:Entorhinal cortex [Body Part, Organ, or Organ Component]
   760   C0007776:Cortex [Body Part, Organ, or Organ Component]
   760   C1176472:Cortex [Body Part, Organ, or Organ Component]
   760   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "AD hippocampi"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   861   C0949582:Hippocampus [Fish]
   861   C1029104:Hippocampus [Fish]
   861   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Supplemental Figs. 13"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0349966:Figs [Food]
   827   C2348609:Supplemental [Functional Concept]
   793 E C1337208:FIG [Food]
   755 E C0242295:Supplement [Food]
   755 E C1947943:Supplement [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.297: That is, an increased NFT formation in a specific hippocampal region correlates negatively with the levels of WOX1 and WOX2. 

Phrase: "That"

Phrase: "is"

Phrase: ","

Phrase: "an increased NFT formation in a specific hippocampal region"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0175202:Hippocampal Formation [Body Part, Organ, or Organ Component]
   742   C0220781:formation [Biologic Function]
   742   C0439634:formation [Spatial Concept]
   742   C1522492:Formation [Functional Concept]

Phrase: "correlates"

Phrase: "negatively with the levels of WOX1"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0441889:Levels [Qualitative Concept]
   753   C1421525:WOX1 [Gene or Genome]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "WOX2."
Processing 00000000.tx.298: There are six isoforms of Tau in human brains, and the microtubule-binding repeat region plays an important role in Tau polymerization (for a review, see Ref. 17). 

Phrase: "There"

Phrase: "are"

Phrase: "six isoforms of Tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "in human brains,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "the microtubule-binding repeat region"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   902   C1183338:Microtubule region [Cell Component]
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an important role in Tau polymerization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "("

Phrase: "for a review,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Ref. 17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.299: However, regions outside the microtubule-binding repeat, such as exons 2 and 3 and the COOH-terminal tail, can greatly influence its polymerization. 

Phrase: "However,"

Phrase: "regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0017446:Region [Geographic Area]
   966   C0205147:Region [Spatial Concept]
   916 E C0205276:Regional [Spatial Concept]
   916 E C1947913:Regional [Spatial Concept]

Phrase: "outside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205101:Outside [Spatial Concept]

Phrase: "the microtubule-binding repeat,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C1149274:microtubule binding [Molecular Function]
   827   C0026046:Micro-tubule [Cell Component]
   827   C0205341:Repeat [Functional Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1547730:Repeat [Temporal Concept]
   827   C1705914:Repeat [Conceptual Entity]

Phrase: "such as exons 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "the COOH-terminal tail,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0039259:Tail [Body Part, Organ, or Organ Component]

Phrase: "can"

Phrase: "greatly"

Phrase: "influence"

Phrase: "its polymerization."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0314672:Polymerisation [Phenomenon or Process]
Processing 00000000.tx.300: Recently the NH2 terminus of Tau has also been shown to regulate tangle formation (43). 

Phrase: "Recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "the NH2 terminus of Tau"

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "regulate"

Phrase: "tangle formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.301: Abnormal polymerization of mutant Tau into insoluble filaments contributes to neurodegeneration in AD (4446). 

Phrase: "Abnormal polymerization of mutant Tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0314672:Polymerisation [Phenomenon or Process]

Phrase: "into insoluble filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0010851:Filament [Cell Component]
   777 E C1979891:Filamentous [Qualitative Concept]

Phrase: "contributes to neurodegeneration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
   790   C1880177:Contribute [Activity]

Phrase: "in AD (4446"

Phrase: ")."
Processing 00000000.tx.302: Numerous enzymes are involved in Tau hyperphosphorylation, and cdk5 and GSK-3 appear to play a dominant role in Tau pathology (1824). 

Phrase: "Numerous enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]

Phrase: "are"

Phrase: "involved in Tau hyperphosphorylation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1314939:Involved [Functional Concept]
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "cdk5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CDK5 [Gene or Genome]

Phrase: "and"

Phrase: "GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a dominant role in Tau pathology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "(1824"

Phrase: ")."
Processing 00000000.tx.303: Aberrant cdk5 activation by p25 induces neurodegeneration and tangle formation (47). 

Phrase: "Aberrant cdk5 activation by p25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "tangle formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "(47"

Phrase: ")."
Processing 00000000.tx.304: Nonetheless brain levels of cdk5 activator p25 are not increased in Alzheimer's or other neurodegenerative diseases with neurofibrillary tangles (48). 

Phrase: "Nonetheless brain levels of cdk5 activator p25"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0441889:Levels [Qualitative Concept]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increased in Alzheimer's"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "or"

Phrase: "other neurodegenerative diseases with neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   753   C0012634:Diseases [Disease or Syndrome]

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.305: We have exhaustively examined Tau phosphorylation in the AD hippocampi versus age-matched normal controls using a panel of specific antibodies against phospho-Tau (see Supplemental Figs. 13). 

Phrase: "We"

Phrase: "have"

Phrase: "exhaustively examined Tau phosphorylation in the AD hippocampi"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0031715:Phosphorylation [Molecular Function]
   744   C1158886:Phosphorylation [Molecular Function]

Phrase: "versus"

Phrase: "age-matched normal controls"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   827   C2705716:normal control [Qualitative Concept]
   812   C0205307:Normal [Qualitative Concept]
   812   C0439166:% normal [Quantitative Concept]
   812   C2347086:% Normal [Quantitative Concept]
   779   C0243148:control [Qualitative Concept]
   779   C1550141:Control [Substance]
   779   C1882979:Control [Conceptual Entity]
   779   C2587213:Control [Functional Concept]
   779   C3274648:Control [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a panel of specific antibodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0441833:Panel [Idea or Concept]
   760   C1999270:Panel [Intellectual Product]
   760   C3537156:Panel [Manufactured Object]

Phrase: "against phospho-Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Supplemental Figs. 13"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0349966:Figs [Food]
   827   C2348609:Supplemental [Functional Concept]
   793 E C1337208:FIG [Food]
   755 E C0242295:Supplement [Food]
   755 E C1947943:Supplement [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.306: GSK-3-dependent phosphorylation of Tau at Thr181/Thr212/Thr231 and Ser404, but not at Ser262/Ser396, was significantly increased. 

Phrase: "GSK-3-dependent phosphorylation of Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0031715:Phosphorylation [Molecular Function]
   744   C1158886:Phosphorylation [Molecular Function]

Phrase: "at Thr181/Thr212/Thr231"

Phrase: "and"

Phrase: "Ser404,"

Phrase: "but"

Phrase: "not at Ser262/Ser396,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1518422:Not [Functional Concept]

Phrase: "was"

Phrase: "significantly"

Phrase: "increased."
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.307: Also phosphorylation of GSK-3/cdk5-dependent Thr205/Ser202 and ERK-dependent Ser422/Ser515/Ser516 was significantly increased. 

Phrase: "Also phosphorylation of GSK-3/cdk5-dependent Thr205/Ser202"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0031715:Phosphorylation [Molecular Function]
   738   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "ERK-dependent Ser422/Ser515/Ser516"

Phrase: "was"

Phrase: "significantly"

Phrase: "increased."
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.308: In contrast, protein kinase A-dependent phosphorylation of Ser214/Ser409 was barely detectable in both controls and AD. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "protein kinase A-dependent phosphorylation of Ser214/Ser409"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   744   C0031715:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "barely detectable in both controls"

Phrase: "and"

Phrase: "AD."
Processing 00000000.tx.309: The sizes of these phosphorylated Tau proteins are normally from 35 to 75 kDa or even larger, suggesting that polymerization of Tau up to certain sizes is needed for phosphorylation at certain residues. 

Phrase: "The sizes of these phosphorylated Tau proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0456389:SIZES [Spatial Concept]

Phrase: "are"

Phrase: "normally from 35"

Phrase: "to 75 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "or"

Phrase: "even larger,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0443228:larger [Quantitative Concept]
   861   C0549177:Larger [Quantitative Concept]
   861   C1704243:Larger [Quantitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that polymerization of Tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0314672:Polymerisation [Phenomenon or Process]

Phrase: "up to certain sizes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0456389:SIZES [Spatial Concept]

Phrase: "is"

Phrase: "needed for phosphorylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0027552:Needed [Qualitative Concept]
   790   C0031715:Phosphorylation [Molecular Function]
   790   C0686904:needed [Functional Concept]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "at certain residues."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.310: In parallel, NFT formation and phosphorylation of GSK-3 were also increased in the AD hippocampi. 

Phrase: "In parallel, NFT formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0220781:formation [Biologic Function]
   812   C0439634:formation [Spatial Concept]
   812   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "phosphorylation of GSK-3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
   716   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "also"

Phrase: "increased in the AD hippocampi."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0949582:Hippocampus [Fish]
   760   C1029104:Hippocampus [Fish]
   760   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
Processing 00000000.tx.311: Remarkably, when WOX1 expression was knocked down by siRNA in SK-N-SH cells, endogenous Tau in these cells became phosphorylated selectively at Thr212/Thr231 and Ser202/Ser515/Ser516 along with enhanced phosphorylation of GSK-3 and ERK and NFT formation (data not shown for Ser202 phosphorylation). 

Phrase: "Remarkably,"

Phrase: "when"

Phrase: "WOX1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "knocked down"

Phrase: "by siRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0521102:interfering [Qualitative Concept]
   827   C0700321:Small [Quantitative Concept]

Phrase: "in SK-N-SH cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "endogenous Tau in these cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]

Phrase: "became"

Phrase: "phosphorylated"

Phrase: "selectively at Thr212/Thr231"

Phrase: "and"

Phrase: "Ser202/Ser515/Ser516 along with enhanced phosphorylation of GSK-3"

Phrase: "and"

Phrase: "ERK"

Phrase: "and"

Phrase: "NFT formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown for Ser202 phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]
   737   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.312: These events are specific. 

Phrase: "These events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441471:Events [Event]
  1000   C3541888:Events [Classification]

Phrase: "are"

Phrase: "specific."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205369:Specific [Qualitative Concept]
  1000   C1552740:specific [Intellectual Product]
Processing 00000000.tx.313: We knocked down WOX1 expression using siRNA against both the 3' end and the WW domain area of WOX mRNA. 

Phrase: "We"

Phrase: "knocked down WOX1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C1421525:WOX1 [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "siRNA against both"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0521102:interfering [Qualitative Concept]
   760   C0700321:Small [Quantitative Concept]

Phrase: "the 3' end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0444930:End [Spatial Concept]
   861   C2746065:End [Temporal Concept]
   805 E C0205088:Terminal [Temporal Concept]
   805 E C1705314:Terminal [Manufactured Object]
   805 E C1705315:Terminal [Spatial Concept]

Phrase: "and"

Phrase: "the WW domain area of WOX mRNA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0017446:Area [Geographic Area]
   748   C0205146:Area [Spatial Concept]
Processing 00000000.tx.314: Phosphorylation of these sites in Tau is also found in the AD hippocampi. 

Phrase: "Phosphorylation of these sites"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C1519063:Phosphorylation Site [Amino Acid Sequence]
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "in Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "is"

Phrase: "also"

Phrase: "found in the AD hippocampi."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   760   C0150312:Found [Quantitative Concept]
   760   C0949582:Hippocampus [Fish]
   760   C1029104:Hippocampus [Fish]
   760   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
   726 E C0243095:Find [Finding]
Processing 00000000.tx.315: SK-N-SH cells appear to express four isoforms of Tau (35, 55, 60, and 100 kDa). 

Phrase: "SK-N-SH cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "four isoforms of Tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "(35,"

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "60,"

Phrase: "and"

Phrase: "100 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.316: The 120-kDa Tau (with Thr212 phosphorylation) in the WOXsi and/or anisomycin-treated SK-N-SH cells corresponds to a soluble NFT form of the same size, suggesting that Thr212 is phosphorylated when Tau is polymerized to this size. 

Phrase: "The 120-kDa Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "("

Phrase: "with Thr212 phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: ")"

Phrase: "in the WOXsi"

Phrase: "and/or"

Phrase: "anisomycin-treated SK-N-SH cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "corresponds to a soluble NFT form of the same size,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   739   C0085400:NFT [Acquired Abnormality]
   739   C0348078:Form [Qualitative Concept]
   739   C0376315:Form [Manufactured Object]
   739   C0445247:Same [Qualitative Concept]
   739   C0456389:size [Spatial Concept]
   739   C1522492:Form [Functional Concept]
   739   C1749467:soluble [Cell Component]
   739   C1948047:Soluble [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that Thr212"

Phrase: "is"

Phrase: "phosphorylated"

Phrase: "when"

Phrase: "Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "is"

Phrase: "polymerized to this size."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0314672:Polymerized [Phenomenon or Process]
   770   C0456389:size [Spatial Concept]
Processing 00000000.tx.317: Thr231 phosphorylation was increased in a 55-kDa, but not a 100-kDa, Tau in the WOXsi-expressing cells. 

Phrase: "Thr231 phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "increased in a 55-kDa,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0450382:55 [Intellectual Product]
   760   C1532717:kDa [Quantitative Concept]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a 100-kDa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "Tau in the WOXsi-expressing cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]
Processing 00000000.tx.318: In addition, phosphorylation at Thr212/Ser202 was shown in a 120-kDa Tau. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "phosphorylation at Thr212/Ser202"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "shown in a 120-kDa Tau."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1532717:kDa [Quantitative Concept]
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]
   719   C1547282:Show [Intellectual Product]
Processing 00000000.tx.319: Nonetheless phosphorylation of Ser214, a site of the AT100 epitope (Thr212/Ser214) in Tau (3235), was not observed both in the AD hippocampi and in the WOXsi-expressing SK-N-SH cells. 

Phrase: "Nonetheless phosphorylation of Ser214,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "a site of the AT100 epitope"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C2945843:Site of [Qualitative Concept]
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]

Phrase: "(Thr212/Ser214"

Phrase: ")"

Phrase: "in Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "(3235"

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "both in the AD hippocampi"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   760   C0238767:Both [Spatial Concept]
   760   C0949582:Hippocampus [Fish]
   760   C1029104:Hippocampus [Fish]
   760   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
   760   C1706086:Both [Qualitative Concept]

Phrase: "and in the WOXsi-expressing SK-N-SH cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   742   C0007634:Cells [Cell]
   742   C0038108:SH [Geographic Area]
   742   C1515981:And [Idea or Concept]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.320: These data suggest that, when Tau is in a specific conformation, certain sites can readily undergo phosphorylation, whereas other sites resist phosphorylation. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that,"

Phrase: "when"

Phrase: "Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "is in a specific conformation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0026377:Conformation [Spatial Concept]
   760   C0205369:Specific [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]

Phrase: "certain sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "can"

Phrase: "readily"

Phrase: "undergo"

Phrase: "phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "whereas"

Phrase: "other sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "resist"

Phrase: "phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.321: It has been determined that phosphorylation of Thr212 may affect the subsequent phosphorylation of Ser214 (36). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "determined"

Phrase: "that phosphorylation of Thr212"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "may"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the subsequent phosphorylation of Ser214"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.322: Indeed Ser214 was not phosphorylated in a P301S Tau transgenic model (37). 

Phrase: "Indeed Ser214"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "phosphorylated in a P301S Tau transgenic model"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1519606:Transgenic Model [Experimental Model of Disease]
   748   C0003069:Transgenic [Animal]
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]
   748   C3161035:Model [Intellectual Product]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.323: Stress-induced JNK activation is involved in the Tau hyperphosphorylation and pathology of AD (23, 49). 

Phrase: "Stress-induced JNK activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "involved in the Tau hyperphosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1314939:Involved [Functional Concept]
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "pathology of AD (23,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0030664:Pathology [Biomedical Occupation or Discipline]
   770   C0205469:pathology [Functional Concept]
   770   C0677042:pathology [Pathologic Function]

Phrase: "49"

Phrase: ")."
Processing 00000000.tx.324: Our data clearly demonstrate that Tau phosphorylation at Thr231 and Thr212 can be mediated by both GSK-3 and JNK1. 

Phrase: "Our data clearly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "demonstrate"

Phrase: "that Tau phosphorylation at Thr231"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "Thr212"

Phrase: "can"

Phrase: "be"

Phrase: "mediated by both GSK-3"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "JNK1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367731:JNK1 [Gene or Genome]
  1000   C1705632:JNK1 [Gene or Genome]
Processing 00000000.tx.325: Thus, these enzymes and perhaps others could phosphorylate these sites in a nonspecific manner. 

Phrase: "Thus,"

Phrase: "these enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "perhaps others"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1955473:Others [Finding]

Phrase: "could"

Phrase: "phosphorylate"

Phrase: "these sites in a nonspecific manner."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   767   C0457192:Nonspecific site [Body Location or Region]
   753   C0205145:Sites [Spatial Concept]
   719 E C1515974:Site [Body Location or Region]
   719 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.326: Inhibition of JNK1 activity by SP600125 (a JNK inhibitor) abolished NFT formation and phosphorylation of Ser515/Ser516 and Thr212/Thr231 (data not shown for Thr212/Thr231). 

Phrase: "Inhibition of JNK1 activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "by SP600125"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0968383:SP600125 [Organic Chemical,Pharmacologic Substance]

Phrase: "("

Phrase: "a JNK inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: ")"

Phrase: "abolished NFT formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "phosphorylation of Ser515/Ser516"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "Thr212/Thr231"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown for Thr212/Thr231"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.327: Similarly suppression of ERK activity by PD-98059 blocked NFT formation and ERK-dependent Ser515/Ser516 phosphorylation. 

Phrase: "Similarly suppression of ERK activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0221103:Suppression [Pathologic Function]
   760   C0301625:Suppression [Organism Function]
   760   C0439181:% suppression [Quantitative Concept]
   760   C0728721:suppression [Mental Process]

Phrase: "by PD-98059 blocked NFT formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0220781:formation [Biologic Function]
   804   C0439634:formation [Spatial Concept]
   804   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "ERK-dependent Ser515/Ser516 phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0031715:Phosphorylation [Molecular Function]
   804   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.328: Heat shock also induces Tau hyperphosphorylation. 

Phrase: "Heat shock also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0282498:Heat Shock [Physiologic Function]
   827   C0018837:Heat [Natural Phenomenon or Process]
   827   C0036974:Shock [Pathologic Function]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "Tau hyperphosphorylation."
Processing 00000000.tx.329: It is of interest to note that molecular chaperones or heat shock proteins Hsp70, Hsp90, and Hsp27 reduce phosphorylation but promote solubility and binding of Tau to microtubules, thereby increasing cell survival (50, 51). 

Phrase: "It"

Phrase: "is of interest to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0543488:Interest [Mental Process]

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that molecular chaperones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243041:Molecular Chaperones [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Chaperone

Phrase: "or"

Phrase: "heat shock proteins Hsp70,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1415760:HSP70 [Gene or Genome]
   812   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   756   C0018850:Heat shock proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Hsp90,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243044:HSP90 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1825534:Hsp90 [Gene or Genome]
  1000   C3273507:Hsp90 [Gene or Genome]

Phrase: "and"

Phrase: "Hsp27"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0018847:hsp27 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1333928:HSP27 [Gene or Genome]
  1000   C1708296:HSP27 [Gene or Genome]

Phrase: "reduce"

Phrase: "phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "but"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "solubility"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0037628:Solubility [Qualitative Concept]
   928 E C1749467:soluble [Cell Component]
   928 E C1948047:Soluble [Qualitative Concept]

Phrase: "and"

Phrase: "binding of Tau"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]

Phrase: "to microtubules,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Microtubules [Cell Component]

Phrase: "thereby"

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "cell survival"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007620:Cell Survival [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "(50,"

Phrase: "51"

Phrase: ")."
Processing 00000000.tx.330: Also CHIP (carboxyl terminus of the Hsc70-interacting protein) and Hsp70 regulate Tau ubiquitination, degradation, and aggregation and enhance cell survival (52, 53). 

Phrase: "Also CHIP (carboxyl terminus of the Hsc70-interacting protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0596260:Carboxyl [Organic Chemical]

Phrase: ")"

Phrase: "and"

Phrase: "Hsp70"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415760:HSP70 [Gene or Genome]
  1000   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "regulate"

Phrase: "Tau ubiquitination,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519751:Ubiquitination [Molecular Function]

Phrase: "degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "and"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "cell survival"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007620:Cell Survival [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "(52,"

Phrase: "53"

Phrase: ")."
Processing 00000000.tx.331: Phosphorylated ERK, p38, JNK1, and calmodulin kinase II are differentially expressed in Tau deposits in neurons and glial cells in tauopathies (18, 19). 

Phrase: "Phosphorylated ERK,"

Phrase: "p38,"

Phrase: "JNK1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367731:JNK1 [Gene or Genome]
  1000   C1705632:JNK1 [Gene or Genome]

Phrase: "and"

Phrase: "calmodulin kinase II"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0006776:Calmodulin-Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "differentially"

Phrase: "expressed in Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720655:Tau [Intellectual Product]
   790   C1947974:Tau [Research Activity]

Phrase: "deposits in neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0027882:Neurons [Cell]
   790   C0333562:Deposit [Functional Concept]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "glial cells in tauopathies"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0027836:Glial Cells [Cell]
           Glial
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(18,"

Phrase: "19"

Phrase: ")."
Processing 00000000.tx.332: We determined that WOX1 physically interacted with Tau, JNK1, and GSK-3 in the extracts of rat brains and cultured cells (data not shown for rat brains). 

Phrase: "We"

Phrase: "determined"

Phrase: "that WOX1 physically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1421525:WOX1 [Gene or Genome]

Phrase: "interacted with Tau,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720655:Tau [Intellectual Product]
   790   C1947974:Tau [Research Activity]

Phrase: "JNK1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367731:JNK1 [Gene or Genome]
  1000   C1705632:JNK1 [Gene or Genome]

Phrase: "and"

Phrase: "GSK-3 in the extracts of rat brains"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   782   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "cultured cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown for rat brains"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   816   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   770   C0006104:Brains [Body Part, Organ, or Organ Component]
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   737 E C1269537:Brain [Body Part, Organ, or Organ Component]
   737   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.333: Thus, WOX1 is likely to prevent phosphorylation of Tau by JNK1, GSK-3, and other enzymes in vivo. 

Phrase: "Thus,"

Phrase: "WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421525:WOX1 [Gene or Genome]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "phosphorylation of Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "by JNK1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367731:JNK1 [Gene or Genome]
  1000   C1705632:JNK1 [Gene or Genome]

Phrase: "GSK-3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "other enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.334: This notion is supported by the observation that WOX1 bound Tau via its COOH-terminal ADH/SDR domain. 

Phrase: "This notion"

Phrase: "is"

Phrase: "supported by the observation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0302523:Observation [Research Activity]
   770   C0700325:observation [Health Care Activity]
   770   C1521721:Supported [Conceptual Entity]
   770   C1964257:Observation [Diagnostic Procedure]
   737 E C0183683:Support [Medical Device]

Phrase: "that WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421525:WOX1 [Gene or Genome]

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "Tau via its COOH-terminal ADH/SDR domain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1720655:Tau [Intellectual Product]
   742   C1947974:Tau [Research Activity]
Processing 00000000.tx.335: Our preliminary data show that ectopic expression of this domain suppressed E2-induced Tau phosphorylation at Thr212/Ser214 and Ser515/Ser516. 

Phrase: "Our preliminary data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that ectopic expression of this domain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1512167:Ectopic Expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]

Phrase: "E2-induced Tau phosphorylation at Thr212/Ser214"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "Ser515/Ser516."
Processing 00000000.tx.336: The ADH/SDR domain possesses a conserved NSYK motif that may bind substrates such as E2 and other sex hormones (11). 

Phrase: "The ADH/SDR domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "possesses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "a conserved NSYK motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514562:Motif [Amino Acid Sequence]

Phrase: "that"

Phrase: "may"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "substrates such as E2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1710236:Substrate [Manufactured Object]

Phrase: "and"

Phrase: "other sex hormones"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0036884:Sex Hormones [Hormone,Pharmacologic Substance]
   861   C0009253:Sex [Organism Function]
   861   C0019932:Hormones [Hormone]
   861   C0036864:Sex [Behavior]
   861   C0079399:sex [Organism Attribute]
   861   C1314687:Sex [Finding]
   861   C1522384:sex [Organism Attribute]
   777 E C0458083:Hormonal [Qualitative Concept]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.337: Estrogen is protective against neuronal death (2528). 

Phrase: "Estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
  1000   C2936882:Estrogen [Pharmacologic Substance]
   928 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "protective against neuronal death"

Phrase: "(2528"

Phrase: ")."
Processing 00000000.tx.338: E2 induces cytosolic Tau expression during 24-h treatment of human SH-SY5Y neuroblastoma cells (56), induces differentiation of a neuronal cell line (57), but cannot change Tau expression in rat brains (58). 

Phrase: "E2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539520:E2 [Gene or Genome]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "cytosolic Tau expression during 24-h treatment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of human SH-SY5Y neuroblastoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   897   C0427861:Human cells [Laboratory or Test Result]
   823   C0815000:neuroblastoma cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "(56"

Phrase: ")"

Phrase: ","

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "differentiation of a neuronal cell line"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   783   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   783   C1518294:Neuronal Differentiation [Finding]
   753   C1511938:Differentiation [Clinical Attribute]
   753   C2945687:Differentiation [Functional Concept]
   748 E C1159970:neuron differentiation [Cell Function]

Phrase: "(57"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "cannot"

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "Tau expression in rat brains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(58"

Phrase: ")."
Processing 00000000.tx.339: In this study, we determined that during a short term treatment for less than 1 h, E2 enhanced the binding of WOX1 with phosphorylated Tau at Thr212/Ser214 and Ser515/Ser516 and GSK-3 with Tau and WOX1 in L929 cells. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "determined"

Phrase: "that during a short term treatment"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0443303:Short-term [Temporal Concept]
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1282927:short [Qualitative Concept]
   753   C1515273:Term [Temporal Concept]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C1705313:Term [Idea or Concept]
   753   C1806781:Short [Quantitative Concept]
   753   C2350002:Short [Quantitative Concept]
   753   C2826302:TERM [Intellectual Product]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "for less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "than 1 h,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "E2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539520:E2 [Gene or Genome]

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "the binding of WOX1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "with phosphorylated Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "at Thr212/Ser214"

Phrase: "and"

Phrase: "Ser515/Ser516"

Phrase: "and"

Phrase: "GSK-3 with Tau"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   882   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   783   C2362079:TAU 3 [Immunologic Factor]
   753   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "WOX1 in L929 cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1421525:WOX1 [Gene or Genome]
Processing 00000000.tx.340: However, E2 may increase Tau phosphorylation during treatment for longer than 1 h (data not shown). 

Phrase: "However,"

Phrase: "E2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539520:E2 [Gene or Genome]

Phrase: "may"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "Tau phosphorylation during treatment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "for longer"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0205166:Long [Qualitative Concept]
   966   C1706317:Long [Qualitative Concept]
   916 E C1444754:Length [Quantitative Concept]
   916 E C1706316:LENGTH [Research Activity]

Phrase: "than 1 h (data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
   734   C0700308:1 H [Element, Ion, or Isotope]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.341: Accordingly, WOX1 is likely to prevent further enzyme-mediated Tau phosphorylation. 

Phrase: "Accordingly,"

Phrase: "WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421525:WOX1 [Gene or Genome]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "further enzyme-mediated Tau phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0031715:Phosphorylation [Molecular Function]
   804   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.342: The functional role of WOX1 in preventing E2-increased Tau phosphorylation in vivo remains to be established. 

Phrase: "The functional role of WOX1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1705810:Functional Role [Conceptual Entity]
           Role
   760   C0035820:Role [Social Behavior]

Phrase: "in preventing E2-increased Tau phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0031715:Phosphorylation [Molecular Function]
   804   C1158886:Phosphorylation [Molecular Function]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "established."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]
Processing 00000000.tx.343: Finally, both WOX1 and prolyl isomerase PIN1 interact with phosphorylated or activated p53 (on (Ser/Thr)-Pro motifs) during DNA damage (for a review, see Ref. 11). 

Phrase: "Finally,"

Phrase: "both WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421525:WOX1 [Gene or Genome]

Phrase: "and"

Phrase: "prolyl isomerase PIN1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1418582:PIN1 [Gene or Genome]
   827   C1826563:PIN1 [Gene or Genome]
   734   C0136073:Prolyl Isomerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "interact with phosphorylated"

Phrase: "or"

Phrase: "activated p53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079419:P53 [Gene or Genome]
   861   C1705526:p53 [Gene or Genome]

Phrase: "(on (Ser/Thr)-Pro motifs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1514562:Motif [Amino Acid Sequence]

Phrase: ")"

Phrase: "during DNA damage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   861   C0010957:Damage [Injury or Poisoning]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1883709:Damage [Functional Concept]

Phrase: "("

Phrase: "for a review,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Ref. 11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.344: PIN1 possesses an NH2-terminal WW domain and a COOH-terminal isomerase domain. 

Phrase: "PIN1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418582:PIN1 [Gene or Genome]
  1000   C1826563:PIN1 [Gene or Genome]

Phrase: "possesses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "an NH2-terminal WW domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1861696:WW [Disease or Syndrome]
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "a COOH-terminal isomerase domain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.345: The WW domain in PIN1 binds to phosphorylated p53 on the (Ser/Thr)-Pro motifs and the polyproline region. 

Phrase: "The WW domain in PIN1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1861696:WW [Disease or Syndrome]
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C3541951:Domain [Intellectual Product]

Phrase: "binds to phosphorylated p53"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0079419:P53 [Gene or Genome]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   770   C1705526:p53 [Gene or Genome]

Phrase: "on the (Ser/Thr)-Pro motifs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1514562:Motif [Amino Acid Sequence]

Phrase: "and"

Phrase: "the polyproline region."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.346: This type of binding is similar to that of the WOX1 interaction with p53 (7, 11). 

Phrase: "This type of binding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332307:Type [Qualitative Concept]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "is"

Phrase: "similar to that of the WOX1 interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2348205:Similar [Qualitative Concept]

Phrase: "with p53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:P53 [Gene or Genome]
  1000   C1705526:p53 [Gene or Genome]

Phrase: "(7,"

Phrase: "11"

Phrase: ")."
Processing 00000000.tx.347: PIN1 binds (via its WW domain) and colocalizes with Thr231-phosphorylated Tau in Alzheimer's disease and other tauopathies (42, 54, 59). 

Phrase: "PIN1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418582:PIN1 [Gene or Genome]
  1000   C1826563:PIN1 [Gene or Genome]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "("

Phrase: "via its WW domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1861696:WW [Disease or Syndrome]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "colocalizes with Thr231-phosphorylated Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]

Phrase: "in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "other tauopathies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949664:Tauopathies [Disease or Syndrome]

Phrase: "(42,"

Phrase: "54,"

Phrase: "59"

Phrase: ")."
Processing 00000000.tx.348: In contrast, WOX1 binds Tau through its ADH/SDR domain. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421525:WOX1 [Gene or Genome]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "Tau through its ADH/SDR domain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]
Processing 00000000.tx.349: Like WOX1, PIN1 expression is inversely correlated with predicted neuronal vulnerability and actual neurofibrillary degeneration in Alzheimer's disease (55). 

Phrase: "Like WOX1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421525:WOX1 [Gene or Genome]

Phrase: "PIN1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "inversely"

Phrase: "correlated with predicted neuronal vulnerability"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0521390:Neuronal [Immunologic Factor]
   760   C0681842:Predicted [Idea or Concept]
   760   C1707520:Correlated [Qualitative Concept]
   760   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "and"

Phrase: "actual neurofibrillary degeneration in Alzheimer's disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C0085400:Alzheimer's neurofibrillary degeneration [Acquired Abnormality]
           Neurofibrillary degeneration
   753   C0011164:Degeneration [Pathologic Function]
   753   C1880269:Degeneration [Functional Concept]

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.350: A transgenic PIN1 mouse model shows that PIN1 is able to protect against age-dependent neurodegeneration (55). 

Phrase: "A transgenic PIN1 mouse model"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C1519606:Transgenic Model [Experimental Model of Disease]
   861   C2986594:Mouse Model [Experimental Model of Disease]
   812   C3161035:Model [Intellectual Product]
   708   C0025936:Mouse, Transgenic [Mammal]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that PIN1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418582:PIN1 [Gene or Genome]
  1000   C1826563:PIN1 [Gene or Genome]

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "protect against age-dependent neurodegeneration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0001779:Age [Organism Attribute]
   760   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.351: In summary, our study demonstrated that WOX1 binds Tau via its ADH/SDR domain and is likely to prevent E2- and enzyme-mediated Tau phosphorylation in vivo. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "demonstrated"

Phrase: "that WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421525:WOX1 [Gene or Genome]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "Tau via its ADH/SDR domain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "E2-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539520:E2 [Gene or Genome]

Phrase: "and"

Phrase: "enzyme-mediated Tau phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031715:Phosphorylation [Molecular Function]
   812   C1158886:Phosphorylation [Molecular Function]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.352: Down-regulation of WOX1 in the AD neurons induces Tau hyperphosphorylation and subsequent NFT formation, indicating a protective role of WOX1 in neurodegeneration.  

Phrase: "Down-regulation of WOX1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0013081:Down-Regulation [Cell Function,Molecular Function]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]
   715   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   715   C2626739:Lanugo [Eukaryote]

Phrase: "in the AD neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "Tau hyperphosphorylation"

Phrase: "and"

Phrase: "subsequent NFT formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "indicating"

Phrase: "a protective role of WOX1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in neurodegeneration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
Processing 00000000.tx.353: FOOTNOTES  * This work was supported by the National Institutes of Health (to C.-I. S., co-principal investigator with Lynn Heasley) and by the American Heart Association and Department of Defense Grant DAMD17-03-1-0736 (to N.-S. C.). 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by the National Institutes of Health"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   853   C0027468:National Institutes of Health [Health Care Related Organization]
           national health institutes
   748   C0018684:Health [Idea or Concept]
   748   C0021622:Institutes [Organization]
   748   C1521721:Supported [Conceptual Entity]
   748   C3245503:national [Intellectual Product]
   714 E C0183683:Support [Medical Device]
   714 E C1272753:Institute [Idea or Concept]

Phrase: "("

Phrase: "to C.-I."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1547546:C-I [Classification]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "S."

Phrase: ","

Phrase: "co-principal investigator with Lynn Heasley"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1521895:Principal Investigator [Professional or Occupational Group]
   783   C1707421:Co-Investigator [Professional or Occupational Group]
   753   C0035173:Investigator [Professional or Occupational Group]
   753   C0205225:Principal [Qualitative Concept]
   753   C0401925:Principal [Professional or Occupational Group]

Phrase: ")"

Phrase: "and by the American Heart Association"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0002458:American Heart Association [Health Care Related Organization]
   753   C0004083:Association [Mental Process]
   753   C0018787:Heart [Body Part, Organ, or Organ Component]
   753   C0439849:Association [Qualitative Concept]
   753   C0596070:American [Population Group]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]
   753   C1281570:Heart [Body Part, Organ, or Organ Component]
   753   C1515981:And [Idea or Concept]

Phrase: "and"

Phrase: "Department of Defense Grant DAMD17-03-1-0736"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   835   C1511775:Department of Defense [Organization]
   835   C3496101:Department of Defense [Health Care Related Organization]
   793   C0018173:Grant [Quantitative Concept]
   793   C1548284:Grant [Idea or Concept]
   793   C1704729:Department [Organization]
   793   C1880266:Defense [Conceptual Entity]

Phrase: "("

Phrase: "to N.-S. C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C2349138:N/C [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.354: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.355: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.356: Section 1734 solely to indicate this fact. 

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.357: The on-line version of this article (available at http://www.jbc.org) contains Supplemental Figs. 

Phrase: "The on-line version of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0333052:Version [Functional Concept]
   748   C2607870:Version [Spatial Concept]

Phrase: "(available at http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]

Phrase: ":"

Phrase: "//www.jbc.org"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1522486:ORG [Professional or Occupational Group]

Phrase: ")"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "Supplemental Figs."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]
Processing 00000000.tx.358: 1-3. 

Phrase: "1-3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]
Processing 00000000.tx.359: || Supported by Ministry of Education, Taiwan, Republic of China Grant 91-B-FA09-1-4. 

Phrase: "||"

Phrase: "Supported by Ministry of Education,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0013621:Education [Educational Activity]
   760   C0013622:education [Classification]
   760   C0013658:Education, NOS [Finding]
   760   C0039401:Education [Educational Activity]
   760   C1521721:Supported [Conceptual Entity]
   726 E C0183683:Support [Medical Device]

Phrase: "Taiwan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039260:Taiwan [Geographic Area]

Phrase: "Republic of China Grant 91-B-FA09-1-4."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0039260:Republic of China [Geographic Area]
   791   C0008115:China [Geographic Area]
   791   C0018173:Grant [Quantitative Concept]
   791   C1548284:Grant [Idea or Concept]
Processing 00000000.tx.360: Visting scientist from the National Cheng Kung University Medical College, Tainam, Taiwan. 

Phrase: "Visting scientist from the National Cheng Kung University Medical College,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0402112:Scientist [Professional or Occupational Group]

Phrase: "Tainam,"

Phrase: "Taiwan."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039260:Taiwan [Geographic Area]
Processing 00000000.tx.361: ** To whom correspondence should be addressed. 

Phrase: "*"

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.362: Fax: 570-882-4643; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "570-882-4643"

Phrase: ";"
Processing 00000000.tx.363: E-mail: chang_nanshan{at}guthrie.org . 1 The abbreviations used are: AD, Alzheimer's disease; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "chang_nanshan{at}guthrie.org . 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1522486:ORG [Professional or Occupational Group]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "AD,"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.364: WOX1, WW domain-containing oxidoreductase; 

Phrase: "WOX1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421525:WOX1 [Gene or Genome]

Phrase: "WW domain-containing oxidoreductase"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1421525:WW DOMAIN-CONTAINING OXIDOREDUCTASE [Gene or Genome]
   812   C0030016:Oxidoreductase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0332256:Containing [Functional Concept]
   812   C1537381:oxidoreductase [Gene or Genome]
   812   C1861696:WW [Disease or Syndrome]
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C2700400:Containing [Activity]
   812   C3541951:Domain [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.365: JNK, c-Jun NH2-terminal kinase; 

Phrase: "JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "c-Jun NH2-terminal kinase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   937   C0248813:jun-NH2-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   911   C0872123:c JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0872053:JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C1334482:Jun kinase [Gene or Genome]
   875   C1367019:Jun Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   708   C1707271:C-Terminal [Amino Acid Sequence]

Phrase: ";"
Processing 00000000.tx.366: GSK-3, glycogen synthase kinase 3; 

Phrase: "GSK-3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "glycogen synthase kinase 3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.367: siRNA, small interfering RNA; 

Phrase: "siRNA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0521102:interfering [Qualitative Concept]
   827   C0700321:Small [Quantitative Concept]

Phrase: "small interfering RNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0521102:interfering [Qualitative Concept]
   827   C0700321:Small [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.368: NFT, neurofibrillary tangle; 

Phrase: "NFT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085400:NFT [Acquired Abnormality]

Phrase: "neurofibrillary tangle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085400:Neurofibrillary tangle [Acquired Abnormality]
  1000   C3543859:neurofibrillary tangle [Cell Component]

Phrase: ";"
Processing 00000000.tx.369: p-WOX1, Tyr33-phosphorylated WOX1; 

Phrase: "p-WOX1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "Tyr33-phosphorylated WOX1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1421525:WOX1 [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.370: WOX1si, siRNA-targeting WOX1; 

Phrase: "WOX1si,"

Phrase: "siRNA-targeting WOX1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1421525:WOX1 [Gene or Genome]
   717   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ";"
Processing 00000000.tx.371: ADH/SDR, short-chain alcohol dehydrogenase/reductase; 

Phrase: "ADH/SDR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0001942:Alcohol dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "short-chain alcohol dehydrogenase/reductase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   911   C0163885:short chain reductase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.372: E2, 17-estradiol; 

Phrase: "E2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539520:E2 [Gene or Genome]

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: ";"
Processing 00000000.tx.373: PHF-Tau, paired helical filaments of Tau; 

Phrase: "PHF-Tau,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2700455:PHF-Tau [Amino Acid, Peptide, or Protein]
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "paired helical filaments of Tau"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   883   C2700455:Paired Helical Filament-Tau [Amino Acid, Peptide, or Protein]
   828   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   760   C1709450:Paired [Qualitative Concept]
   726   C0010851:Filament [Cell Component]

Phrase: ";"
Processing 00000000.tx.374: ERK, extracellular signal-regulated kinase; 

Phrase: "ERK,"

Phrase: "extracellular signal-regulated kinase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   979   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   979   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0521119:Extracellular [Cell Component]
   812   C0851285:Regulated [Governmental or Regulatory Activity]
   812   C1710082:Signal [Phenomenon or Process]

Phrase: ";"
Processing 00000000.tx.375: cdk5, cyclin-dependent kinase 5; 

Phrase: "cdk5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CDK5 [Gene or Genome]

Phrase: "cyclin-dependent kinase 5"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0249586:Cyclin-Dependent Kinase 5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CYCLIN-DEPENDENT KINASE 5 [Gene or Genome]
   923   C0243045:Cyclin-Dependent Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0851827:Dependent [Qualitative Concept]
   812   C1150565:cyclin [Molecular Function]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]

Phrase: ";"
Processing 00000000.tx.376: MEK, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase; 

Phrase: "MEK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0752313:mek [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "mitogen-activated protein kinase/extracellular signal-regulated kinase kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   888   C0211705:Mitogen-Activated Protein Kinase Kinase Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.377: p-, phospho-; 

Phrase: "p-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "phospho-"

Phrase: ";"
Processing 00000000.tx.378: GFP, green fluorescent protein. 

Phrase: "GFP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "green fluorescent protein."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]
Processing 00000000.tx.379: 2 N.-S. 

Phrase: "2 N.-S."
Processing 00000000.tx.380: Chang, L. 

Phrase: "Chang,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.381: Schultz, and C.-I. 

Phrase: "Schultz,"

Phrase: "and"

Phrase: "C.-I."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1547546:C-I [Classification]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.382: Sze, unpublished. 

Phrase: "Sze,"

Phrase: "unpublished."
Processing 00000000.tx.383: 3 S. 

Phrase: "3 S."
Processing 00000000.tx.384: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.385: Chen, J. 

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "J."
Processing 00000000.tx.386: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.387: Chuang, M. 

Phrase: "Chuang,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.388: Y. 

Phrase: "Y."
Processing 00000000.tx.389: Li, and N.-S. 

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "N.-S."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.390: Chang, submitted.  

Phrase: "Chang,"

Phrase: "submitted."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515023:Submitted [Functional Concept]
Processing 00000000.tx.391: ACKNOWLEDGMENTS  We are indebted to the patients and families who donated the brains to the University of Colorado Health Sciences Center Brain Bank to make this study possible. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "We"

Phrase: "are"

Phrase: "indebted to the patients"

Phrase: "and"

Phrase: "families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "who"

Phrase: "donated"

Phrase: "the brains to the University of Colorado Health Sciences Center Brain"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   738   C0006104:Brains [Body Part, Organ, or Organ Component]
   704 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "Bank"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442598:Bank [Manufactured Object]
  1000   C0872261:Bank [Manufactured Object]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "possible."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]
Processing 00000000.tx.392: We thank Lisa Lizenberger for kind assistance with photographs and figures preparation and Terri Zimmer for antibody production in rabbits. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Lisa Lizenberger for kind assistance"

Phrase: "with photographs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0441468:Photographs [Manufactured Object]
  1000   C1548899:Photographs [Health Care Activity]
   893 E C0031749:Photographies [Occupational Activity]

Phrase: "and"

Phrase: "figures"

Phrase: "preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: "and"

Phrase: "Terri Zimmer for antibody production"

Phrase: "in rabbits."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034493:Rabbit [Mammal]
Processing 00000000.tx.393: Development of specific antibodies against WOX1/FOR2 and WOX2/FOR1 was a joint effort of the laboratories of Nan-Shan Chang (Guthrie Research Institute) and Robert I. 

Phrase: "Development of specific antibodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]

Phrase: "against WOX1/FOR2"

Phrase: "and"

Phrase: "WOX2/FOR1"

Phrase: "was"

Phrase: "a joint effort of the laboratories of Nan-Shan Chang"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0015264:Effort [Organism Function]

Phrase: "(Guthrie Research Institute"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0035172:Research Institute [Organization]
   827   C0021622:institute [Organization]
   827   C0035168:research [Research Activity]
   827   C0242481:Research [Research Activity]
   827   C1272753:Institute [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "Robert I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.394: Richards (University of Adelaide, Adelaide, Australia).  

Phrase: "Richards"

Phrase: "(University of Adelaide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Adelaide,"

Phrase: "Australia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004340:Australia [Geographic Area]
   928 E C0238711:AUSTRALIAN [Finding]

Phrase: ")."
Processing 00000000.tx.395: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Kitamura, Y., Shimohama, S., Kamoshima, W., Matsuoka, Y., Nomura, Y., and Taniguchi, T. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Kitamura,"

Phrase: "Y.,"

Phrase: "Shimohama,"

Phrase: "S."

Phrase: ","

Phrase: "Kamoshima,"

Phrase: "W.,"

Phrase: "Matsuoka,"

Phrase: "Y.,"

Phrase: "Nomura,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Taniguchi,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.396: (1997) Biochem. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.397: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.398: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.399: Commun. 

Phrase: "Commun."
Processing 00000000.tx.400: 232, 418-421[CrossRef][Medline] [OrderarticleviaInfotrieve] De La Monte, S.M., Sohn, Y. 

Phrase: "232,"

Phrase: "418-421"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] De La Monte,"

Phrase: "S.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Sohn,"

Phrase: "Y."
Processing 00000000.tx.401: K., and Wands, J. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Wands,"

Phrase: "J."
Processing 00000000.tx.402: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.403: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.404: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.405: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.406: 152, 73-83[CrossRef][Medline] [OrderarticleviaInfotrieve] Rohn, T. 

Phrase: "152,"

Phrase: "73-83"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Rohn,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.407: T., Head, E., Nesse, W. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Head,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0018670:Head [Body Location or Region]
  1000   C1281590:Head [Body Part, Organ, or Organ Component]
  1000   C1706305:Head [Manufactured Object]
   944 E C0205096:Cephalic [Spatial Concept]

Phrase: "E.,"

Phrase: "Nesse,"

Phrase: "W."
Processing 00000000.tx.408: H., Cotman, C. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Cotman,"

Phrase: "C."
Processing 00000000.tx.409: W., and Cribbs, D. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Cribbs,"

Phrase: "D."
Processing 00000000.tx.410: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.411: (2001) Neurobiol. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.412: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.413: 8, 1006-1016[CrossRef][Medline] [OrderarticleviaInfotrieve] Morishima, Y., Gotoh, Y., Zeig, J., Barret, T., Takano, H., Flavell, R., Davis, R. 

Phrase: "8,"

Phrase: "1006-1016"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Morishima,"

Phrase: "Y.,"

Phrase: "Gotoh,"

Phrase: "Y.,"

Phrase: "Zeig,"

Phrase: "J.,"

Phrase: "Barret,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Takano,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Flavell,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Davis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.414: J., Shirasaki, Y., and Greenberg, M. 

Phrase: "J.,"

Phrase: "Shirasaki,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Greenberg,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.415: E. 

Phrase: "E."
Processing 00000000.tx.416: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.417: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.418: 21, 7551-7560[Abstract/Free FullText] Jellinger, K. 

Phrase: "21,"

Phrase: "7551-7560"

Phrase: "[Abstract/Free FullText"

Phrase: "] Jellinger,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.419: A. 

Phrase: "A."
Processing 00000000.tx.420: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.421: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.422: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.423: Med. 

Phrase: "Med."
Processing 00000000.tx.424: 5, 1-17[Medline] [OrderarticleviaInfotrieve] Mattson, M. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "1-17"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Mattson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.425: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.426: (2000) Nat. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.427: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.428: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.429: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.430: Biol. 

Phrase: "Biol."
Processing 00000000.tx.431: 1, 120-129[CrossRef][Medline] [OrderarticleviaInfotrieve] Chang, N.-S., Pratt, N., Heath, J., Schultz, L., Sleve, D., Carey, G. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "120-129"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Chang,"

Phrase: "N.-S.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "Pratt,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Heath,"

Phrase: "J.,"

Phrase: "Schultz,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Sleve,"

Phrase: "D."

Phrase: ","

Phrase: "Carey,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.432: B., and Zevotek, N. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Zevotek,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.433: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.434: Biol. 

Phrase: "Biol."
Processing 00000000.tx.435: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.436: 276, 3361-3370[Abstract/Free FullText] Richards, R. 

Phrase: "276,"

Phrase: "3361-3370"

Phrase: "[Abstract/Free FullText"

Phrase: "] Richards,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.437: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.438: (2001) Trends Genet. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.439: 17, 339-345[CrossRef][Medline] [OrderarticleviaInfotrieve] Chang, N.-S. 

Phrase: "17,"

Phrase: "339-345"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Chang,"

Phrase: "N.-S."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.440: (2002) Int. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.441: J. 

Phrase: "J."
Processing 00000000.tx.442: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.443: Med. 

Phrase: "Med."
Processing 00000000.tx.444: 9, 19-24[Medline] [OrderarticleviaInfotrieve] Chang, N.-S., Doherty, J., and Ensign, A. 

Phrase: "9,"

Phrase: "19-24"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Chang,"

Phrase: "N.-S.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "Doherty,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Ensign,"

Phrase: "A."
Processing 00000000.tx.445: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.446: Biol. 

Phrase: "Biol."
Processing 00000000.tx.447: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.448: 278, 9195-9202[Abstract/Free FullText] Chang, N.-S., Doherty, J., Ensign, A., Lewis, J., Heath, J., Schultz, L., Chen, S. 

Phrase: "278,"

Phrase: "9195-9202"

Phrase: "[Abstract/Free FullText"

Phrase: "] Chang,"

Phrase: "N.-S.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "Doherty,"

Phrase: "J.,"

Phrase: "Ensign,"

Phrase: "A.,"

Phrase: "Lewis,"

Phrase: "J.,"

Phrase: "Heath,"

Phrase: "J.,"

Phrase: "Schultz,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.449: T., and Oppermann, U. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Oppermann,"

Phrase: "U."
Processing 00000000.tx.450: (2003)Biochem. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.451: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.452: 66, 1347-1354[CrossRef][Medline] [OrderarticleviaInfotrieve] Driouch, K., Prydz, H., Monese, R., Johansen, H., Lidereau, R., and Frengen, E. 

Phrase: "66,"

Phrase: "1347-1354"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Driouch,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Prydz,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Monese,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Johansen,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lidereau,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Frengen,"

Phrase: "E."
Processing 00000000.tx.453: (2002) Oncogene 21, 1832-1840[CrossRef][Medline] [OrderarticleviaInfotrieve] Bednarek, A. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Oncogene 21,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029016:Oncogene [Gene or Genome]

Phrase: "1832-1840"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bednarek,"

Phrase: "A."
Processing 00000000.tx.454: K., Keck-Waggoner, C. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Keck-Waggoner,"

Phrase: "C."
Processing 00000000.tx.455: L., Daniel, R. 

Phrase: "L., Daniel,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.456: L., Laflin, K. 

Phrase: "L., Laflin,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.457: J., Bergsagel, P. 

Phrase: "J.,"

Phrase: "Bergsagel,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.458: L., Kiguchi, K., Brenner, A. 

Phrase: "L., Kiguchi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Brenner,"

Phrase: "A."
Processing 00000000.tx.459: J., and Aldaz, C. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Aldaz,"

Phrase: "C."
Processing 00000000.tx.460: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.461: (2001) Cancer Res. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.462: 61, 8068-8073[Abstract/Free FullText] Paige, A. 

Phrase: "61,"

Phrase: "8068-8073"

Phrase: "[Abstract/Free FullText"

Phrase: "] Paige,"

Phrase: "A."
Processing 00000000.tx.463: J., Taylor, K. 

Phrase: "J.,"

Phrase: "Taylor,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.464: J., Taylor, C., Hillier, S. 

Phrase: "J.,"

Phrase: "Taylor,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Hillier,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0442532:Hill [Spatial Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.465: G., Farrington, S., Scott, D., Porteous, D. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Farrington,"

Phrase: "S."

Phrase: ","

Phrase: "Scott,"

Phrase: "D."

Phrase: ","

Phrase: "Porteous,"

Phrase: "D."
Processing 00000000.tx.466: J., Smyth, J. 

Phrase: "J.,"

Phrase: "Smyth,"

Phrase: "J."
Processing 00000000.tx.467: F., Gabra, H., and Watson, J. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Gabra,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Watson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3476816:Watson [Quantitative Concept]

Phrase: "J."
Processing 00000000.tx.468: E. 

Phrase: "E."
Processing 00000000.tx.469: (2001) Proc. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.470: Natl. 

Phrase: "Natl."
Processing 00000000.tx.471: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.472: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.473: U. 

Phrase: "U."
Processing 00000000.tx.474: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.475: A. 

Phrase: "A."
Processing 00000000.tx.476: 98, 11417-11422[Abstract/Free FullText] Watanabe, A., Hippo, Y., Taniguchi, H., Iwanari, H., Yashiro, M., Hirakawa, K., Kodama, T., and Aburatani, H. 

Phrase: "98,"

Phrase: "11417-11422"

Phrase: "[Abstract/Free FullText"

Phrase: "] Watanabe,"

Phrase: "A.,"

Phrase: "Hippo,"

Phrase: "Y.,"

Phrase: "Taniguchi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Iwanari,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yashiro,"

Phrase: "M."

Phrase: ","

Phrase: "Hirakawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kodama,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Aburatani,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.477: (2003) Cancer Res. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.478: 63, 8629-8633[Abstract/Free FullText] Chen, S. 

Phrase: "63,"

Phrase: "8629-8633"

Phrase: "[Abstract/Free FullText"

Phrase: "] Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.479: T., Chuang, J. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Chuang,"

Phrase: "J."
Processing 00000000.tx.480: I., Wang, J. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Wang,"

Phrase: "J."
Processing 00000000.tx.481: P., Tsai, M. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Tsai,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.482: S., Li, H., and Chang, N.-S. 

Phrase: "S."

Phrase: ","

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Chang,"

Phrase: "N.-S."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.483: (2004) Neuroscience 124, 831-839[CrossRef][Medline] [OrderarticleviaInfotrieve] Ried, K., Finnis, M., Hobson, L., Mangelsdorf, M., Dayan, S., Nancarrow, J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Neuroscience 124,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "831-839"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ried,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Finnis,"

Phrase: "M."

Phrase: ","

Phrase: "Hobson,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Mangelsdorf,"

Phrase: "M."

Phrase: ","

Phrase: "Dayan,"

Phrase: "S."

Phrase: ","

Phrase: "Nancarrow,"

Phrase: "J."
Processing 00000000.tx.484: K., Woollatt, E., Kremmidiotis, G., Gardner, A., Venter, D., Baker, E., and Richards, R. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Woollatt,"

Phrase: "E.,"

Phrase: "Kremmidiotis,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Gardner,"

Phrase: "A.,"

Phrase: "Venter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0224086:Venter [Body Part, Organ, or Organ Component]

Phrase: "D."

Phrase: ","

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "E.,"

Phrase: "and"

Phrase: "Richards,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.485: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.486: (2000) Hum. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Hum."
Processing 00000000.tx.487: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.488: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.489: 9, 1651-1663[Abstract/Free FullText] Ferrer, I., Blanco, R., Carmona, M., and Puig, B. 

Phrase: "9,"

Phrase: "1651-1663"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ferrer,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Blanco,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Carmona,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Puig,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.490: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.491: Neural Transm. 

Phrase: "Neural Transm."
Processing 00000000.tx.492: 108, 1397-1415[CrossRef][Medline] [OrderarticleviaInfotrieve] Pei, J. 

Phrase: "108,"

Phrase: "1397-1415"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Pei,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0814202:PEI [Intellectual Product]
  1000   C1880568:PEI [Therapeutic or Preventive Procedure]

Phrase: "J."
Processing 00000000.tx.493: J., Braak, E., Braak, H., Grundke-Iqbal, I., Iqbal, K., Winblad, B., and Cowburn, R. 

Phrase: "J.,"

Phrase: "Braak,"

Phrase: "E.,"

Phrase: "Braak,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Grundke-Iqbal,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Iqbal,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Winblad,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Cowburn,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.494: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.495: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.496: Alzheimer's Dis. 

Phrase: "Alzheimer's Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0451119:DIS [Intellectual Product]
   861   C1444662:DIS [Finding]
Processing 00000000.tx.497: 3, 41-48[Medline] [OrderarticleviaInfotrieve] Zhu, X., Raina, A. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "41-48"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Zhu,"

Phrase: "X.,"

Phrase: "Raina,"

Phrase: "A."
Processing 00000000.tx.498: K., Rottkamp, C. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Rottkamp,"

Phrase: "C."
Processing 00000000.tx.499: A., Aliev, G., Perry, G., Boux, H., and Smith, M. 

Phrase: "A.,"

Phrase: "Aliev,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Perry,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Boux,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.500: A. 

Phrase: "A."
Processing 00000000.tx.501: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.502: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.503: 76, 435-441[CrossRef][Medline] [OrderarticleviaInfotrieve] Kaytor, M. 

Phrase: "76,"

Phrase: "435-441"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kaytor,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.504: D., and Orr, H. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Orr,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.505: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.506: (2002) Curr. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.507: Opin. 

Phrase: "Opin."
Processing 00000000.tx.508: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.509: 12, 275-278[CrossRef][Medline] [OrderarticleviaInfotrieve] Liu, F., Iqbal, K., Grundke-Iqbal, I., and Gong, C. 

Phrase: "12,"

Phrase: "275-278"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Liu,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Iqbal,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Grundke-Iqbal,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Gong,"

Phrase: "C."
Processing 00000000.tx.510: X. 

Phrase: "X."
Processing 00000000.tx.511: (2002) FEBS Lett. 

Phrase: "(2002"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.512: 530, 209-214[CrossRef][Medline] [OrderarticleviaInfotrieve] Morishima-Kawashima, M., and Ihara, Y. 

Phrase: "530,"

Phrase: "209-214"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Morishima-Kawashima,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Ihara,"

Phrase: "Y."
Processing 00000000.tx.513: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.514: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.515: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.516: 70, 392-401[CrossRef][Medline] [OrderarticleviaInfotrieve] Noble, W., Olm, V., Takata, K., Casey, E., Mary, O., Meyerson, J., Gaynor, K., LaFrancois, J., Wang, L., Kondo, T., Davies, P., Burns, M., Veeranna., Nixon, R., Dickson, D., Matsuoka, Y., Ahlijanian, M., Lau, L. 

Phrase: "70,"

Phrase: "392-401"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Noble,"

Phrase: "W.,"

Phrase: "Olm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0327004:Olm [Amphibian]

Phrase: "V.,"

Phrase: "Takata,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Casey,"

Phrase: "E.,"

Phrase: "Mary,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Meyerson,"

Phrase: "J.,"

Phrase: "Gaynor,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "LaFrancois,"

Phrase: "J.,"

Phrase: "Wang,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Kondo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Davies,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Burns,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006434:Burns [Injury or Poisoning]
   966 E C1550619:Burn [Substance]

Phrase: "M."

Phrase: ","

Phrase: "Veeranna.,"

Phrase: "Nixon,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Dickson,"

Phrase: "D."

Phrase: ","

Phrase: "Matsuoka,"

Phrase: "Y.,"

Phrase: "Ahlijanian,"

Phrase: "M."

Phrase: ","

Phrase: "Lau,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.517: F., and Duff, K. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Duff,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.518: (2003) Neuron 38, 555-565[Medline] [OrderarticleviaInfotrieve] Ba, F., Pang, P. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Neuron 38,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "555-565"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ba,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Pang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413561:PANG [Gene or Genome]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.519: K., Davidge, S. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Davidge,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.520: T., and Benishin, C. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Benishin,"

Phrase: "C."
Processing 00000000.tx.521: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.522: (2004) Neurochem. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Neurochem."
Processing 00000000.tx.523: Int. 

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.524: 44, 401-411[CrossRef][Medline] [OrderarticleviaInfotrieve] Belcredito, S., Vegeto, E., Brusadelli, A., Ghisletti, S., Mussi, P., Ciana, P., and Maggi, A. 

Phrase: "44,"

Phrase: "401-411"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Belcredito,"

Phrase: "S."

Phrase: ","

Phrase: "Vegeto,"

Phrase: "E.,"

Phrase: "Brusadelli,"

Phrase: "A.,"

Phrase: "Ghisletti,"

Phrase: "S."

Phrase: ","

Phrase: "Mussi,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ciana,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Maggi,"

Phrase: "A."
Processing 00000000.tx.525: (2001) Brain Res. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.526: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.527: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.528: 37, 335-342[Medline] [OrderarticleviaInfotrieve] Greenfield, J. 

Phrase: "37,"

Phrase: "335-342"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Greenfield,"

Phrase: "J."
Processing 00000000.tx.529: P., Leung, L. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Leung,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.530: W., Cai, D., Kaasik, K., Gross, R. 

Phrase: "W., Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "D."

Phrase: ","

Phrase: "Kaasik,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Gross,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439806:Gross [Qualitative Concept]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.531: S., Rodriguez-Boulan, E., Greengard, P., and Xu, H. 

Phrase: "S."

Phrase: ","

Phrase: "Rodriguez-Boulan,"

Phrase: "E.,"

Phrase: "Greengard,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Xu,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.532: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.533: Biol. 

Phrase: "Biol."
Processing 00000000.tx.534: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.535: 277, 12128-12136[Abstract/Free FullText] Bonnefont, A. 

Phrase: "277,"

Phrase: "12128-12136"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bonnefont,"

Phrase: "A."
Processing 00000000.tx.536: B., Munoz, F. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Munoz,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.537: J., and Inestrosa, N. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Inestrosa,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.538: C. 

Phrase: "C."
Processing 00000000.tx.539: (1998) FEBS Lett. 

Phrase: "(1998"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.540: 441, 220-224[CrossRef][Medline] [OrderarticleviaInfotrieve] Bennett, B. 

Phrase: "441,"

Phrase: "220-224"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bennett,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.541: L., Sasaki, D. 

Phrase: "L., Sasaki,"

Phrase: "D."
Processing 00000000.tx.542: T., Murray, B. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Murray,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.543: W., O'Leary, E. 

Phrase: "W., O'Leary,"

Phrase: "E."
Processing 00000000.tx.544: C., Sakata. 

Phrase: "C., Sakata."
Processing 00000000.tx.545: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.546: T., Xu, W., Leisten, J. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Xu,"

Phrase: "W.,"

Phrase: "Leisten,"

Phrase: "J."
Processing 00000000.tx.547: C., Motiwala, A., Pierce, S., Satoh, Y., Bhagwat, S. 

Phrase: "C., Motiwala,"

Phrase: "A.,"

Phrase: "Pierce,"

Phrase: "S."

Phrase: ","

Phrase: "Satoh,"

Phrase: "Y.,"

Phrase: "Bhagwat,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.548: S., Manning, A. 

Phrase: "S."

Phrase: ","

Phrase: "Manning,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0024554:MAN [Finding]
   966   C0025266:Man [Population Group]
   966   C0086418:Man [Human]

Phrase: "A."
Processing 00000000.tx.549: M., and Anderson, D. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Anderson,"

Phrase: "D."
Processing 00000000.tx.550: W. 

Phrase: "W."
Processing 00000000.tx.551: (2001) Proc. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.552: Natl. 

Phrase: "Natl."
Processing 00000000.tx.553: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.554: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.555: U. 

Phrase: "U."
Processing 00000000.tx.556: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.557: A. 

Phrase: "A."
Processing 00000000.tx.558: 98, 13681-13686[Abstract/Free FullText] Mirra, S. 

Phrase: "98,"

Phrase: "13681-13686"

Phrase: "[Abstract/Free FullText"

Phrase: "] Mirra,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.559: S., Heyman, A., McKeel, D., Sumi, S. 

Phrase: "S."

Phrase: ","

Phrase: "Heyman,"

Phrase: "A.,"

Phrase: "McKeel,"

Phrase: "D."

Phrase: ","

Phrase: "Sumi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.560: M., Brownlee, L. 

Phrase: "M."

Phrase: ","

Phrase: "Brownlee,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.561: M., Vogel, F. 

Phrase: "M."

Phrase: ","

Phrase: "Vogel,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.562: S., Hughes, J. 

Phrase: "S."

Phrase: ","

Phrase: "Hughes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551730:Hughes [Population Group]

Phrase: "J."
Processing 00000000.tx.563: P., Van Belle, G., and Berg, L. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Van Belle,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Berg,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.564: (1991) Neurology 41, 479-486[Abstract] Pugazhenthi, S., Nesterova, A., Sables, C., Heidenreich, K. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Neurology 41,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: "479-486"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Pugazhenthi,"

Phrase: "S."

Phrase: ","

Phrase: "Nesterova,"

Phrase: "A.,"

Phrase: "Sables,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325046:Sables [Mammal]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Heidenreich,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.565: A., Boxer, L. 

Phrase: "A.,"

Phrase: "Boxer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0324320:Boxer [Mammal]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.566: M., Heasley, L. 

Phrase: "M."

Phrase: ","

Phrase: "Heasley,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.567: E., and Reusch, J. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Reusch,"

Phrase: "J."
Processing 00000000.tx.568: E. 

Phrase: "E."
Processing 00000000.tx.569: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.570: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.571: Biol. 

Phrase: "Biol."
Processing 00000000.tx.572: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.573: 275, 10761-10766[Abstract/Free FullText] Mailliot, C., Bussiere, T., Hamdane, M., Sergeant, N., Caillet, M. 

Phrase: "275,"

Phrase: "10761-10766"

Phrase: "[Abstract/Free FullText"

Phrase: "] Mailliot,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Bussiere,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hamdane,"

Phrase: "M."

Phrase: ","

Phrase: "Sergeant,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Caillet,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.574: L., Delacourte, A., and Buee, L. 

Phrase: "L., Delacourte,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Buee,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.575: (2000) Ann. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.576: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.577: Y. 

Phrase: "Y."
Processing 00000000.tx.578: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.579: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.580: 920, 107-114[Abstract/Free FullText] Zheng-Fischhofer, Q., Biernat, J., Mandelkow, E. 

Phrase: "920,"

Phrase: "107-114"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zheng-Fischhofer,"

Phrase: "Q.,"

Phrase: "Biernat,"

Phrase: "J.,"

Phrase: "Mandelkow,"

Phrase: "E."
Processing 00000000.tx.581: M., Illenberger, S., Godemann, R., and Mandelkow, E. 

Phrase: "M."

Phrase: ","

Phrase: "Illenberger,"

Phrase: "S."

Phrase: ","

Phrase: "Godemann,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Mandelkow,"

Phrase: "E."
Processing 00000000.tx.582: (1998) Eur. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.583: J. 

Phrase: "J."
Processing 00000000.tx.584: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.585: 252, 542-552[Abstract] Goedert, M., Jakes, R., Crowther, R. 

Phrase: "252,"

Phrase: "542-552"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.586: A., Cohen, P., Vanmechelen, E., Vandermeeren, M., and Cras, P. 

Phrase: "A.,"

Phrase: "Cohen,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Vanmechelen,"

Phrase: "E.,"

Phrase: "Vandermeeren,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Cras,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.587: (1994) Biochem. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.588: J. 

Phrase: "J."
Processing 00000000.tx.589: 301, 871-877[Medline] [OrderarticleviaInfotrieve] Paudel, H. 

Phrase: "301,"

Phrase: "871-877"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Paudel,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.590: K., Lew, J., Ali, Z., and Wang, J. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lew,"

Phrase: "J.,"

Phrase: "Ali,"

Phrase: "Z.,"

Phrase: "and"

Phrase: "Wang,"

Phrase: "J."
Processing 00000000.tx.591: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.592: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.593: Biol. 

Phrase: "Biol."
Processing 00000000.tx.594: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.595: 268, 23512-23518[Abstract/Free FullText] Ksiezak-Reding, H., Pyo, H. 

Phrase: "268,"

Phrase: "23512-23518"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ksiezak-Reding,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Pyo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033809:Pyo [Bacterium]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.596: K., Feinstein, B., and Pasinetti, G. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Feinstein,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Pasinetti,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.597: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.598: (2003) Biochim. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Biochim."
Processing 00000000.tx.599: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.600: Acta 1639, 159-168[Medline] [OrderarticleviaInfotrieve] Allen, B., Ingram, E., Takao, M., Smith, M. 

Phrase: "Acta 1639,"

Phrase: "159-168"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Allen,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Ingram,"

Phrase: "E.,"

Phrase: "Takao,"

Phrase: "M."

Phrase: ","

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.601: J., Jakes, R., Virdee, K., Yoshida, H., Holzer, M., Craxton, M., Emson, P. 

Phrase: "J.,"

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Virdee,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Yoshida,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Holzer,"

Phrase: "M."

Phrase: ","

Phrase: "Craxton,"

Phrase: "M."

Phrase: ","

Phrase: "Emson,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.602: C., Atzori, C., Migheli, A., Crowther, R. 

Phrase: "C., Atzori,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Migheli,"

Phrase: "A.,"

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.603: A., Ghetti, B., Spillantini, M. 

Phrase: "A.,"

Phrase: "Ghetti,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.604: G., and Goedert, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.605: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.606: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.607: 22, 9340-9351[Abstract/Free FullText] Giannakopoulos, P., Herrmann, F. 

Phrase: "22,"

Phrase: "9340-9351"

Phrase: "[Abstract/Free FullText"

Phrase: "] Giannakopoulos,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Herrmann,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.608: R., Bussiere, T., Bouras, C., Kovari, E., Perl, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Bussiere,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Bouras,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Kovari,"

Phrase: "E.,"

Phrase: "Perl,"

Phrase: "D."
Processing 00000000.tx.609: P., Morrison, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Morrison,"

Phrase: "J."
Processing 00000000.tx.610: H., Gold, G., and Hof, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Gold,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018026:Gold [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1304897:Gold [Functional Concept]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Hof,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538150:HOF [Gene or Genome]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.611: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.612: (2003) Neurology 60, 1495-1500[Abstract/Free FullText] Takayama, N., Iseki, E., Yamamoto, T., and Kosaka, K. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Neurology 60,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: "1495-1500"

Phrase: "[Abstract/Free FullText"

Phrase: "] Takayama,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1491778:Takayama [Eukaryote]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Iseki,"

Phrase: "E.,"

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Kosaka,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.613: (2002) Neuropathology 22, 147-153[CrossRef][Medline] [OrderarticleviaInfotrieve] Fukutani, Y., Cairns, N. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Neuropathology 22,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0876934:Neuropathology [Biomedical Occupation or Discipline]
   861   C1540677:neuropathology [Pathologic Function]
   861   C1555824:Neuropathology [Intellectual Product]

Phrase: "147-153"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Fukutani,"

Phrase: "Y.,"

Phrase: "Cairns,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.614: J., Shiozawa, M., Sasaki, K., Sudo, S., Isaki, K., and Lantos, P. 

Phrase: "J.,"

Phrase: "Shiozawa,"

Phrase: "M."

Phrase: ","

Phrase: "Sasaki,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sudo,"

Phrase: "S."

Phrase: ","

Phrase: "Isaki,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Lantos,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.615: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.616: (2000) Psychiatry Clin. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Psychiatry"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0033872:Psychiatry [Professional or Occupational Group]
  1000   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   928 E C0205487:Psychiatric [Functional Concept]

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.617: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.618: 54, 523-529[CrossRef][Medline] [OrderarticleviaInfotrieve] Casanova, M. 

Phrase: "54,"

Phrase: "523-529"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Casanova,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.619: F., Carosella, N. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Carosella,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.620: W., Gold, J. 

Phrase: "W., Gold,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0018026:Gold [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1304897:Gold [Functional Concept]

Phrase: "J."
Processing 00000000.tx.621: M., Kleinman, J. 

Phrase: "M."

Phrase: ","

Phrase: "Kleinman,"

Phrase: "J."
Processing 00000000.tx.622: E., Weinberger, D. 

Phrase: "E.,"

Phrase: "Weinberger,"

Phrase: "D."
Processing 00000000.tx.623: R., and Powers, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Powers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032863:powers [Human-caused Phenomenon or Process]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.624: E. 

Phrase: "E."
Processing 00000000.tx.625: (1993) Psychiatry Res. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Psychiatry Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.626: 49, 41-62[CrossRef][Medline] [OrderarticleviaInfotrieve] Holzer, M., Gartner, U., Stobe, A., Hartig, W., Gruschka, H., Bruckner, M. 

Phrase: "49,"

Phrase: "41-62"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Holzer,"

Phrase: "M."

Phrase: ","

Phrase: "Gartner,"

Phrase: "U.,"

Phrase: "Stobe,"

Phrase: "A.,"

Phrase: "Hartig,"

Phrase: "W.,"

Phrase: "Gruschka,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Bruckner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.627: K., and Arendt, T. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Arendt,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.628: (2002) Acta Neuropathol. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Acta Neuropathol."
Processing 00000000.tx.629: 104, 471-481[Medline] [OrderarticleviaInfotrieve] Gamblin, T. 

Phrase: "104,"

Phrase: "471-481"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Gamblin,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.630: C., Berry, R. 

Phrase: "C., Berry,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005135:Berry [Food]
   861   C0982158:BERRY [Food]
   861   C3495134:BERRY [Organic Chemical,Pharmacologic Substance]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.631: W., and Binder, L. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Binder,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0179302:Binder [Medical Device]
  1000   C1706253:Binder [Biomedical or Dental Material]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.632: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.633: (2003) Biochemistry 42, 2252-2257[CrossRef][Medline] [OrderarticleviaInfotrieve] Tatebayashi, Y., Miyasaka, T., Chui, D. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Biochemistry 42,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "2252-2257"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Tatebayashi,"

Phrase: "Y.,"

Phrase: "Miyasaka,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Chui,"

Phrase: "D."
Processing 00000000.tx.634: H., Akagi, T., Mishima, K., Iwasaki, K., Fujiwara, M., Tanemura, K., Murayama, M., Ishiguro, K., Planel, E., Sato, S., Hashikawa, T., and Takashima, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Akagi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mishima,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Iwasaki,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Fujiwara,"

Phrase: "M."

Phrase: ","

Phrase: "Tanemura,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Murayama,"

Phrase: "M."

Phrase: ","

Phrase: "Ishiguro,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Planel,"

Phrase: "E.,"

Phrase: "Sato,"

Phrase: "S."

Phrase: ","

Phrase: "Hashikawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Takashima,"

Phrase: "A."
Processing 00000000.tx.635: (2002) Proc. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.636: Natl. 

Phrase: "Natl."
Processing 00000000.tx.637: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.638: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.639: U. 

Phrase: "U."
Processing 00000000.tx.640: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.641: A. 

Phrase: "A."
Processing 00000000.tx.642: 99, 13896-13901[Abstract/Free FullText] Tanemura, K., Akagi, T., Murayama, M., Kikuchi, N., Murayama, O., Hashikawa, T., Yoshiike, Y., Park, J. 

Phrase: "99,"

Phrase: "13896-13901"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tanemura,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Akagi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Murayama,"

Phrase: "M."

Phrase: ","

Phrase: "Kikuchi,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Murayama,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Hashikawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yoshiike,"

Phrase: "Y.,"

Phrase: "Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "J."
Processing 00000000.tx.643: M., Matsuda, K., Nakao, S., Sun, X., Sato, S., Yamaguchi, H., and Takashima, A. 

Phrase: "M."

Phrase: ","

Phrase: "Matsuda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Nakao,"

Phrase: "S."

Phrase: ","

Phrase: "Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "X.,"

Phrase: "Sato,"

Phrase: "S."

Phrase: ","

Phrase: "Yamaguchi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Takashima,"

Phrase: "A."
Processing 00000000.tx.644: (2001) Neurobiol. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.645: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.646: 8, 1036-1045[CrossRef][Medline] [OrderarticleviaInfotrieve] Lewis, J., Dickson, D. 

Phrase: "8,"

Phrase: "1036-1045"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lewis,"

Phrase: "J.,"

Phrase: "Dickson,"

Phrase: "D."
Processing 00000000.tx.647: W., Lin, W. 

Phrase: "W., Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0861352:LIN [Neoplastic Process]

Phrase: "W."
Processing 00000000.tx.648: L., Chisholm, L., Corral, A., Jones, G., Yen, S. 

Phrase: "L., Chisholm,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Corral,"

Phrase: "A.,"

Phrase: "Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443013:Jones [Intellectual Product]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Yen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555429:Yen [Quantitative Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.649: H., Sahara, N., Skipper, L., Yager, D., Eckman, C., Hardy, J., Hutton, M., and McGowan, E. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sahara,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205654:Sahara [Geographic Area]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Skipper,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Yager,"

Phrase: "D."

Phrase: ","

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "McGowan,"

Phrase: "E."
Processing 00000000.tx.650: (2001) Science 293, 1487-1491[Abstract/Free FullText] Cruz, J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Science 293,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1487-1491"

Phrase: "[Abstract/Free FullText"

Phrase: "] Cruz,"

Phrase: "J."
Processing 00000000.tx.651: C., Tseng, H. 

Phrase: "C., Tseng,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.652: C., Goldman, J. 

Phrase: "C., Goldman,"

Phrase: "J."
Processing 00000000.tx.653: A., Shih, H., and Tsai, L. 

Phrase: "A.,"

Phrase: "Shih,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Tsai,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.654: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.655: (2003) Neuron 40, 471-483[Medline] [OrderarticleviaInfotrieve] Tandon, A., Yu, H., Wang, L., Rogaeva, E., Sato, C., Chishti, M. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Neuron 40,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0027882:Neuron [Cell]
   861   C0439509:/40 [Temporal Concept]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "471-483"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Tandon,"

Phrase: "A.,"

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wang,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Rogaeva,"

Phrase: "E.,"

Phrase: "Sato,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Chishti,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.656: A., Kawarai, T., Hasegawa, H., Chen, F., Davies, P., Fraser, P. 

Phrase: "A.,"

Phrase: "Kawarai,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hasegawa,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Davies,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Fraser,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.657: E., Westaway, D., and St George-Hyslop, P. 

Phrase: "E.,"

Phrase: "Westaway,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "St George-Hyslop,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1553316:St. George [Population Group]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.658: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.659: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.660: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.661: 86, 572-581[CrossRef][Medline] [OrderarticleviaInfotrieve] Okazawa, H., and Estus, S. 

Phrase: "86,"

Phrase: "572-581"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Okazawa,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Estus,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.662: (2002) Am. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.663: J. 

Phrase: "J."
Processing 00000000.tx.664: Alzheimer's Dis. 

Phrase: "Alzheimer's Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0451119:DIS [Intellectual Product]
   861   C1444662:DIS [Finding]
Processing 00000000.tx.665: Other Dement. 

Phrase: "Other Dement."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0860630:dement [Mental or Behavioral Dysfunction]
   900 E C0011265:dementia [Mental or Behavioral Dysfunction]
   900 E C0497327:Dementia [Mental or Behavioral Dysfunction]
Processing 00000000.tx.666: 17, 79-88 Dou, F., Netzer, W. 

Phrase: "17,"

Phrase: "79-88 Dou,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Netzer,"

Phrase: "W."
Processing 00000000.tx.667: J., Tanemura, K., Li, F., Hartl, F. 

Phrase: "J.,"

Phrase: "Tanemura,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Hartl,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.668: U., Takashima, A., Gouras, G. 

Phrase: "U.,"

Phrase: "Takashima,"

Phrase: "A.,"

Phrase: "Gouras,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.669: K., Greengard, P., and Xu, H. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Greengard,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Xu,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.670: (2003) Proc. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.671: Natl. 

Phrase: "Natl."
Processing 00000000.tx.672: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.673: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.674: U. 

Phrase: "U."
Processing 00000000.tx.675: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.676: A. 

Phrase: "A."
Processing 00000000.tx.677: 100, 721-726[Abstract/Free FullText] Shimura, H., Miura-Shimura, Y., and Kosik, K. 

Phrase: "100,"

Phrase: "721-726"

Phrase: "[Abstract/Free FullText"

Phrase: "] Shimura,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Miura-Shimura,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Kosik,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.678: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.679: (2004) J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.680: Biol. 

Phrase: "Biol."
Processing 00000000.tx.681: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.682: 279, 17957-17962[Abstract/Free FullText] Petrucelli, L., Dickson, D., Kehoe, K., Taylor, J., Snyder, H., Grover, A., De Lucia, M., McGowan, E., Lewis, J., Prihar, G., Kim, J., Dillmann, W. 

Phrase: "279,"

Phrase: "17957-17962"

Phrase: "[Abstract/Free FullText"

Phrase: "] Petrucelli,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Dickson,"

Phrase: "D."

Phrase: ","

Phrase: "Kehoe,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Taylor,"

Phrase: "J.,"

Phrase: "Snyder,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Grover,"

Phrase: "A.,"

Phrase: "De Lucia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1214637:Lucia [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "McGowan,"

Phrase: "E.,"

Phrase: "Lewis,"

Phrase: "J.,"

Phrase: "Prihar,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Kim,"

Phrase: "J.,"

Phrase: "Dillmann,"

Phrase: "W."
Processing 00000000.tx.683: H., Browne, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Browne,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.684: E., Hall, A., Voellmy, R., Tsuboi, Y., Dawson, T. 

Phrase: "E.,"

Phrase: "Hall,"

Phrase: "A.,"

Phrase: "Voellmy,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Tsuboi,"

Phrase: "Y.,"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.685: M., Wolozin, B., Hardy, J., Hutton, M. 

Phrase: "M."

Phrase: ","

Phrase: "Wolozin,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Hutton,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.686: (2004) Hum. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Hum."
Processing 00000000.tx.687: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.688: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.689: 13, 703-714[Abstract/Free FullText] Shimura, H., Schwartz, D., Gygi, S. 

Phrase: "13,"

Phrase: "703-714"

Phrase: "[Abstract/Free FullText"

Phrase: "] Shimura,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Schwartz,"

Phrase: "D."

Phrase: ","

Phrase: "Gygi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.690: P., and Kosik, K. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Kosik,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.691: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.692: (2004) J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.693: Biol. 

Phrase: "Biol."
Processing 00000000.tx.694: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.695: 279, 4869-4876[Abstract/Free FullText] Lu, P. 

Phrase: "279,"

Phrase: "4869-4876"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024171:LU [Body System]
  1000   C0024176:LU [Geographic Area]
  1000   C2697939:LU [Quantitative Concept]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.696: J., Wulf, G., Zhou, X. 

Phrase: "J.,"

Phrase: "Wulf,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Zhou,"

Phrase: "X."
Processing 00000000.tx.697: Z., Davies, P., and Lu, K. 

Phrase: "Z.,"

Phrase: "Davies,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024171:LU [Body System]
  1000   C0024176:LU [Geographic Area]
  1000   C2697939:LU [Quantitative Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.698: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.699: (1999) Nature 399, 784-788[CrossRef][Medline] [OrderarticleviaInfotrieve] Liou, Y. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nature 399,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "784-788"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Liou,"

Phrase: "Y."
Processing 00000000.tx.700: C., Sun, A., Ryo, A., Zhou, X. 

Phrase: "C., Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038817:Sun [Natural Phenomenon or Process]
   861   C0376223:Sun [Geographic Area]

Phrase: "A.,"

Phrase: "Ryo,"

Phrase: "A.,"

Phrase: "Zhou,"

Phrase: "X."
Processing 00000000.tx.701: Z., Yu, Z. 

Phrase: "Z.,"

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "Z."
Processing 00000000.tx.702: X., Huang, H. 

Phrase: "X.,"

Phrase: "Huang,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.703: K., Uchida, T., Bronson, R., Bing, G., Li, X., Hunter, T., and Lu, K. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Uchida,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Bronson,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Bing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596170:bing [Mental or Behavioral Dysfunction]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "X.,"

Phrase: "Hunter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239971:HUNTER [Professional or Occupational Group]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024171:LU [Body System]
  1000   C0024176:LU [Geographic Area]
  1000   C2697939:LU [Quantitative Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.704: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.705: (2003) Nature 424, 556-561[CrossRef][Medline] [OrderarticleviaInfotrieve] Lew, G. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Nature 424,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "556-561"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lew,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.706: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.707: (1993) Gen. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Gen."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704351:GEN [Quantitative Concept]
  1000   C2239486:Gen [Gene or Genome]
Processing 00000000.tx.708: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.709: 24, 1383-1386[Medline] [OrderarticleviaInfotrieve] Ma, Z. 

Phrase: "24,"

Phrase: "1383-1386"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ma,"

Phrase: "Z."
Processing 00000000.tx.710: Q., Spreafico, E., Pollio, G., Santagati, S., Conti, E., Cattaneo, E., and Maggi, A. 

Phrase: "Q., Spreafico,"

Phrase: "E.,"

Phrase: "Pollio,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Santagati,"

Phrase: "S."

Phrase: ","

Phrase: "Conti,"

Phrase: "E.,"

Phrase: "Cattaneo,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Maggi,"

Phrase: "A."
Processing 00000000.tx.711: (1993) Proc. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.712: Natl. 

Phrase: "Natl."
Processing 00000000.tx.713: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.714: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.715: U. 

Phrase: "U."
Processing 00000000.tx.716: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.717: A. 

Phrase: "A."
Processing 00000000.tx.718: 90, 3740-3744[Abstract] Reyna-Neyra, A., Camacho-Arroyo, I., Ferrera, P., and Arias, C. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "3740-3744"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Reyna-Neyra,"

Phrase: "A.,"

Phrase: "Camacho-Arroyo,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Ferrera,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Arias,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006301:Aria [Plant]

Phrase: "C."
Processing 00000000.tx.719: (2002) Brain Res. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.720: Bull. 

Phrase: "Bull."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007452:Bull [Mammal]
Processing 00000000.tx.721: 58, 607-612[CrossRef][Medline] [OrderarticleviaInfotrieve] Ramakrishnan, P., Dickson, D. 

Phrase: "58,"

Phrase: "607-612"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ramakrishnan,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Dickson,"

Phrase: "D."
Processing 00000000.tx.722: W., and Davies, P. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Davies,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.723: (2003) Neurobiol. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.724: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.725: 14, 251-264[CrossRef][Medline] [OrderarticleviaInfotrieve]

Phrase: "14,"

Phrase: "251-264"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]"

